The C. elegans RAS/MAPK and WNT signalling pathways are modified by polymorphic genes and molecular oxygen by Maxeiner, Sabrina
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2018
The C. elegans RAS/MAPK and WNT signalling pathways are modified by
polymorphic genes and molecular oxygen
Maxeiner, Sabrina
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-152759
Dissertation
Published Version
Originally published at:
Maxeiner, Sabrina. The C. elegans RAS/MAPK and WNT signalling pathways are modified by poly-
morphic genes and molecular oxygen. 2018, University of Zurich, Mathematisch-naturwissenschaftliche
Fakultät.
Dissertation
zur
Erlangung der naturwissenschaftlichen Doktorwürde 
(Dr. sc. nat.)
vorgelegt der 
Mathematisch-naturwissenschaftlichen Fakultät 
der 
Universität Zürich
von
Sabrina Maxeiner
aus
Buchs ZH
Promotionskommission
Prof. Dr. Alex Hajnal (Vorsitz)
Prof. Dr. Konrad Basler
Prof. Dr. Jan Kammenga
Prof. Dr. Beatrice Beck-Schimmer
Zürich, 2018
The C. elegans RAS/MAPK and WNT Signalling 
Pathways are Modified by Polymorphic 
Genes and Molecular Oxygen

iii
Die weltweit zweithäufigste menschliche Todesursache ist Krebs. Während fundamentale Sig-
naltransduktionswege wie z.B. WNT, RAS/MAPK und NOTCH in direkten Zusammenhang mit 
der Krankheit gebracht wurden, ist die Beschreibung von mitwirkenden Modifikatoren erst in den 
Kinderschuhen. Modifikatoren (Risikofaktoren) haben alleine kleine Effekte, die allerdings quan-
titativ den Ausgang einer Krankheit beeinflussen und daher vielversprechende therapeutische 
Angriffspunkte darstellen. Obwohl genomweite Assoziationsstudien (GWAS) zur Identifikation 
von Risikofaktoren beigetragen haben, sind sie eingeschränkt durch limitierte Stichproben. Wir 
haben C. elegans als Model verwendet, um solche Modifikatoren zu identifizieren, da genetisch 
unterschiedliche Wildisolate existieren und fehlerhafte WNT, RAS/MAPK und NOTCH Signalak-
tivität auffällige phänotypische Veränderungen mit sich bringt, besonders während der Entwick-
lung der Vulva. 
In unserer Studie haben wir CB4856 / N2 Inzuchtlinien benutzt, die wir mit einer Funktionsver-
lustmutation in ß-catenin oder einer Funktionsgewinnmutation in RAS genetisch sensibilisiert 
hatten. Mit diesen Linien verifizierten wir eine zuvor vermutete Region quantitativer Merkmale 
(engl. QTL) für RAS/MAPK Signalaktivität auf dem ersten Chromosom und schränkten diese 
positionell ein (QTL1a). Des Weiteren verifizierten wir eine Region quantitativer Merkmale, eben-
falls auf dem ersten Chromosom, für WNT Signalaktivität und unterteilten diese in zwei kleinere 
Regionen, nachdem die eingekreuzte DNA Sequenz rekombiniert hatte (QTL1A und QTL1B). In 
einem ersten Projekt haben wir durch RNA Interferenz innerhalb von QTL1B und QTL1a gene-
relle Modifikatoren sowie Risikofaktoren spezifisch für den genetischen Hintergrund gefunden, 
die wir noch nicht weiter charakterisiert haben. In einem zweiten Projekt haben wir den Zu-
sammenhang zwischen polymorphen Kandidatengenen und assoziierten zellulären Signalwe-
gen der vorgängig beschriebenen QTL1b Region mit dem RAS/MAPK Signaltransduktionsweg 
charakterisiert. Zwei Gene interessierten uns besonders: pfd-3 ist ein Ortholog von VHL binding 
protein 1 und F44F1.1 ist ein Paralog eines vermuteten Calpains. Beide Gene supprimieren 
den Eiablagedefekt in egl-9 Mutanten. Dies impliziert eine Verbindung zum stark konservierten 
Hypoxiereaktionsweg, der durch die C. elegans Gene hif-1, egl-9 und vhl-1 kodiert und durch 
Sauerstoff reguliert wird. Wir haben die aktivierende G13E Mutation in das RAS Wurmgen let-60 
von CB4856 und N2 eingefügt und entdeckten, dass starke Hypoxie (0.5% O2) die RAS/MAPK 
Signalaktivität in der Vulva ungeachtet des genetischen Hintergrundes auf dasselbe Niveau 
supprimierte, wohingegen milde Hypoxie (> 0.5% O2) keinen Effekt zeigte. Dieses Resultat war 
erstaunlich, da CB4856 einen höheren Level an RAS/MAPK Grundsignalaktivität besitzt und 
deutet auf eine genetische Komponente hin, die Sauerstoff in Verbindung setzt mit RAS/MAPK 
und darüber hinaus die natürliche Differenz in der RAS/MAPK Signalstärke eliminiert. Tatsäch-
lich entdeckten wir, dass der Verlust von VHL-1 oder EGL-9 die RAS/MAPK Signalaktivität von 
let-60(n1046) Mutanten verringerte, während ein Funktionsverlust von HIF-1 die Signalaktivität 
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erhöhte. Zusätzlich zeigen wir, dass Hypoxie die RAS/MAPK Signalaktivität auch in der exkreto-
rischen Kanalzelle und der Keimbahn inhibiert, wobei der hypoxische Effekt im letzteren Gewebe 
HIF-1 abhängig zu sein scheint. Dem gegenüber gestellt ist der hypoxische Effekt in der Vulva 
unabhängig von HIF-1 und benötigt stattdessen wahrscheinlich Serotonin. Unter normoxischen 
Bedingungen ist der inhibitorische Effekt durch HIF-1 auf RAS/MAPK Signalaktivität gewebs-
spezifisch und abhängig von dem HIF-1 Zielgen NHR-57, das in den ventralen Pn.p Zellen inklu-
sive der vulva-spezifischen Vorläuferzellen exprimiert ist, allerdings am markantesten in jenen Pn.p 
Zellen, die keine Vulva formen können. Zuletzt zeigen wir, dass das HIF-1 Hydroxylase-Protein 
EGL-9 ein Zielgen des NOTCH Signalweges ist und schlagen ein Szenario vor, in dem EGL-9 
mit NHR-57 konkurriert, um vulva-spezifische Kompetenz aufrecht zu erhalten. Unsere Resultate 
decken einen neuen Mechanismus auf, durch den die RAS/MAPK und NOTCH Signaltransduk-
tionswege die Umweltkomponente Sauerstoff integrieren um die Festlegung von Zellschicksa-
len zu kontrollieren.   
vThe worldwide second leading cause of human death is cancer. Fundamental signalling pathways 
such as WNT, RAS/MAPK and NOTCH have been linked to the disease, however the description 
of contributing genetic modifiers is only at the beginning. Modifiers (risk factors or susceptibility 
genes) have small effects on their own but quantitatively change disease outcome and are thus 
promising therapeutic targets. Genome-wide association studies (GWAS) have helped in identify-
ing risk factors but are limited by sample number. We have used C. elegans as a model to identify 
such modifiers, since genetically divergent wild isolates exist and erroneous WNT, RAS/MAPK 
and NOTCH signalling pathway activity causes easily discernible phenotypic outcomes, especially 
during vulval development.  
By using CB4856 / N2 introgression lines genetically sensitised with a ß-catenin(lf) or RAS(gf) 
mutation, we verified and spatially refined a previously identified quantitative trait locus (QTL) for 
RAS/MAPK signalling on LG I (QTL1a) and another QTL on LG I for WNT signalling, which we sub-
divided into two smaller QTLs upon recombination in the introgression (QTL1A and QTL1B). In a 
first project, we identified general as well as isolate-specific candidate modifiers within QTL1B and 
QTL1a by RNAi that await further characterisation. Secondly, we characterised the connection of 
polymorphic candidates within the previously described QTL1b and associated cellular pathways 
with RAS/MAPK signalling. Two genes in the QTL1b region attracted our attention: pfd-3 is an 
ortholog of VHL binding protein 1 and F44F1.1 is a paralog of a probable calpain. Both were descri-
bed to suppress the egl-9 mutant phenotype. This suggests a link to the highly conserved hypoxia 
response pathway, which is encoded by the worm hif-1, egl-9 and vhl-1 genes. We introduced into 
the CB4856 and N2 wild strains the activating G13E mutation in the worm RAS gene let-60 and 
found that severe hypoxia (0.5% O2) suppressed RAS/MAPK activity in the vulva to equal levels 
irrespective of the genetic background, whereas mild hypoxia (> 0.5% O2) had no effect. This 
was striking, since CB4856 inherently exhibits higher ground RAS/MAPK levels and suggests a 
genetic component that links oxygen sensing to RAS/MAPK signalling. Indeed, we found that a 
loss of VHL-1 or EGL-9 reduces whereas a loss in HIF-1 function increases RAS/MAPK signalling 
strength in let-60(gf) mutants. We further show that hypoxia inhibits RAS/MAPK activity in the duct 
cell and the germline. In the latter tissue, the hypoxic effect is completely HIF-1 dependent while it 
appears to be partially HIF-1 independent and regulated through serotonin in the vulva. In normoxic 
conditions, the inhibitory effect of HIF-1 on RAS/MAPK activity in the vulva is cell autonomous and 
depends on the HIF-1 target gene NHR-57. Interestingly, NHR-57 is expressed in the ventral Pn.p 
cells including the vulval precursor cells (VPCs), but expression is most prominent in those VPCs 
that are incompetent of forming the vulva. Finally, we show that the HIF-1 hydroxylase EGL-9 is a 
target of the NOTCH pathway. We propose a competition between NOTCH signalling and NHR-57 
to maintain the VPCs competent to differentiate. Our findings reveal a novel mechanism, by which 
the RAS/MAPK and NOTCH pathways integrate oxygen in order to control cell fate specification. 
SUMMARY
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1Caenorhabditis elegans is a small, free-living, non-parasitic nematode that primarily inhabits soil 
(Altun and Hall 2009). It feeds on bacteria and develops through four larval stages until it reaches 
adulthood and a length of approximately 1 mm (Fig. 1.1A). Each larval stage is terminated by a 
moulting event and is accompanied by an increase in size. If the worm encounters food shortage, 
overcrowding or inadequate temperature, it can enter an alternative L3 stage as a dauer larva 
(Golden and Riddle 1982). The dauer larvae arrest in development and can endure for several 
months until the situation improves. 
The predominant sex of C. elegans is the hermaphrodite, although males exist at a frequency 
of 0.1% and can arise from spontaneous nondisjunction of the X chromosome or after a herm-
aphrodite has mated with a male (Fig. 1.1B). Hermaphrodites self-fertilise by producing sperm 
and eggs in a sequential manner, thus a population can arise from a single worm and is clonal 
(Herman 2005). One hermaphrodite can produce approximately 300 offspring during its life – a 
highly appreciated fact among geneticists.
The wild-type (wt) strain of C. elegans, N2, was isolated in Bristol, England, and established as a 
model organism in 1965 by Sydney Brenner (Brenner 1974). It has since gained in popularity in 
studies on behaviour, developmental and cell biology due to several key aspects. These include 
its short life cycle of only 3.5 days, a large number of progeny, small size, transparency, a small 
genome of which the sequence was known by 1998 (The C. elegans Sequencing Consortium 
1998), its convenience of cultivation in the laboratory, where it feeds on E. coli OP50 seeded 
on agar plates, the simplicity of applying RNAi by feeding (Timmons and Fire 1998) as well as 
its invariant cell lineage, a feature known as eutely (Martini 1923). Sydney Brenner, H. Robert 
Horvitz and John E. Sulston received the Nobel Prize for Physiology and Medicine in 2002 for 
their work on describing the cell lineage: Hermaphrodites consist of 959 somatic cells (131 of 
originally 1090 cells die by apoptosis) and males comprise 1031 somatic cells (Sulston and 
Horvitz 1977; Sulston et al. 1983).
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Figure 1.1. Schematic representation of the C. elegans life cycle and sexes. (A) The worm passes four 
larval stages before it reaches adulthood. An alternative L2 dauer stage allows endurance in unfavoura-
ble environmental conditions. Each larval stage is terminated by a moulting event and accompanied by 
an increase in size. At 20 °C, one life cycle is completed after approximately three days. (B) C. elegans 
males are slightly smaller (top) than hermaphrodites (bottom). Males have only one gonad arm to exclusi-
vely produce sperm whereas hermaphrodites produce oocytes and sperm sequentially and in two gonad 
arms. The vulva of the hermaphrodite serves as the egg-laying and mating organ. Figures adaptes from 
WormAtlas.
In addition to the wild-type N2 strain, genetically divergent isolates were collected for develop-
mental, evolutionary or population studies (Wicks et al. 2001; Thompson et al. 2015): CB4857 
from mushrooms in Claremont (California), RC301 from compost in the Botanical Garden of Frei-
burg (Germany), CB4856 from a pineapple field in Hawaii and AB2 from soil in Adelaide (Austra-
lia) (Hodgkin 1993) to name only a few. The CB4856 strain is one of the most divergent isolates 
from N2 with 3.3 Mb of N2 sequence absent in CB4856 and 1.4 Mb CB4856 sequence not pre-
sent in N2 (Thompson et al. 2015) which demonstrates the power of employing C. elegans wild 
isolates to study natural variation and quantitative traits (de Bono and Bargmann 1998; Jansen 
and Nap 2001; Li et al. 2006; Palopoli et al. 2008; McGrath et al. 2009; Ghosh et al. 2012). 
3Vulval development
The formation of the C. elegans hermaphrodite vulva is an excellent tool to study organogene-
sis, signal transduction and a network of intercellular signalling pathways including epidermal 
growth factor (EGF) signalling, Notch mediated lateral signalling and WNT signalling (Sternberg 
and Horvitz 1986; Kornfeld 1997). The vulva is the worm’s organ for egg-laying and copulation 
with males and connects the uterus to the environment (Kornfeld 1997). Aberrant signalling is 
easily visible, as the vulva is wrongly or not formed. It is built up of only 22 polarised ventral 
epidermal cells. The development of the organ starts in the early L1 larva, when twelve ventral 
neuroectoblasts P1 - P12 divide and give rise to anterior neurons or glia cells (Pn.a) and pos-
terior Pn.p cells, of which six (P3.p - P8.p) will form the vulval precursor cell (VPC) equivalence 
group (Sulston and Horvitz 1977) (Fig. 1.2). The remaining posterior daughters P1.p, P2.p and 
P9.p - P12.p fuse with hyp7, the syncytial hypodermis. P3.p fuses with the hypodermis in 50% 
of the cases (Sulston and White 1980).
1.2 Vulval development
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Figure 1.2. Development of the C. elegans hermaphrodite vulva. (A) Only six of the twelve ventral epi-
dermal cells make up the vulval competence group that is defined by the presence of LIN-39 and BAR-1 
(light blue). (B) Consecutive and interconnected inductive LIN-3/EGF and lateral LIN-12/NOTCH signalling 
during the L2 and early L3 stages determine the pattern cell fate acquisition and subsequent cell division. 
P6.p adopts the 1° cell fate and generates eight descendants, while P5.p and P7.p acquire the 2° cell fate 
and give rise to seven descendants each. P3.p, P4.p and P8.p fuse to the hypodermal syncytium hyp7 as 
uninduced 3° VPCs after one round of cell division.
1.2.1 WNT signalling establishes the vulval fate and cell polarity
The VPCs, P3.p - P8.p, are specified via lin-39, a Hox gene preventing the fusion of the VPCs to 
hyp7 and conferring vulval cell fate competence (Clark et al. 1993) (Fig. 1.2A). WNT signalling is 
necessary to maintain lin-39 expression in P3.p - P8.p (Eisenmann et al. 1998). Compromising 
mutations in ß-catenin (bar-1) or Wntless (mig-14) cause too few cells to adopt a vulval cell fate 
and an underinduced phenotype (Eisenmann and Kim 2000; Bänziger et al. 2006). As opposed 
to vertebrates or Drosophila, the function of ß-catenin in cell adhesion, non-canonical signal-
ling and canonical signalling is separated onto the three C. elegans ß-catenin genes, hmp-2 
(Natarajan et al. 2001), wrm-1 (Korswagen et al. 2000) and bar-1 (Eisenmann et al. 1998). A 
fourth ß-catenin, SYS-1, regulates asymmetric cell divisions in the early embryo in a variant of 
canonical signalling (Miskowski et al. 2001). Presumably, several rather than one single WNT 
ligand and receptor mediate WNT signalling in the vulva (Gleason et al. 2006). The C. elegans 
genome encodes five WNT ligands (lin-44, egl-20, mom-2, cwn-1 and cwn-2) (Shackleford et 
al. 1993; Herman et al. 1995; Rocheleau et al. 1997; Thorpe et al. 1997; Maloof et al. 1999), 
four Frizzled related WNT receptors (lin-17, mom-5, mig-1 and cfz-2) (Sawa et al. 1996; Ro-
cheleau et al. 1997; Ruvkun and Hobert 1998) and one Ryk/Derailed related WNT receptor 
(lin-18) (Inoue et al. 2004) and defects in VPC specification can be observed only if several 
ligand and/or receptor genes are mutated (Gleason et al. 2006). The C. elegans WNT, Axin, 
APC, CK1, GSK-3ß and TCF homologues mig-14 (Thorpe et al. 1997), pry-1 (Korswagen 
2002), apr-1 (Rocheleau et al. 1997), kin-19 (Peters et al. 1999), gsk-3 (Schlesinger et al. 
1999) and pop-1 (Rocheleau et al. 1997) contribute to vulval development, indicating that 
a canonical WNT pathway is active in the VPCs (Gleason et al. 2002). In animals mutant for 
pry-1, apr-1, kin-19 or gsk-3 P3.p, P4.p and P8.p can adopt a vulval cell fate (Gleason et al. 
2002). Conversely, loss of POP-1 can suppress this overinduced phenotype. 
In addition to the role in vulval fate specification, WNT signalling is involved in patterning the 
fates of the P6.p descendants VulE and VulF into vulE-vulF-vulF-vulE (anterior to posterior) 
(Wang and Sternberg 2000) and establishing a mirrored polarity of P7.p in respect to P5.p 
(Kornfeld 1997; Inoue et al. 2004). Mutant animals exhibiting the default polarity of P7.p often 
display a reversal of the vulval lineage, which results in an additional invagination posterior to 
the main vulva (also known as “Bivulva”) (Green et al. 2008).
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1.2.2 EGFR/RAS/MAPK and DELTA/NOTCH activity confer 1° and 2° cell fates
During the L2 stage, the gonadal anchor cell (AC) residing above the VPCs and closest to 
P6.p secretes the inductive LIN-3/EGF signal in a graded manner (Kornfeld 1997) (Fig. 1.2B). 
LET-23/EGFR is present on the basolateral membrane of the VPCs, receives LIN-3/EGF and 
activates a downstream RAS/MAPK cascade that involves LET-60/RAS (Han and Sternberg 
1990), LIN-45/BRAF (Han et al. 1993), MEK-2/MEK (Church et al. 1995) and MPK-1/ERK 
(Lackner et al. 1994; Sundaram et al. 1996; Tan and Kim 1999; Moghal and Sternberg 2003). 
The cascade is strongest in P6.p and confers the 1° cell fate (Yoo et al. 2004). LIN-1, an ETS 
family transcription factor, is a target of the RAS/MAPK cascade and inhibitor of vulval induction 
(Beitel et al. 1995). LIN-1 forms a complex with LIN-31 which is disrupted by phosphorylation of 
MPK-1/ERK and the loss of LIN-1 results in a highly penetrant and strong Multivulva (Muv) phe-
notype (Tan et al. 1998). Another target of the cascade is egl-17/FGF which guides the migration 
of sex myoblast precursors during the formation of the vulval and uterine muscles via another 
RAS/MAPK cascade downstream of EGL-15/FGFR (Sundaram et al. 1996; Burdine et al. 1998). 
Positive factors of the cascade include SUR-2, EOR-1, LIN-25 and EOR-2 (Tuck and Greenwald 
1995; Singh and Han 1995; Howard 2002).
RAS/MAPK signalling in P6.p leads to the expression of the NOTCH transmembrane ligands 
apx-1 and lag-2 and the secreted ligand dsl-1 and the activation of LIN-12/NOTCH in P5.p and 
P7.p to confer the 2° and inhibit the 1° cell fate (Greenwald et al. 1983; Chen and Greenwald 
2004). The low dose of both LIN-3/EGF and LIN-12/NOTCH signal that is received by P3.p, P4.p 
and P8.p results in these cells adopting the uninduced 3° cell fate and fusing to hyp7 after one 
cell division (Sternberg and Horvitz 1986). Extensive coupling and crosstalk between LET-23/EGFR 
and LIN-12/NOTCH signalling ensures such an invariable 3°-3°-2°-1°-2°-3° cell fate patterning (Berset 
et al. 2001; Yoo et al. 2004). LET-23/EGFR activation leads not only to the adoption of the 1° cell fate 
but also to the endocytosis and downregulation of LIN-12/NOTCH in the same cell, P6.p (Shaye and 
Greenwald 2002), and to the upregulation of lateral inhibitory signals to prevent the neighbouring 
P5.p and P7.p from adopting the 1° cell fate (Sternberg 1988). Vice versa, the MAPK phospha-
tase lip-1, dpy-23 and the lst-1, -2, -3 and -4 genes are targets of LIN-12/NOTCH and inhibit 
RAS/MAPK signalling in P5.p and P7.p (Berset et al. 2001; Yoo et al. 2004).
1.2.3 Morphogenetic events complete the vulva
During the L3 and L4 stages, 1° and 2° cells divide three times to give rise to the 22 vulval 
cells (Kornfeld 1997). The 1° cell lineage generates vulE and vulF cells in a mirror symmetrical 
fashion (E-F-F-E) around the AC (Sharma-Kishore et al. 1999), which is dependent on WNT 
and RAS/MAPK signalling (Inoue et al. 2004) (see 1.2.1, 1.2.2). The 2° fate cells produce a 
symmetrical patterning of vulA, vulB1, vulB2, vulC and vulD (ABCD and DCBA) due to a WNT 
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signal from the AC. The vulval muscles vm1 innervate between vulE and vulF cells, whereas the 
vm2 muscles insert between the vulC and vulD cells to provide the musculature for egg-laying 
(Burdine et al. 1998; Sharma-Kishore et al. 1999). The vulF cells express LIN-3/EGF to activa-
te RAS/MAPK in the future uv1 cell and establish the vulval-uterine connection (Chang et al. 
1999) (see also 1.4.4). The vulval cells move towards the AC, which breaks down the basement 
membrane between the gonad and the developing vulva to invade between the two vulF cells 
(Sherwood and Sternberg 2003). The seven types of vulval cells fuse pair-wise to build toroids 
(Sharma-Kishore et al. 1999). The formation of the hermaphrodite vulva is completed during the 
L4-to-adult moult by eversion.
1.2.4 Vulval induction index as a readout for signalling strength
During wt vulval development, P3.p to P8.p divide once during the L3 stage and prior to induction 
by LIN-3/EGF, with P3.p dividing only in 50% of the cases (Sulston and White 1980; Kornfeld 
1997) (Fig. 1.3A). In response to LIN-3/EGF, P5.p, P6.p and P7.p divide three more times to give 
rise to eight (P6.p) or seven daughter cells (P5.p and P7.p) (Kornfeld 1997), hence three VPCs 
became induced which determines a vulval induction index (VI) of three (Fig. 1.3). In cases of 
enhanced signalling activity, e.g. as a result of let-60/RAS gain-of-function or pry-1/Axin loss-
of-function mutations, P3.p, P4.p or P8.p can be induced and cause excessive invaginations 
(Fig. 1.3B, middle). This Muv phenotype is caused by ectopically dividing VPCs and can increa-
se the VI to a maximum of six, if all VPCs are fully induced. If only one Pn.px of a VPC divides, it 
is counted as half induction (0.5). Conversely, the reduced signalling strength in bar-1/ß-catenin 
or let-23/EGFR mutant animals leads to too few induced cells and a Vulvaless (Vul) phenotype 
with a VI below three and minimally 0 (Fig. 1.3B, bottom). To determine the VI, the cells within the 
invaginations and the undivided Pn.p cells are counted while scanning the worm from the tail, since 
P3.p can sometimes fuse with the hypodermis prior to the Pn.px stage (Sulston and Horvitz 1977).
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Figure 1.3. Vulval induction index. (A, top) Each VPC divides once prior to induction by LIN-3/EGF to pro-
duce two daughter cells. Upon induction, each daughter cell can be induced independently. Induction of 
one daughter cell results in only this cell dividing whereas its sister does not undergo division and a VI of 
0.5 is determined for a given VPC. A full induction is counted if both daughter cells of a VPC have divided. 
(A, bottom) Example VIs of wild-type (= 3), Multivulva (> 3) and Vulvaless (< 3) phenotypes. The VI ranges 
between one to six induced VPCs. Nomarski images in (B) show the situation depicted schematically in 
(A, bottom). The bars indicate invaginations formed by induced VPCs and the triangles indicate uninduced, 
undivided VPCs. The scale bar indicates 10 μm.
1.2.5 Robustness of the system
In wild-type animals, the 3°-3°-2°-1°-2°-3° vulval fate patterning is invariant (Félix and Barkoulas 
2012). This robustness is achieved by redundancy and extensive crosstalk between the EGFR/
RAS/MAPK, Notch and WNT pathways and ensures that naturally occurring stochastic fluctuations 
are buffered and do not result in visible phenotypes (Gleason et al. 2002; Yoo et al. 2004; Gleason 
et al. 2006). The intrinsic variability and contributing factors have been and are being described in 
detail to understand how such a simple cellular system can deal with and interpret natural fluctuati-
on to generate a solid functional unit (van Zon et al. 2015; Huelsz-Prince and van Zon 2017). 
Due to this robustness, the identification of regulators is only possible in combination with sen-
sitising mutations in core pathway members that challenge the balanced system to an extent 
sufficient to reveal minor changes in signalling phenotypically. The terms „regulator“, „modifier“ 
and „fine-tuning“ underscore the nature of such candidates: A defect in a regulating gene does not 
necessarily cause a phenotype but can enhance or suppress a sensitising mutation. One example 
is one of the worms GTPase activating proteins, GAP-1, which turns LET-60/RAS into its inactive 
form during vulval development (Hajnal et al. 1997). A mutation in gap-1 does not cause a Muv by 
itself but can enhance overactivated and rescue compromised RAS/MAPK signalling. Robustness 
is further exemplified by the lack of phenotypes in single mutants for sli-1 (c-Cbl) (Yoon et al. 1995), 
sra-13 (Battu et al. 2003), unc-101 and apm-1 (medium chains of adaptin) (Lee et al. 1994; Jaegal 
Shim 2000) or for genes of one of two classes containing so called synMuv genes (Ferguson and 
Horvitz 1989). These genes cause a Muv when combined with further defective regulators or en-
hance the outcome of a sensitising mutation. Apart from genetic influences, the environment contri-
butes strongly to variation. A Vul can be partially suppressed when worms had been starved, gone 
through dauer or cultivated in liquid medium instead of NGM plates (Horvitz and Ferguson 1985; 
Moghal et al. 2003). Our lab has further observed that vulval induction of mutants carrying overac-
tivated RAS is reduced on crowded NGM plates and variable in terms of the type of food source 
provided (I. Nakdimon, doctoral thesis). Finally, Zn ions inhibit RAS/MAPK signalling strength in 
a sensitised setting (Bruinsma et al. 2002; Yoder et al. 2003) as does the serotonin metabolite 
5-HIAA (Schmid et al. 2015). Thus, although biological systems are highly robust against changes, 
fluctuations can become visible under certain conditions and can even cause profoundly different 
outcomes – a fact that is frequently underestimated but just as important. 
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1.2.6 Inequality in the vulval competence group
The vulval competence group that comprises P3.p to P8.p is often referred to as “vulval equiva-
lence group” as all the Pn.p cells are able to adopt 1°, 2° or 3° cell fates as shown by ablation 
experiments (Sternberg and Horvitz 1986). However, this notion is not entirely correct as the 
following findings suggest. The homeodomain transcription factor, mab-5, which is related to 
the Antennapedia, Ultrabithorax and abdominal-A family of homeodomain genes, is expressed 
in P7.p and P8.p where it reduces the sensitivity to inductive LIN-3/EGF signalling (Salser et 
al. 1993; Clandinin et al. 1997). Expression of another homeodomain protein LIN-39 in all the 
VPCs is promoted by WNT and RAS/MAPK signalling and confers a vulval fate and sensitivity 
to inductive signalling (Eisenmann et al. 1998; Maloof et al. 1999). Moreover, the zinc-finger 
protein SEM-4 is present in the VPCs with strongest expression in P7.p and acts in concert with 
LIN-39 to specify vulval cell fates (Grant et al. 2000). Finally, Gleason et al. (2006) found defects 
especially in the adoption of anterior vulval fates if they combined mutations in three WNT ligan-
ds lin-44, cwn-1 and egl-20. Using fluorescent reporter genes, they and others found enhanced 
expression of these ligands in the posterior of the worm and proposed a graded action of WNT 
ligands on vulval cell fate specification (Whangbo and Kenyon 1999; Coudreuse 2006; Gleason 
et al. 2006; Zinovyeva et al. 2008). Although all six VPCs are able to respond to inductive signal-
ling by LIN-3/EGF and lateral signalling via LIN-12/NOTCH (Greenwald et al. 1983; Ferguson 
et al. 1987), they do so with unequal sensitivity, which should be taken into consideration during 
studies on vulval cell fate determination.
1.3 WNT signalling
WNT signalling is fundamental during the patterning of early embryos, in establishing cell po-
larity, in the regulation of cell migration and proliferation, as well as during the maintenance of 
adult tissue (Logan and Nusse 2004; Clevers and Nusse 2012). WNT pathways are divided into 
canonical and non-canonical signalling (Sugimura and Li 2010; Clevers and Nusse 2012). The 
WNT ligands can act as long-range morphogens to impose spatial information as exemplified in 
the Drosophila wing disc (van den Heuvel et al. 1989). Alternatively, short-range signalling takes 
place e.g. between engrailed and wingless expressing cells to establish cell fate boundaries and 
segments in the early fruit fly embryo (Swarup and Verheyen 2012) or in the maintenance of a 
stem cell niche that gives rise to a range of differentiated cells like hair follicle cells (DasGupta 
and Fuchs 1999) or the various types of intestinal crypt cells (Satoh et al. 2000; Crosnier et al. 
2006). The importance of WNT signalling during these processes foreshadows its significance in 
a number of diseases.
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1.3.1 The WNT/ß-catenin pathway
During canonical WNT signalling, the signal transduced by WNT ligands arrives in the nucleus 
through the inhibition of an inhibitory destruction complex in the cytoplasm (Logan and Nusse 
2004). Lipid modification of WNTs via palmitoylation is essential for their secretion and function 
as becomes obvious in fruit flies mutant for a gene that regulates WNT secretion, porcupine. 
These flies show phenotypes similar to the loss of WNTs themselves (wingless in Drosophila) 
(Kadowaki et al. 1996; Clevers and Nusse 2012). Given the necessity of lipid modification, the 
identification of small molecules inhibiting this process are promising drugs in diseases caused 
by deregulated WNT signalling (Lu et al. 2009). In the absence of a WNT signal, ß-catenin 
resides in a cytoplasmic complex consisting of the scaffold protein Axin, Dishevelled (Dvl), 
glycogen synthase kinase-3ß (GSK-3ß), casein kinase 1 (CK1) and Adenomatous Polyposis 
Coli (APC) (Hart et al. 1998; Amit 2002; Weis and Stamos 2013). ß-catenin is phosphorylated by 
GSK-3ß and CK1 and the recruitment of the E3 ubiquitin ligase ß-TrCP causes its proteasomal 
degradation (Aberle et al. 1997; Xiao et al. 2014) (Fig. 1.4, left). Upon WNT ligand binding to a 
seven-transmembrane (7TM) Frizzled receptor and in presence of a single-pass TM Frizzled co-
receptor LRP5/6 (low density lipoprotein (LDL) receptor-related protein), Axin leaves the destruc-
tion complex which loses activity and ß-catenin is stabilised (Cliffe et al. 2003) (Fig. 1.4, right). 
Liberated ß-catenin translocates to the nucleus to displace the transcriptional repressor Groucho 
from TCF/LEF DNA-binding proteins and itself interact with TCF/LEF as well as co-activators and 
histone modification proteins to promote target gene expression (van de Wetering et al. 1997; 
Miller and Moon 1997). WNT targets include not only components of the pathway itself to supply 
a negative feedback (Cadigan et al. 1998; Sato et al. 1999), but also genes whose products are 
involved in proliferation, such as MYC or CCND1 (He 1998; Tetsu and McCormick 1999).
Non-canonical WNT signalling does not employ ß-catenin and TCF/LEF to exert its function 
(Veeman et al. 2003). Also, co-receptor function is not fulfilled by LRP5/6 but by members of 
the ROR and RYK family of tyrosine kinase receptors (Sugimura and Li 2010; van Amerongen 
2012). Non-canonical signalling through WNT ligands organises cell polarity, cell migrations and 
more generally cytoskeletal rearrangements in the planar cell polarity pathway that recruits the 
small GTPases RHO and RAC (Axelrod 2009; Gómez-Orte et al. 2013) (Fig. 1.5, left). Other 
downstream effects include phospholipase C regulated calcium signalling and actin remodelling 
via CDC42 or negative regulation of the canonical WNT pathway involving ß-catenin (Sugimura 
and Li 2010) (Fig. 1.5, right).
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Figure 1.4. Canonical WNT signalling pathway. (LEFT) Without ligand binding, ß-catenin resides in a cytoplasmic complex with Axin, Dishevelled 
(Dvl), glycogen synthase kinase-3ß (GSK-3ß), casein kinase 1 (CK1) and Adenomatous Polyposis Coli (APC). ß-catenin is phosphorylated and the 
recruitment of the E3 ubiquitin ligase ß-TrCP causes proteasomal degradation. (RIGHT) Upon WNT ligand binding to the 7TM receptor Frizzled (Fzd) 
and in presence of its co-receptor LRP5/6, the destruction complex is disassembled and ß-catenin can enter the nucleus. Transcriptional repressors 
like Groucho are displaced and ß-catenin enhances expression of target genes through the interaction with TCF/LEF and co-activators.
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Figure 1.4. Canonical WNT signalling pathway. (Left) Without ligand binding, ß-catenin resides in a 
cytoplasmic complex with Axin, Dishevelled (Dvl), glycogen synthase kinase-3ß (GSK-3ß), casein kinase 1 
(CK1) and Adenomatous Polyposis Coli (APC). ß-catenin is phosphorylated and the recruitment of the E3 
ubiquitin ligase ß-TrCP causes proteasomal degradation. (Right) Upon WNT ligand binding to the 7TM re-
ceptor Frizzled (Fzd) and in presence of its co-receptor LRP5/6, the destruction complex is disassembled 
and ß-catenin can enter the nucleus. Transcriptional repressors like Groucho are displaced and ß-catenin 
enhances expression of target genes through the interaction with TCF/LEF and co-activators.
Figure 1.5. Noncanonical WNT signalling pathway. (Left) The planar cell polarity pathway recruits the 
small GTPases RHO and RAC to impinge on the cytoskeleton or cell survival. (Right) In the WNT/Calcium 
signalling pathway, WNT binding triggers the recruitment of PLC to produce the second messengers IP3 
and DAG and induce calcium dependent cell signalling responses or cytoskeletal rearrangements. 
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1.3.2 WNT signalling during disease
Mutations affecting the stabilisation of ß-catenin, i.e. phosphorylation of ß-catenin itself or the 
function of the destruction complex, contribute to cancer development as a consequence of 
constitutive pathway activation (Yost et al. 1996; Giles et al. 2003). A famous example is familial 
adenomatous polyposis (FAP), in which a defective copy of APC was inherited and the second 
allele is lost thereafter in a subset of cells (Kinzler et al. 1991; Nishisho et al. 1991). In combina-
tion with the loss of further tumour suppressor genes or activating mutations in proto-oncogenes, 
initially benign polyps can become malignant (Kinzler and Vogelstein 1996; Ivanov et al. 2006). 
Strikingly, approx. 80% of colorectal cancers originate from the complete loss of APC, which 
highlights the importance of the pathway in cell proliferative events (Wood et al. 2007; Nishisho 
et al. 1991). Furthermore, a loss of Axin was found in hepatocellular carcinoma (Rubinfeld et al. 
1997). Mutations preventing the phosphorylation and hence degradation of ß-catenin have been 
associated with colon cancer and melanoma (Rubinfeld et al. 1997; Reya and Clevers 2005) 
and TCF/LEF was found to be lost in sebaceous skin tumour (Takeda et al. 2006). It is worth 
mentioning that defective WNT signalling is further involved in bone density defects (Gong et al. 
2001; Boyden et al. 2002), type II diabetes (Kanazawa et al. 2004; Christodoulides et al. 2006) 
and other diseases. 
1.3.3 Other roles of ß-catenin
ß-catenin does not only act to mediate transcriptional responses but also plays a role in mi-
crotubule organisation at the centrosome (Huang et al. 2007). Furthermore, it is found in cell 
adhesion complexes together with E-cadherin and α-catenin (reviewed in detail in (Nelson and 
Nusse 2004; Valenta et al. 2012)). This is of special interest, since the stable pool of ß-catenin 
in cell junctions is unavailable for signalling and coordinated with the cytoplasmic unstable pool 
(Gumbiner 2000; Logan and Nusse 2004). The different functions of ß-catenin are highlighted in 
C. elegans. While Drosophila and vertebrates possess one ß-catenin to carry out all functions, 
C. elegans has split the roles of ß-catenin onto four proteins (Korswagen et al. 2000). ß-catenin-
armadillo-related (BAR-1) is the main signalling member of the canonical WNT pathway (Maloof 
et al. 1999) and participates in vulval cell fate specification (see 1.2.1), Q neuroblast migrati-
on or the specification of the P12 fate through interaction with POP-1, the worm TCF. Another 
ß-catenin, humpback (hmp-2), interacts with HMR-1 (cadherin) and HMP-1 (α-catenin) at cell 
junctions (Korswagen et al. 2000). WRM-1 (Worm armadillo 1) and SYS-1 (symmetrical sister 
cell hermaphrodite gonad defect 1) act in a worm-specific variation of the canonical pathway to 
regulate asymmetric cell divisions (Takeshita 2005; Gómez-Orte et al. 2013). Here, the members 
of the destruction complex, APR-1 (APC), PRY-1 (Axin) and GSK-3 (GSK-3ß) act as activators 
rather than repressors (Park et al. 2004). A polarized WNT signal induces the complex and hence 
WRM-1, which displaces POP-1 from the nucleus into the cytoplasm upon which SYS-1 can turn 
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on transcription (Bowerman et al. 1999; Lo et al. 2004). Thus, the outcome of this type of pathway 
is the same as in all canonical WNT pathways, i.e. transcription is turned on upon WNT ligand 
binding. As in Drosophila and vertebrates, an association with of SYS-1 with the centrosome has 
been observed (Vora and Phillips 2015). 
1.4 RAS signalling
Signalling through RAS (rat sarcoma) regulates multiple developmental events such as pro-
liferation, cell differentiation, cytoskeletal rearrangements, apoptosis or survival and is highly 
conserved (Satoh et al. 1992; Downward 2003). The small GTP-binding protein RAS acts as a 
molecular switch to direct downstream pathways through effector proteins like RAF, PI3K, PLCE 
or RALGEF (Rodriguez-Viciana et al. 2004; Repasky et al. 2004) (Fig. 1.6).
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Figure 1.6. Effector pathways downstream of RAS. The small GTP-binding protein RAS activates several 
effectors to control various cellular events. Activation of the RAF protein kinase initiates the mitogen-acti-
vated protein (MAP) kinase cascade that phosphorylates ERK. ERK targets are present both in the cytosol 
and the nucleus and comprise transcription factors like ETS family members, ELK1 or c-Myc as well as 
the 90 kDa ribosomal protein S6 kinases (RSKs) to impact on transcription. Activation of phosphoinositide 
3-kinases (PI3Ks) results in the second messenger PIP3 that promotes survival signalling through AKT or 
in active RAC GTPases that influence cytoskeletal architecture. RAL guanine exchange factors promote 
RAS-related RAL proteins and the stimulation of PLCE leads to an accumulation of diacyglycerol DAG and 
IP3 and signalling by PKC and calcium. Figure adapted from Downward (2003).   
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1.4.1 The GTPase-binding protein RAS
Initially, RAS was discovered in retroviruses that showed a strong carcinogenic potential 
(Harvey 1964; Kirsten and Mayer 1967; Peters et al. 1974; Rasheed et al. 1978; Cox and Der 
2014 for review). Subsequently, mutations that prevent GTP hydrolysis (positions G12, G13 
and Q61) were found in 20-30% of all human cancers (Forbes et al. 2010; Prior et al. 2012). 
Within the three isoforms encoded by the RAS locus, mutations in KRAS are predominant 
(86%) whereas NRAS and HRAS are less frequently mutated in cancers (11% and 3% respec-
tively) (Fernandez-Medarde and Santos 2011; Beukers et al. 2014). 
As a master regulatory switch, the RAS protein is subject to extensive regulation. Activation is 
achieved through the exchange of GDP for GTP, which is mediated by guanine nucleotide ex-
change factors (GEFs) containing a CDC25 homology catalytic domain, e.g. the son of sevenless 
gene product SOS (Vigil et al. 2010; Cherfils and Zeghouf 2013). Conversely, GTPase-activating 
proteins (GAPs) enhance the low intrinsic GTPase activity of RAS to mediate inactivation. Fur-
thermore, signalling activity strongly depends on RAS subcellular localisation (Prior and Hancock 
2012). Substantial post-translational modifications involving stable farnesylation, proteolysis, 
methylation as well as reversible palmitoylation allow the localisation at the plasma membrane, 
where most of the signalling originates from. Depalmitoylated RAS accumulates in the cytosol 
and arrives at the Golgi apparatus, where re-palmitoylation takes place to shuttle RAS back to 
the plasma membrane (Rocks et al. 2010). While NRAS and HRAS participate in this palmito-
ylation cycle, the KRAS isoform cannot undergo palmitoylation (Ahearn et al. 2011). Instead, 
basic residues within the hypervariable region of KRAS promote its solubilisation by binding of 
the prenyl-binding protein PDEδ and facilitated trafficking to the plasma membrane (Chandra et 
al. 2011). These basic residues in KRAS have further been shown to be essential for calmodulin 
binding and removal from the plasma membrane (Villalonga et al. 2001) as well as for phospho-
rylation by PKC and induction of apoptosis at mitochondria (Bivona et al. 2006). Thus, numerous 
studies aim at developing small molecules to interfere with one of the many steps of RAS modi-
fication (Downward 2003; Roberts and Der 2007; Spiegel et al. 2014).
1.4.2 The EGFR/RAS/MAPK signalling pathway
Extracellular signals such as growth factors, cytokines and hormones bind to and activate cell 
surface proteins such as receptor tyrosine kinases or G-protein coupled 7TM receptors (Satoh 
et al. 1992), the modules upstream of RAS. One of the signal transduction pathways that has 
been studied in great detail is initiated by epidermal growth factor (EGF) and its receptor (EGFR) 
and involves the downstream kinases RAF, MAP kinase-ERK kinase (MEK1/2) and extracellular-
signal regulated kinase (ERK1/2, MAPK) (Scaltriti and Baselga 2006) (Fig. 1.7). Ligand binding 
causes EGFR dimerisation, auto-phosphorylation within the cytoplasmic domain and binding 
of the SHC adaptor protein (Ravichandran 2001), which interacts with GRB2 (Ravichandran 
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et al. 1995). The stable association of GRB2 with SOS and the localisation of RAS at the plas-
ma membrane facilitate the exchange of GDP for GTP and thus the activation of RAS and a 
downstream mitogen-activated kinase (MAPK) cascade (Schlessinger 1993). In this cascade, 
RAS binds the RAF serine/threonine kinase at the membrane, which in turn relays the signal 
to MEK1 and MEK2 via phosphorylation (Crews et al. 1992). MEKs are dual specificity kinases 
of ERK1 and ERK2, i.e. they phosphorylate both threonine and tyrosine residues (Crews et al. 
1992). Phosphorylated ERK translocates to the nucleus and phosphorylates transcription factors 
including ELK1, ETS, HIF1A (see also 1.6.3) or MYC upon which gene expression is enhanced, 
e.g. of proteins required for cell cycle progression (cyclin D1, c-Fos) (Marais et al. 1993; Price et 
al. 1996; Sears 2000; Berra et al. 2000; Murphy et al. 2002). Further transcription factor targets 
are the nuclear receptors estrogen receptor (ER) (Kato et al. 1995) or peroxisome proliferator-
activated receptor gamma (PPARG) (Farmer 2005). Phosphorylation of ELK1, MYC, HIF1A and 
ER is activating whereas phosphorylation renders ETS and PPARG inactive.
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Figure 1.7. EGFR/RAS/MAPK signalling pathway. The binding of epidermal growth factor (EGF) leads to 
EGF receptor dimerisation and auto-phosphorylation, upon which the adaptor protein SHC binds. SHC 
recruits GRB2 which is associated with the RAS-GEF SOS1. The localisation of RAS at the membrane 
facilitates the exchange of GDP for GTP by SOS1 and RAS activation, which is counteracted by GAP. Ac-
tive RAS promotes the RAF kinase, which phosphorylates the MEK1/2 dual specificity kinases. MEK1/2 in 
turn activate ERK1/2, which phosphorylates targets both in the nucleus and the cytoplasm to elicit various 
cellular responses. 
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1.4.3 Non-nuclear ERK functions
Activated ERK1/2 is sorted into and to a number of cellular compartments to exert several func-
tions. Some examples are described below and the interested reader is referred to extensive 
reviews (e.g. Kolch 2005; Wortzel and Seger 2011). 
Within the cytosol, ERK phosphorylates components of its upstream cascade to establish a 
negative feedback loop (Brummer et al. 2003), the MAPK-interacting Kinases (MNKs) which 
enhance the activity of EIF4E and hence general translation efficiency (Waskiewicz 1997) or 
the 90 kDa ribosomal protein S6 kinases (RSKs) that regulate transcription (Chen et al. 1992). 
ERK1/2 prevents apoptosis by phosphorylating BCL2 at mitochondria (Deng et al. 2000) and has 
been detected to accumulate in mitochondria (Galli et al. 2009). The co-localisation of ERK1/2 
with endosomes is mainly thought to enhance signalling by bringing the components of the cas-
cade into close proximity with the activated and internalising RTKs (Schaeffer 1998; Luttrell et al. 
2001). Interactions with microtubules and actin filaments not only ensures the proper transport 
and localisation of ERK1/2 throughout the cell (Reszka et al. 1995) but also regulates cell motility 
through direct phosphorylation of myosin light chain kinase (MLCK) (Klemke et al. 1997). Finally, 
an ERK1 splice variant is involved in the fragmentation of the Golgi apparatus at the onset of 
mitosis, which occurs to distribute the Golgi building blocks to the emerging daughter cells (Shaul 
and Seger 2006; Persico et al. 2010).
1.4.4 RAS/MAPK signalling in C. elegans tissues other than the vulva
The single C. elegans orthologue of mammalian N-, H- and KRAS, LET-60 (Han and Sternberg 
1990), controls a MAPK cascade downstream of LET-23/EGFR in the vulval tissue (Aroian and 
Sternberg 1991; Kornfeld 1997) (see 1.2.2), during induction of the excretory duct cell fate, 
during P12 development and in the specification of the uterine uv1 fate (Chang et al. 1999). A 
MAPK cascade acts downstream of the worm FGF receptor, EGL-15, to regulate sex myoblast 
migration (in response to EGL-17/FGF) (DeVore et al. 1995; Burdine et al. 1998) and axon 
guidance (in response to FGF-like LET-756) (Bülow et al. 2004). Downstream of the insulin-like 
receptor DAF-2, RAS/MAPK promotes the exit from pachytene during meiosis in the germline 
(Church and Lambie 2003; Lopez et al. 2013) and it is required for chemotaxis (Iino et al. 2000; 
Battu et al. 2003). In differentiated muscle, RAS/MAPK activates protein degradation (Szewcyk 
et al. 2002).  The loss of LET-60/RAS can thus cause the lack of a duct cell (Abdus-Saboor 
et al. 2011), a P12 to P11 cell fate transformation (Jiang and Sternberg 1998), defects in the 
vulval-uterine connection (Chang et al. 1999), defects in sex myoblast migration and vulval 
muscle function (Burdine et al. 1998), axon guidance defects (Bülow et al. 2004), sterility due 
to arresting germ cells in the pachytene (Church and Lambie 2003) or altered chemotaxis (Iino 
et al. 2000). Null mutants of let-60 die as zygotes, probably due to loss of the duct cell and 
associated osmoregulation (Nelson and Riddle 1984; Sundaram et al. 1997).
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1.5 NOTCH signalling
1.5.1 Core components of NOTCH signalling
Both the ligands and receptor proteins of the NOTCH pathway exclusively encode TM proteins 
(Kimble and Simpson 1997). As a consequence, LIN-12/NOTCH acts in cell fate decision events 
via cell-cell interactions and close physical cell contacts (Greenwald 1994; Kimble and Simpson 
1997). The core components of the NOTCH signalling pathway are the DSL ligands (originating 
from the first ligands identified, Delta, Serrate and LAG-2), LNG receptors (LIN-12, NOTCH and 
GLP-1) and the CSL proteins (CBF-1, Su(H) and LAG-1) (Fig. 1.8A). The DSL ligands are pre-
sent on signalling cells and contain a TM domain, epidermal growth factor (EGF)-like repeats 
(Lieber et al. 1992; Gao et al. 1997; Bray 2006), as well as a DSL domain and a N-terminal 
motif that have signalling activity (Lieber et al. 1992; Gao et al. 1997). Both CSL proteins and 
LNG receptors are present in receiving cells (Bray 2006) and the latter consist of extracellular 
EGF-like repeats involved in ligand binding (Fehon et al. 1990; Rebay et al. 1991; Lieber et al. 
1992), LNR repeats (for LIN-12/Notch Repeat repeats) with negative signalling activity (Lieber et 
al. 1993; Bray 2006), a TM region as well as intracellularly a RAM domain and cdc10/ankyrin 
repeats (ANK repeats) that interact with CSL proteins (Greenwald and Seydoux 1990; Roehl 
and Kimble 1993; Lieber et al. 1993), a transcriptional activation domain (TAD) (Hori et al. 
2013) and a C-terminal PEST domain through which the receptor can be degraded (Öberg et 
al. 2001; Hori et al. 2013) (Fig. 1.8A). 
The NOTCH signalling pathway is highly conserved in all animals (Artavanis-Tsakonas 1999; 
D‘Souza et al. 2008). In Drosophila melanogaster, Delta and Serrate are the DSL ligands that 
activate the only Notch receptor (Bray 2006). Five mammalian ligands have been described, 
three Delta-like ligands DLL1, DLL3 and DLL4 and two Serrate homologues Jagged 1 and 2 that 
activate one of four Notch receptors (NOTCH1-4) (D‘Souza et al. 2008). In C. elegans, lin-12 
and glp-1 encode the two Notch receptors while apx-1, lag-2, arg-1 and dsl-1 are the DSL ligan-
ds (Lambie and Kimble 1991; Mello et al. 1994; Mickey et al. 1996; Artavanis-Tsakonas 1999; 
Chen and Greenwald 2004). The CSL proteins are Su(H) in Drosophila, CBF1 in mammals and 
LAG-1 in the worm (Bray 2006). Although the ligands and receptors act in different tissues, they 
are interchangeable to some extent: In C. elegans, APX-1 has been shown to rescue the loss 
of LAG-2 (Fitzgerald and Greenwald 1995) as does GLP-1 in lin-12(lf) mutants (Fitzgerald et al. 
1993). Similarly, the overexpression of Serrate can substitute for Delta during early Drosophila 
development (Gu et al. 1995). Thus, organisms appear to have several NOTCH receptors and 
DSL ligands that are at least partially interchangeable. The presence of several different com-
ponents of one NOTCH pathway has been proposed to help achieve a temporally and spatially 
distinctive pattern of expression to carry out the numerous differing tasks during development 
(Weinmaster et al. 1992; Swiatek et al. 1994). 
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Figure 1.8. NOTCH signalling pathway. (A) DSL ligands are present on the signalling cell and consist of 
EGF repeats and a DSL domain. LNG receptors are present on receiving cells and comprise extracellular 
EGF and LNR repeats. The intracellular fraction contains a RAM domain, ANK repeats, a TAD and a PEST 
domain next to nuclear localisation signals. (B) Binding of a DSL ligand to a LNG receptor leads to the 
cleavage of the extracellular receptor domain by a metalloproteinase ADAM. The extracellular part is en-
docytosed with the DSL ligand by the signalling cell. A second cleavage event carried out by a γ-secretase 
complex releases the NOTCH intracellular domain (NICD), which enters the nucleus and activates gene 
expression in cooperation with Mastermind and co-activators. 
1.5.2 The signalling pathway
In the absence of DSL ligands, the CSL proteins form transcriptional repressor complexes on 
NOTCH target gene sequences (Bray 2006) (Fig. 1.8B). Upon ligand binding, the extracellular 
domain of Notch receptors is cleaved (S2 cleavage) by a metalloproteinase ADAM (Hori et al. 
2013) and endocytosed with the DSL ligand on the signal sending cell (Bray 2006). The LNR re-
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peats prevent the S2 cleavage event in the absence of DSL ligand and thereby restrict signalling 
(Bray 2006; Kopan and Ilagan 2013). A second cleavage event (S3) involving Presenilin within 
a γ-secretase complex releases the NOTCH intracellular domain (ICD) (Struhl et al. 1993; Brou 
et al. 2000). The NICD enters the nucleus and forms a transcriptional complex via the RAM and 
ANK domains with CSL protein, Mastermind and co-activators to activate gene expression (Bray 
2006; Choi et al. 2012). Thus, NOTCH signalling activity converts the function of CSL proteins 
from repression to activation. NICD is subject to both stabilisation through phosphorylation by ki-
nases like GSK-3ß (Espinosa et al. 2003) (see also WNT signalling) as well as to degradation via 
SEL10 (Hubbard et al. 1997), an E3 ubiquitin ligase that interacts with the NOTCH intracellular 
PEST domain (Öberg et al. 2001) and has been implicated in regulating C. elegans LIN-45/BRAF 
in a negative feedback loop (de la Cova and Greenwald 2012). These regulatory interactions 
imply a tight link of the Notch pathway to other developmentally fundamental signalling pathways. 
1.5.3 NOTCH signalling during development 
Notch signalling is employed in various developmental cell fate decision events (Artavanis-
Tsakonas et al. 1995; Bray 2006; Hori et al. 2013). During „lateral inhibition“, Notch specifies 
one of two cell fates within a group of developmentally equivalent cells (Hori et al. 2013). Initially, 
cells express the same amount of Notch receptor and ligand and the balance is tipped to either 
by an inductive signal or stochastic fluctuation. Signal amplification through positive feedback 
loops fortifies the imbalance in that the signal sending cell (expressing the ligand) activates 
NOTCH in the receiving cell that enhances receptor expression and vice versa (Bray 2006). 
This results in the ligand expressing cell adopting one cell fate and the receptor expressing 
cell adopting another. Prominent examples for lateral inhibition are the AC vs. ventral-uterine 
(VU) decision during C. elegans gonad development (Wilkinson et al. 1994) (see below), VPC 
fate acquisition (see 1.2.2) or the decision of a neuronal vs. ectodermal cell fate in Drosophila, 
where NOTCH represses neurogenesis (Campos-Ortega 1994). Another mechanism to confer 
different fates among cells is achieved through the asymmetric inheritance of NOTCH regulators. 
In Drosophila, the NOTCH inhibitor Numb is asymmetrically distributed to daughter cells of the 
sensory organ precursor (SOP) (Frise et al. 1996; Artavanis-Tsakonas 1999). In two consecutive 
cell divisions and asymmetric Numb segregation, the SOP will give rise to two cells with active 
NOTCH signalling, a socket and a sheath cell, as well as two cells with suppressed NOTCH ac-
tivity due to presence of Numb, a hair cell and a neuron. Finally, NOTCH can act to induce non-
equivalent cells. NOTCH mediated induction is presented by the DTC in the C. elegans germline 
that expresses the DSL ligand LAG-2 (Crittenden et al. 2003). LAG-2 binds GLP-1 and induces 
germline mitosis (see also 1.5.4). Induction by NOTCH signalling further establishes the dorso-
ventral wing margin during Drosophila wing disc development (Doherty et al. 1996). Here, dorsal 
cells induce ventral cells to express wingless and vice versa and this pattern depends on Delta, 
Serrate and Notch. 
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Oncogenic receptor forms lack the regulatory extracellular or intracellular PEST domains, trans-
duce signal independently of DSL ligands (Struhl et al. 1993; Lieber et al. 1993) and have been 
associated with T cell leukemia (TAN-1 (Ellisen et al. 1991)) or mouse breast cancer (INT-3 
(Gallahan and Callahan 1987; Robbins et al. 1992)). It is poorly understood how NOTCH ac-
tivation can contribute to transformation. However, its involvement in cellular differentiation and 
crosstalk to other fundamental signalling pathways is likely to play a role (Radtke and Raj 2003). 
Surprisingly, NOTCH has also been associated with a tumour suppressive function, as it induces 
differentiation in mammalian skin and a cell-cycle arrest (Nicolas et al. 2003; Radtke and Raj 
2003). These contradicting findings highlight the importance of a given cellular context and 
appreciate the many outcomes of NOTCH signalling activity. 
1.5.4 NOTCH signalling in C. elegans tissues other than the vulva
In C. elegans, NOTCH signalling is crucial in several instances during early embryo development 
where the ligand apx-1 and the receptors glp-1 and lin-12 are used (Lambie and Kimble 1991 and 
reviewed in Priess 2005) as well as embryonic and larval cell fate decisions and mitosis in the 
germline (Kimble and Simpson 1997). Prior to vulval induction, the ligand lag-2 acts through 
LIN-12/NOTCH in the VU vs. AC precursor fate decision process and promotes the VU fate in 
a feedback mechanism (Greenwald et al. 1983; Seydoux and Greenwald 1989; Wilkinson et al. 
1994; Park et al. 2013). In animals mutant for lin-12 or with impaired cell movement resulting in lack 
of precursor cell contact, two ACs develop and overactivation of LIN-12 results in the absence of 
any AC (Greenwald et al. 1983; Hedgecock et al. 1990). Later during development, the AC induces 
descendants of the VU cell via LIN-12 to adopt the pi cell fate (Newman et al. 1995). These pi cells 
will be induced by the vulF cells (see 1.4.4) and RAS/MAPK activity to become uv1 cells and contri-
bute to the vulval-uterine connection for functional egg-laying (Chang et al. 1999). LIN-12 has also 
been found to regulate spontaneous reversal rate of the worm in cooperation with the glutamate re-
ceptor glr-1 (Chao et al. 2005). Another Notch receptor in C. elegans, GLP-1 (Pepper et al. 2003), is 
crucial during the development of the germline and its maintenance in the adult worm (Kimble and 
White 1981). The two distal tip cells (DTCs) in the gonad express the ligand LAG-2 and activate 
NOTCH signalling via GLP-1 and the CSL protein LAG-1, which leads to mitotic divisions of germ 
cells (Kimble and White 1981; Henderson et al. 1994). In the absence of the DTCs or GLP-1, germ 
cells enter meiosis and the pool of mitotic stem cells is lost. 
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1.6 The relevance of oxygen during development and disease
Molecular oxygen is a double-edged sword. On the one hand, it serves as an external energy sour-
ce that participates in a variety of metabolic processes and acts as the terminal electron accep-
tor molecule in the electron transport chain during mitochondrial aerobic respiration (Gleadle and 
Ratcliffe 2001). The obligatory dependence of organisms on oxygen is exemplified by elaborate 
mechanisms that ensure oxygen homeostasis as well as a number of pathologies associated with 
inappropriate oxygen supply. On the other hand, the metabolism of oxygen produces reactive 
oxygen species (ROS) that are toxic to cells. It is thus not surprising that oxygen availability 
dictates the expression of genes involved in energy metabolism, defence against oxygen toxicity or 
further metabolic pathways that require molecular oxygen. One such example is erythropoiesis, the 
production of red blood cells (Goldberg et al. 1988). Erythrocytes circulate in our body and deliver 
oxygen from the lungs to all tissues by means of the oxygen-transport metalloprotein haemoglo-
bin. Situations including oxygen shortage (hypoxia), bleeding (haemorrhage) or a decrease in the 
number of red blood cells or haemoglobin (anaemia, e.g. as a result of blood donation) cause a 
rise in erythropoietin (EPO), the hormone that controls erythropoiesis, and a boost in erythrocyte 
production (Goldberg et al. 1988). In addition to adjusting the number of red blood cells, the vascu-
lature is modified to match the given metabolic needs through a process known as angiogenesis. 
Analogously, individuals living in higher altitudes with lower oxygen pressure exhibit an increased 
amount of erythrocytes (polycythaemia), myoglobin, mitochondrial volume density and respiratory 
enzymes (Storz et al. 2010). Although some level of oxygen deficiency is crucial during embryo-
nic development to stimulate vascularisation (Patterson and Zhang 2010), prolonged hypoxia can 
result in irreversible tissue damage by inducing cell death via necrosis or apoptosis (Banasiak et 
al. 2000). Hypoxia is characteristic of various pathological conditions such as ischaemia (the re-
striction of blood supply to tissues), stroke, inflammation, thrombosis, anaemia, artherosclerosis 
and solid tumours (Harris 2002; Vannucci 2004; Hare 2004; Hultén and Levin 2009; Eltzschig and 
Carmeliet 2011; Bovill and van der Vliet 2011; Ferdinand and Roffe 2016) and triggers a range of 
cellular responses as discussed below. 
1.6.1 Acute cellular responses to hypoxia
In the case of restricted oxygen availability, both immediate and more gradual changes occur within 
cells, the latter comprising altered gene expression, which is introduced below. Ventilation is tuned 
such that the gas exchange between the lungs and the environment is optimised and this process 
is governed by oxygen sensing cells within the carotid bodies in the artery (Ureña et al. 1994). 
The opening of potassium channels on the membrane of these cells is inhibited by hypoxia, which 
leads to the opening of calcium channels with consequent calcium influx and the release of the 
neurotransmitter dopamine to stimulate ventilation. Although not fully understood, it is assumed 
that oxygen is sensed through redox state dependent structural changes that dictate the activity of 
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ion channels (Kemp and Peers 2007; Muralidharan et al. 2016). Acute responses to hypoxia further 
act to conserve energy via the downregulation of translation through multiple pathways (Koritzinsky 
et al. 2005; Wouters et al. 2005; Koritzinsky et al. 2006). One of these includes the unfolded protein 
response (UPR), which is induced by an accumulation of un- or misfolded proteins during hypoxic 
insult (Koumenis et al. 2007). The endoplasmatic reticulum (ER) kinase PERK is part of the UPR 
and phosphorylates EIF2A to inhibit translation initiation (Koumenis et al. 2002). Other pathways 
are the hypoxic inhibition of the mammalian target of rapamycin mTOR that integrates metabolic 
signals with protein synthesis or the disruption of the mRNA cap-binding complex by targeting 
eukaryotic translation initiation factor 4E (EIF4E) (Wouters and Koritzinsky 2008).
1.6.2 Transcriptional cellular responses to hypoxia: HIF1A
In early studies on erythropoietin induction by hypoxia, it became clear that cells also respond 
to changes in oxygen pressure more gradually, i.e. through transcriptional programmes. A cis-
acting 5’-G/ACGTG-3’ hypoxia-response element (HRE) was found to be required for EPO 
transcription (Beck et al. 1991; Semenza et al. 1991; Pugh et al. 1991; Madan and Curtin 
1993) and soon thereafter, the nuclear hypoxia inducible factor HIF was purified using the EPO 
sequence (Semenza and Wang 1992; Wang and Semenza 1993). These studies revealed the 
existence of a heterodimeric transcription factor complex consisting of an oxygen-degradable 
HIF1A subunit and a constitutive HIF1B subunit (also known as ARNT) (Maxwell et al. 1999). 
Both subunits are basic helix-loop-helix (bHLH) transcription factors of PAS domain family 
proteins (named after their first characterisation in Drosophila Per and Sim and mammalian 
ARNT proteins) (Wang et al. 1995). The description of HREs that are bound by HIF1 triggered 
the discovery of many further HIF1 target genes, among which vascular endothelial growth 
factor (VEGF) (Shweiki et al. 1992), Glucose transporter-1,3 (Chen et al. 2001) or endothelin 
(Kourembanas et al. 1991) (a more detailed list is reviewed in (Harris 2002)). The von Hippel-
Lindau protein VHL is a substrate recognition subunit of the ubiquitin protein ligase complex 
that promotes proteasomal degradation of the HIF1A subunit at normoxia (Salceda and Caro 
1997; Huang et al. 1998; Maxwell et al. 1999). Binding of pVHL was found to require prolyl 
hydroxylation of HIF1A at residues P564 and P402 within a conserved LXXLAP motif in an oxygen-
dependent degradation (ODD) domain (Huang et al. 1998; Yu et al. 2001; Masson et al. 2001) 
(Fig. 1.9). The hydroxylation step is carried out by 2-oxoglutarate and iron dependent prolyl 
hydroxylase domain (PHD) proteins (dioxygenases, also called EGLN) that were described in 
2001 in mammalian cell culture and C. elegans (Ivan et al. 2001; Jaakkola et al. 2001; Yu et al. 
2001; Epstein et al. 2001). Three such dioxygenases exist and PHD2 (EGLN1) appears to be 
the prime HIFA hydroxylase (Berra et al. 2003). The conserved interaction of HIFA, PHD2 and 
VHL is known as the hypoxia response pathway. In addition to destabilising prolyl hydroxylation, 
the inhibitory hydroxylation of an asparagine residue in the HIF1A transactivation domain by 
factor inhibiting HIF1 (FIH1) provides further regulation (Mahon 2001). 
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Mammalian genomes encode three HIFA isoforms regulated by oxygen and one constitutive 
HIF1B gene. HIF1A is expressed ubiquitously, whereas expression of HIF2A appears more 
tissue-specific, e.g. in vascular endothelium or kidney epithelial cells (Tian et al. 1997; Jain et al. 
1998; Wiesener 2003; Simon and Keith 2008). HIF3A, also known as IPAS, acts as a negative 
regulator of HIF1A and HIF2A (Makino et al. 2001 and reviewed in Yang et al. 2015).
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Figure 1.9. Hypoxia response pathway. During normoxia (left), prolyl residues in the oxygen dependent 
degradation (ODD) domain of HIFA proteins are hydroxylated by PHD2, an iron and 2-oxoglutarate de-
pendent dioxygenase. Hydroxylation of HIFA increases its affinity for the E3 ubiquitin ligase VHL which 
promotes subsequent proteasomal degradation. During hypoxic conditions (right), HIFA hydroxylation is 
prevented and stabilised HIFA enters the nucleus to form a heterodimeric transcription factor complex with 
constitutive HIF1B and alter gene expression. 
1.6.3 Hypoxia and HIFA during cancer progression
Given the various roles of hypoxia and hypoxia inducible factors in development and physiology, 
their significance in disease, most prominently in cardiovascular disease and cancer, is not sur-
prising. Mutations in HIF2A are associated with polycythaemia (Percy et al. 2008b; Percy et al. 
2008a) and the activation of HIF1A and HIF2A protects ischaemic tissues from injury (Jurgensen 
2004; Loor and Schumacker 2008). One of the most striking correlations of hypoxia and disease 
was perhaps the finding that tumour hypoxia slows growth and can induce necrosis (Barach and 
Bickerman 1954; Thomlinson 1977). Hypoxic areas are characteristic of tumours and detectable 
once they outgrow the oxygen diffusion limit of 100-200 µm or 10-20 cell layers (Thomlinson and 
Gray 1955; Thomlinson 1965). It was in 1956, when Otto Warburg first described the upregulation 
of glucose transporters, glycolytic enzymes or energetic and metabolic intermediates associated 
with glycolysis in an aerobic environment, a paradoxical phenomenon known as “Warburg effect” 
(Warburg 1956; Denko 2008). The clinical importance of tumour hypoxia came into focus with the 
observation of resistance to radiotherapy and chemotherapy, which rely on the presence of mole-
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cular oxygen and a functional vascularisation (Gray et al. 1953; Davidson et al. 1955; Deschner 
and Gray 1959; Teicher et al. 1981; Teicher 1994; Shannon et al. 2003; Overgaard 2007). Typical 
tumorigenic features including angiogenesis (Blumenson and Bross 1976), metastatic potential 
(van den Brenk et al. 1972; Young et al. 1988) and DNA replication (Young and Hill 1990) were 
ascribed to insufficient oxygenation within the tissue and became predictive of poor patient sur-
vival. Treatment resistance and systemic metastases have been described for prostate, cervix, 
breast or head and neck cancer (Brizel 1996; Chaudary and Hill 2007; Vaupel and Mayer 2007; 
Chan et al. 2007). Limited success has been made with tumour oxygenation during radiotherapy 
or by the administration of hypoxia-activated pro-drugs (Rischin et al. 2005; Overgaard 2007). 
However, treatment can be further complicated by hypoxia promoted expression of the multidrug 
resistance gene MDR1 which regulates efflux of chemotherapeutic drugs (Comerford 2002).  
Tumours experience both chronic hypoxia due to diffusion limitation and acute hypoxia as a 
result of transient changes in blood flow through the disorganised vasculature of large tumours 
(Chaplin et al. 1986; Dewhirst et al. 2008). Hypoxia-reoxygenation cycles are believed to en-
hance the occurrence of DNA strand breaks (DSB) and mutagenesis through the action of ROS 
(Cairns and Hill 2004; Klein et al. 2006), thereby contributing to genetic instability commonly 
associated with cancer. Although hypoxia induces p53 to promote apoptosis, the selection of cells 
defective in apoptotic pathway components leads to increased resistance to apoptosis (Graeber 
1994; Graeber et al. 1996; Zhang and Hill 2004). Furthermore, chronically hypoxic tumour cells 
downregulate DNA repair pathways, which increases the mutational potential on the one hand, 
but also enhances their sensitivity to radiotherapy (Blais et al. 2006; Chan et al. 2008). 
Finally, HIFA and VHL are directly implicated in several malignancies (Maxwell et al. 1999; 
Koukourakis et al. 2002; Semenza 2003; Holmquist-Mengelbier et al. 2006). The activation 
of oncogenes (e.g. SRC, HRAS) or loss of tumour suppressor genes (e.g. VHL (see below) 
or PTEN) lead to the accumulation and activation of HIF1A even in normoxia (Semenza 2003; 
Denko 2008). HIF1A has been associated with poor patient survival in cervical, breast or ovari-
an cancer  (Birner 2000; Birner et al. 2001; Bos et al. 2001; Schindl 2002) and activated HIF2A 
correlates with mortality in the case of neuroblastoma (Holmquist-Mengelbier et al. 2006) or 
head and neck squamous cell carcinoma (Koukourakis et al. 2002). Inhibition of HIF1A in human 
breast and colon cancer cells reduced tumour growth in mice (Livingston et al. 2000) while the 
absence of Hif1a in a mouse transgenic breast cancer model suppressed the potential to me-
tastasise into the lung (Liao et al. 2007). Therefore, drugs to block HIF1 or HIF1 target genes 
as well as anaerobic bacteriolytic therapies are subject to cancer treatment evaluation (Dang et 
al. 2001; Giaccia et al. 2003; Semenza 2007). However, the role of hypoxia-inducible factors in 
cancer progression appears more complex than initially anticipated, since the inhibition of HIF2A 
in renal cell carcinoma indeed resulted in decreased tumour mass in mice while the suppression 
of HIF1A increased tumour mass (Raval et al. 2005). Mutations in VHL are common to sporadic 
kidney cancer and renal cell carcinoma cells (Maxwell et al. 1999). The “von Hippel-Lindau (VHL) 
disease” is a human hereditary cancer syndrome characterised by germline mutations in VHL 
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that exhibit a greatly enhanced susceptibility to highly vascularised tumours (Mandriota et al. 
2002; Raval et al. 2005). Renal cell carcinoma (RCC) commonly originates from loss of VHL 
function but not exclusively through consequent HIFA stabilisation. Although both HIF1A and 
HIF2A have been implicated in this type of cancer (though apparently opposing each other) 
(Raval et al. 2005), a role of insufficient ß-catenin degradation in VHL-/- renal carcinoma cell 
lines as well as defects in extracellular matrix formation and a decreased induction of apoptosis 
upon loss of VHL have been proposed to contribute to a tumorigenic potential (Bishop et al. 
2004; Kurban et al. 2006; Roe et al. 2006; Peruzzi et al. 2006). 
1.7 Quantitative genetics and disease
Phenotypic traits can be discrete, i.e. they are either present or absent and are inherited 
in a Mendelian pattern. Quantitative genetics refers to continuous phenotypes that are not 
brought about by this textbook pattern of inheritance but rather by a number of genes that 
collectively and quantitatively influence the trait in interaction with the environment (Hill and 
Mulder 2011). Examples of such complex traits are the colour and shape of fruit, the height or 
size of organisms as well as diseases like diabetes (Donnelly 2008), schizophrenia (Purcell et 
al. 2009) and cancer (Vazquez et al. 2012). The function and activity of the genes that influence 
a given phenotype is further dependent on natural variation that introduces single nucleotide 
polymorphisms (SNPs) or small insertions or deletions (InDels) into genes or non-coding DNA. 
Genome-wide association studies (GWAS) aim at comparing the genomes of individuals to 
correlate the presence of SNPs within genes with a specific phenotype and in this manner 
define risk factors or susceptibility genes in disease (Illig et al. 2009; Soto-Ortolaza et al. 2013). 
Risk factors have been described and include the BRCA1 gene for breast cancer (Neuhausen et 
al. 1994; Williams et al. 2005), MLH1 in colorectal cancer (Papadopoulos et al. 1994), SNCA in 
Parkinson’s disease (Warner and Schapira 2003; Mueller et al. 2005) and MYO18B in schizo-
phrenia (Purcell et al. 2009) to name only a few within this field of ongoing research (a detailed 
catalogue of GWAS studies is available from the National Human Genome Research Institute). 
With a better knowledge of risk factors, disease progress and outcome is more predictable and 
treatments can be designed more effectively.
1.7.1 Mapping of QTLs
Quantitative trait loci (QTLs) are genomic regions which contain susceptibility genes and are 
distributed over the genome (Collard et al. 2005). They can be identified because they segregate 
with a trait of interest. In GWAS, QTLs are described by the over-representation of the same 
genomic regions containing genetic variants, or in other words by the linkage to a phenotype 
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(Daniels et al. 1996; Chung et al. 2014). Since the sample number in genome-wide association 
studies is limiting (Almasy and Blangero 2008), model organisms with a relatively short life cycle 
are powerful tools to not only identify QTLs, but also to characterise the genes within a given QTL 
in respect to a genetically complex phenotype of interest. QTL mapping has been performed 
in plants (Young 1996), Drosophila melanogaster (Leips and Mackay 2000; Pasyukova et al. 
2000; Edwards and Mackay 2009), yeast (Katou et al. 2009; Liti and Louis 2012) or C. elegans 
(Ayyadevara et al. 2003; Green et al. 2013; Andersen et al. 2015) and resulted in the descrip-
tion of behavioural as well as disease related traits. Basically, wild isolates that are sufficiently 
diverse on a genomic level, are crossed, and recombinant inbred lines (RILs) are obtained via 
backcrossing (Takuno et al. 2012; Mulualem and Bekeko 2016). With the help of molecular 
markers such as fragment-length polymorphisms (FLPs), the parental sequence origin is de-
termined and tracked (Zipperlen et al. 2005). The set of RILs is compared to the original isolate 
to establish genome-wide genotype-phenotype maps and identify linkage disequilibria, i.e. loci 
that are associated with the trait of interest. This straight-forward strategy has helped in gaining 
a deeper understanding in the complex nature of disease.
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As of February 2017, the World Health Organisation describes cancer as the second leading 
cause of death globally, after ischaemic heart disease and stroke (http://www.who.int/cancer/). 
Hereby, the most common types of cancer concern the lung, liver, colon, stomach and breast. 
Cancer is a disease during which cells divide in an uncontrolled manner so that tissues grow 
abnormally to give rise to so called “tumours” that compromise organ function. Cells altered 
in such a way can spread to other parts of the body and build new colonies known as “meta-
stases”, which are the major cause of death from cancer. The transformation of normal cells 
into tumour cells occurs through carcinogens, among which radiation (UV, ionising), tobacco 
smoke or aflatoxins (e.g. present in raw mushrooms) as well as viral and bacterial infections. 
Cell transformation is the process of DNA alterations (mutations) with consequent changes 
in protein activity or function. Progress in research has helped in gaining insight into the con-
tribution of basic cellular signalling pathways involved in the normal development of higher 
organisms during cancer. Prominent examples comprise the highly conserved WNT, EGFR/
RAS/MAPK and NOTCH pathways (Reya and Clevers 2005; Fernandez-Medarde and Santos 
2011; Takebe et al. 2013). However, while deviations in these signalling pathways can initiate 
cell transformation and cancer development, the combination and interaction of further genes 
or “risk factors” present within an individual genome (the entirety of genes) greatly determi-
nes the speed of disease progression, response to treatment and thus prognosis (Stessman 
et al. 2014). Risk factors contribute to a disease through not necessarily obvious processes 
when they exhibit a specific DNA composition brought about by spontaneous mutations. Such 
spontaneous mutations (polymorphisms) occur naturally and are the origin of evolution, since 
they change gene sequences and affect protein function. Therefore, a deeper understanding 
of the effect of polymorphisms on the function of risk factors and thus disease outcome is of 
great importance. In genome-wide association studies (GWAS), the DNA sequence of disease 
patients is compared to discover risk factors, i.e. genes in which mutations occur with incre-
ased frequency (Soto-Ortolaza et al. 2013). Although such studies have helped in describing 
risk factors, they suffer from a limited sample number and the lack of further functional studies. 
Therefore, the application of simple organisms like the nematode C. elegans is preferred, since 
basic signalling pathways are conserved (Spradling et al. 2006). During the development of the 
C. elegans egg-laying organ (vulva), the WNT, RAS/MAPK and NOTCH signalling pathways 
play crucial roles and mis-regulated signalling results in visible quantifiable changes (pheno-
2 
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types) (Sternberg 2005). Thus, it is a feasible system to identify risk factors (also called modi-
fiers) and study their effect on these signalling pathways. 
The aim was to simulate a simplified cancerous environment by employing mutated C. elegans 
lines that exhibit impaired function of ß-catenin, the master regulator of WNT signalling or an 
overactive form of RAS that is frequently found in cancer tissues (Fernandez-Medarde and 
Santos 2011; Clevers and Nusse 2012). Further, to mimic the natural variation in the human 
population, we employed the two worm strains N2 and CB4856 that are diverse on a genomic 
level, mixed their genomes to obtain a range of mutation included introgression lines (miILs) 
carrying different genomic parts of N2 and CB4856 (Doroszuk et al. 2009) and aimed at verifying 
previously predicted quantitative trait loci (QTLs) that contain modifiers of the signalling pathways 
(Schmid et al. 2015). By assessing the effect of defined CB4856 and N2 genomic regions or 
the knockdown of selected genes respectively on the outcome of the mutant phenotype, we 
expected to find a number of modifiers of the WNT and RAS/MAPK pathways, which we could 
then describe in more detail and in that contribute another tiny piece of understanding to the 
vast and incomplete field of cancer research. 
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3 
Projects
3.1 Quantitative trait loci on chromosome I affect Wnt and RAS/MAPK 
signalling during vulval induction
3.1.1 Abstract
A number of studies have aimed at investigating the origin and potential treatment of monogenic 
diseases. However, polygenic diseases arising from an interplay between several malfunctioning 
signalling pathways are the predominant cause of up to 60% of deaths in the human population. 
Quantitative genetic approaches provide a powerful tool to elucidate genetic risk factors under-
lying such complex diseases. 
We have used two isolates of C. elegans, N2 Bristol and CB4856 Hawaii, to study the influence 
of naturally occurring polymorphisms on mutant genetic backgrounds well-known to promote 
diseases such as cancer. We chose the development of the C. elegans vulva as the phenotypic 
readout for WNT and EGFR/RAS/MAPK signalling activity, where changes in signalling result in 
either a Multivulva or Vulvaless phenotype that can be quantified at single-cell resolution. 
Previous work has established comprehensive QTL maps spanning the entire genome. The maps 
were generated by comparing an N2 strain carrying a mutation in let-60/RAS or bar-1/ß-catenin 
to animals carrying the let-60 or bar-1 mutation in a mixed N2/CB4856 background (so called 
mutation included recombinant inbred lines, miRILs). We narrowed down the genomic regions 
containing a QTL by generating N2 strains mutant for bar-1 or let-60 and carrying well-defined 
CB4856 introgressions (miILs). Subsequently, we identified candidate polymorphic modifier 
genes of the two pathways by performing RNAi and continued by verifying the candidates with 
the use of mutants. Further studies will be necessary to study the relation between the candi-
date genes and RAS/MAPK or WNT signalling in more detail.
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3.1.2 Introduction
Quantitative genetics describes phenotypes that are not brought about by the textbook Mende-
lian pattern of inheritance, during which one gene gives rise to a phenotype. It is more often the 
case that a number of genes influence a trait quantitatively and in interaction with the environ-
ment (Hill and Mulder 2011). Many diseases, such as diabetes (Donnelly 2008), schizophrenia 
(Purcell et al. 2009) and cancer (Vazquez et al. 2012) are based on such complex traits. A num-
ber of studies aim at identifying these complex traits or risk factors to predict the progress and 
outcome of diseases and to design more effective treatments. Quantitative trait loci (QTLs) are 
genomic regions that contribute such factors and they can be dispersed over an entire genome. 
The mapping of QTLs has helped scientists in finding and characterising genes which contribute 
to diseases (Fisher 1918; Wright 1921; Paterson et al. 1988). 
In this project, we have used the development of the C. elegans vulva as a model to discover 
QTLs influencing the WNT and RAS/MAPK signalling pathways. We employed previously publis-
hed approaches to study natural variation as follows (Doroszuk et al. 2009; Schmid et al. 2015). 
The two strongly diverging wild isolates of C. elegans, N2 Bristol and CB4856 Hawaii differ by one 
single nucleotide polymorphism (SNP) every 412 bp (Thompson et al. 2013), thus allowing a tho-
rough functional analysis of naturally occurring polymorphisms. In order to analyse polymorphic 
modifiers of a signalling pathway, the N2 isolate carrying a mutant allele of a gene acting in this 
signalling pathway is crossed with the CB4856 Hawaiian isolate to generate mutation included 
recombinant inbred lines (miRILs) (Fig. 3.1). The animals are allowed to self-fertilise to enrich for 
homozygous lines, before the genomic constitution is determined by FLP mapping and establis-
hed genomic markers (Zipperlen et al. 2005). The CB4856 Hawaiian genomic regions that alter 
the mutant phenotype as compared to the N2 Bristol background are selected for further ana-
lysis. These regions are verified and narrowed to a smaller region with the help of introgression 
lines (Doroszuk et al. 2009). Since both the N2 Bristol and CB4856 Hawaiian genome have been 
sequenced (Thompson et al. 2015), polymorphic and/or (partially) deleted genes (Maydan et al. 
2010) within the region are determined and analysed by RNAi and subsequent mutant analysis.
3.1.2.1 QTLs in the let-60(n1046gf) / RAS(gf) mutant background
Schmid et al. 2015 performed QTL mapping as described above to identify three QTLs containing 
modifiers of RAS/MAPK signalling: for QTL1 on chromosome 1 the Bristol background caused 
reduced RAS/MAPK activity while the opposite is true for QTL2 on chromosome 2 and QTL3 on 
chromosome V. The QTLs were verified using appropriate introgression lines (ewIR2, 5, 7, 9, 
10, 11 and 17) (Doroszuk et al. 2009) and the QTL found on chromosome I could be subdivided 
into two smaller regions, QTL1a and QTL1b. While QTL1a has not been studied, 107 of the 142 
candidate genes within the smaller QTL1b region were subjected to RNAi to find effects on vulval 
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Figure 3.1. Strategy of QTL mapping. 1) Modifier genes of a selectable trait (e.g. let-60 / RAS or bar-1 / 
ß-catenin) are analysed. 2) The region contributing to the phenotype is determined by crossing the sensi-
tised N2 Bristol strain with CB4856 Hawaii to create mutation included recombinant inbred lines (miRILs). 
QTLs are predicted via genotype-phenotype associations. 3) The predicted QTL is verified and narrowed 
by using lines carrying defined CB4856 Hawaiian introgressions in an otherwise N2 Bristol background. 
A modifier is contained within the genomic region shared among miILs that differ in phenotype from the 
‘pure’ N2 Bristol background. 4) Polymorphic genes exhibiting coding SNPs between CB4856 and N2 as 
well as (partially) deleted genes are identified within the QTL region. 5) These genes are studied via RNAi, 
over-expression and mutant analysis and correlated with the trait of interest.
induction in both the “pure” N2 and CB4856 introgressed line (general RAS/MAPK modifiers) or 
one of the strains only (isolate-specific modifier). For further experiments, the focus was set on 
the 15 polymorphic modifiers found (Schmid et al. 2015), i.e. genes affecting RAS/MAPK signal-
ling either in the N2 or the CB4856 variant and thereby suggesting functional difference between 
the two isolates. Schmid et al. (2015) extensively studied the polymorphic modifier AMX-2, a 
monoamine oxidase which regulates RAS/MAPK signalling through serotonin metabolism. 
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3.1.2.2 QTL map in the bar-1(ga80lf) / ß-catenin(lf) mutant background
Analogous to the studies on polymorphic RAS/MAPK modifiers mentioned above, linkage 
disequilibria had been found in the bar-1(ga80lf) / ß-catenin(lf) mutant background and two 
QTLs affecting vulval induction were predicted for chromosome I and II (Fig. 3.2). We con-
tinued our analysis on the QTL on chromosome I while the Kammenga group investigated 
both QTLs in more detail and verified the second QTL with the introgression lines ewIR21 
and ewIR23 (J. Kammenga, personal communication).
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Figure 3.2. QTL map in the bar-1(ga80) mutant background. By using bar-1(ga80) sensitised RILs, two 
QTLs affecting Wnt signaling during vulval development were identified. These are localised to the far end 
of chromosome I and centrally on chromosome II. The presumptive QTL on chromosome IV requires more 
detailed analysis. Note the absence of information on chromosome X in close proximity to the bar-1 locus, 
where no recombination took place. The x-axis indicates the position of genetic markers and the y-axis shows 
the likelihood of disequilibrium (LOD) score * significance. Graph adapted from T. Schmid, L.B. Snoek.  
3.1.3 Local refinement of the QTL1 in the bar-1(ga80) background
To find modifiers of WNT signalling during vulval development, we continued to focus on 
the QTL on chromosome I, since it partially overlaps with the QTL that was found in the 
let-60(n1046gf) mutant background (Schmid et al. 2015 and Fig. 3.2). To locally refine the QTL 
found in the region around the fragment length polymorphism marker ZH1-08 (I: 12297522) 
(Fig. 3.2 and T. Schmid, personal communication) we chose to use the introgression lines 
ewIR9 (CB4856 region I: 9135001-11315000, markers ZH1-22-egPO105), ewIR10 (CB4856 
region I: 8654362-14162928, markers ZH1-22-ZH1-06 and III: 6444001-11217000, markers 
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pkP3100-pkP3059), and ewIR17 (CB4856 region I: 12433001-15059000, markers pkP1070-
pkP1072) (Zipperlen et al. 2005; Doroszuk et al. 2009; Thompson et al. 2015) that generously 
span the region (Fig. 3.2 and 3.3). In parallel, the Kammenga group employed ewIR13 (posi-
tioned around the marker egPN104) and ewIR14 (markers egPN104-egPO105) (Doroszuk et 
al. 2009). Note that the sequence positions correspond to the Bristol N2 genome (WormBase 
WS195). We crossed the introgression lines into the bar-1(ga80) mutant and determined their 
genotype by PCR and sequencing (bar-1 locus) as well as FLP mapping as described in Zip-
perlen et al. (2005) to determine the presence of introgressed sequences. As controls, we 
included “pure” N2 Bristol and CB4856 animals into the mapping analysis. Since the ewIR10 
introgression line carries genomic regions of CB4856 on chromosome I and III, we performed 
FLP mapping for both regions. We discarded any bar-1(ga80) mutation including ewIR10 in-
trogression line (miIL) carrying CB4856 genomic sequences on chromosome III. From each 
cross between EW15 (bar-1(ga80) mutant) and ewIR9, ewIR10 and ewIR17, we analysed 48 
lines (Tables 3.1, 3.2 and 3.3). Strain numbers are indicated for lines stored at -80 °C. Where 
sequencing gave ambiguous or no results, regions are marked in blue (“heterozygous”) or 
white (no data). 
During the cloning of progeny from ewIR10 miILs, meiotic recombination events in meiosis 
resulted in the diminution and segmentation of the CB4856 region and we obtained a range 
of lines with a combination of smaller introgressed regions (Table 3.2). No recombination took 
place in the progeny of ewIR9 or ewIR17 miILs. 
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Table 3.1. Genetic constitution of bar-1(ga80) mutants introgressed with ewIR9 (chromosome I). The ge-
nomic location is defined by FLP marker positions and the constitution of ewIR9 is indicated as a reference. 
48 lysates were mapped and stored strains are named. Black indicates Hawaiian sequence and grey in-
dicates N2 Bristol sequence. Blue bars indicate heterozygousity (double peak in the sequence) and white 
bars indicate inconclusive sequencing results.   
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Table 3.2. Genetic constitution of bar-1(ga80) mutants introgressed with ewIR10 (chromosome I). The 
genomic location is defined by FLP marker positions and the constitution of ewIR10 is indicated as a re-
ference. 48 lysates were mapped and stored strains are named. Black indicates Hawaiian sequence and 
grey indicates N2 Bristol sequence. Blue bars indicate heterozygousity (double peak in the sequence) and 
white bars indicate inconclusive sequencing results.   
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Table 3.3. Genetic constitution of bar-1(ga80) mutants introgressed with ewIR17 (chromosome I). The 
genomic location is defined by FLP marker positions and the constitution of ewIR17 is indicated as a re-
ference. 48 lysates were mapped and stored strains are named. Black indicates Hawaiian sequence and 
grey indicates N2 Bristol sequence. White bars indicate inconclusive sequencing results.   
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3.1.4  Two QTLs on chromosome I affect WNT signalling
We continued our analysis by determining the vulval induction index of selected strains to verify 
and locally restrict the QTL on chromosome I. We counted vulval induction of several lines, since 
we expected the presence of background mutations we had not genotyped for and that may in-
fluence induction. As expected, we observed a range of vulval induction indexes for both the out-
crossed and the introgressed lines (Tables 3.4, 3.5, 3.6). With the assumption that analysing a 
number of lines balances the effect of background mutations, we found that the VI of bar-1(ga80) 
mutant animals was increased when the CB4856 introgressions of ewIR9, ewIR10 and ewIR17 
were fully present. However, a small CB4856 genomic region at the marker position ZH1-06 only 
(obtained from recombination in ewIR10) did not change the VI (line #34 and AH3331). Interes-
tingly, a complex introgression in AH3367 (Table 3.2, CB4856 sequence at positions ZH1-22, 
possibly ZH1-23, ZH1-15 and ZH1-06 and N2 Bristol sequence at position ZH1-05, ZH1-08 and 
ZH1-09) suppressed vulval induction compared to the outcrossed bar-1(ga80) mutant lines, 
thereby contradicting our previous finding. However, we did not consider the result of this line as 
we had no supportive data from similar lines at this point. At the same time, the Kammenga group 
found a significant contribution to the change in WNT signalling strength by the introgressions 
provided by ewIR13 and ewIR14 (J. Kammenga, personal communication).  
Table 3.4. Mean VI and 95% confidence intervals of bar-1(ga80) mutants with and without the ewIR9 intro-
gression. The values were derived from bootstrapping 1000 samples. *** indicates p < 0.001.
Line / Strain Mean VI 95% C.I. 
AH3335 2.25 2.04 - 2.47
Line #9 2.26 2.01 - 2.48
Line #13 2.59 2.40 - 2.76
AH3333 2.68 2.50 - 2.83
Line #17 2.70 2.56 - 2.81
AH3370 2.80 2.66 - 2.92
average of all 2.52 2.43 - 2.59
Line #25 2.36 1.92 - 2.76
Line #23 2.75 2.55 - 2.93
AH3383 2.78 2.57 - 2.93
AH3334 2.78 2.68 - 2.88
AH3382 2.79 2.68 - 2.89
Line #15 2.86 2.64 - 3.00
Line #16 2.86 2.76 - 2.94
Line #40 2.88 2.70 - 3.00
Line #27 2.92 2.81 - 3.00
average of all 2.78*** 2.71 - 2.84
ewIR9; bar-1(ga80)
bar-1(ga80) mutant 
siblings without 
introgression
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These findings indicate the presence of two rather than one QTL affecting vulval induction 
of bar-1(ga80) mutant animals: The Hawaiian sequence at position ZH1-06, which is loca-
ted distally to the ewIR9 introgression and within the ewIR17 (beginning) and ewIR10 (end) 
introgressions, did not contribute to the phenotype. Furthermore, the ewIR13 and ewIR14 
introgressions are located within the ewIR9 introgression and both changed vulval induc-
tion (J. Kammenga, personal communication). Thus, we suspect a larger QTL of 1.52 Mb 
(I: 9569913-11085294) covered by ewIR13 and a smaller QTL of 0.9 Mb (I: 14162929 – 
15059001) within ewIR17 (Fig. 3.3). Furthermore, these results suggest that the QTL regions 
found in the let-60(n1046) and bar-1(ga80) backgrounds do not overlap.
Table 3.5. Mean VI and 95% confidence intervals of bar-1(ga80) mutants with and without the ewIR10 
introgression (full and partial). The values were derived from bootstrapping 1000 samples. *** indicates p 
< 0.001.
Line / Strain Mean VI 95% C.I. 
AH3381 1.84 1.36 - 2.30
AH3332 1.90 1.52 - 2.24
AH3418 2.01 1.69 - 2.31
Line #8 2.02 1.61 - 2.41
Line #10 2.48 2.23 - 2.71
Line #17 2.59 2.37 - 2.78
Line #19 2.76 2.64 - 2.86
average of all 2.24 2.12 - 2.37
AH3367 1.53 1.18 - 1.89
Line #34 2.34 2.00 - 2.62
AH3331 2.35 2.10 - 2.57
average of all 2.16 1.99 - 2.33
AH3378 2.61 2.46 - 2.75
Line #37 2.73 2.59 - 2.84
Line #42 2.83 2.70 - 2.94
AH3380 2.88 2.77 - 2.97
average of all 2.73*** 2.66 - 2.80
bar-1(ga80) mutant siblings without 
introgression
ewIR10; bar-1(ga80)
small 
introgression
entire 
introgression
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Table 3.6. Mean VI and 95% confidence intervals of bar-1(ga80) mutants with and without the ewIR17 
introgression. The values were derived from bootstrapping 1000 samples. *** indicates p < 0.001.
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Figure 3.3. Local refinement of the QTL1 in the bar-1(ga80) mutant background. Introgression line ana-
lysis revealed two smaller QTLs where vulval induction is increased by the CB4856 sequence. B_QTL1A 
spans 1.52 Mb while B_QTL1B comprises 0.9 Mb. Black – CB4856 introgression, grey – N2 Bristol ge-
nomic region. Sequencing and FLP mapping information in the strains ewIR13 and ewIR14 were not fully 
available at the time of analysis (marked with “?”). We did not genotype the ewIR9 strain at the position 
ZH1-22 but expect the presence of the CB4856 region according to the WGS data (shaded rectangle).  
Line / Strain Mean VI 95% C.I. 
Line #30 2.16 1.90 - 2.43
AH3377 2.18 1.90 - 2.44
Line #4 2.52 2.21 - 2.76
Line #35 2.66 2.49 - 2.82
AH3329 2.74 2.57 - 2.87
average of all 2.46 2.36 - 2.56
Line #25 2.17 1.92 - 2.44
Line #33 2.18 1.92 - 2.42
AH3328 2.43 2.08 - 2.73
Line #14 2.82 2.60 - 2.98
AH3330 2.86 2.76 - 2.95
Line #25 2.86 2.75 - 2.95
Line #1 2.90 2.77 - 2.99
average of all 2.74*** 2.66 - 2.80
bar-1(ga80) mutant 
siblings without 
introgression
ewIR17; bar-1(ga80)
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3.1.5  RNAi screen of polymorphic genes within the B_QTL1B region
To identify polymorphic genes that modify vulval induction in bar-1(ga80) mutant animals, we 
performed RNAi against genes that either contain coding SNPs (Thompson et al. 2015) or are 
(partially) deleted between CB4856 and N2 (Maydan et al. 2010). The smaller B_QTL1B (0.9 Mb) 
region contains 45 such genes (Table 3.7) while we identified 55 polymorphic genes within the 
B_QTL1A region (Table 7.1, Appendix). The amino acid changes caused by the SNP are indicated 
in brackets, if several isoforms are affected. We started our RNAi analysis with the smaller QTL 
and used bacterial clones from commercially available RNAi libraries (Reboul et al. 2001; Rual 
et al. 2004) that we verified by sequencing. We knocked down the candidate genes in AH3330 
(miIL) and AH3377 (bar-1(ga80) sibling mutant line without introgression). Thirteen genes were 
not analysed, either due to the lack of corresponding RNAi clones or because the gene sequence 
could not be verified by sequencing (see Table 3.7 for details). 
Table 3.7. List of polymorphic genes within the QTL1B region in the bar-1(ga80) mutant background. 
Brackets indicate that several isoforms are affected by the SNP.
Gene
Sequence 
name
Amino acid change RNAi
- C37A5.111) Thr15Ala -
- C37A5.7 [Arg147Gly, Arg147Gly] no change / n.a.
pry-1 C37A5.9 Glu229Gly, Met233Val diff. change
pes-7 F09C3.12) Leu372Gln n.a.
fbxa-103 F09C3.4 Gln44Lys, Gly285Cys no change
- F11C3.1 Phe283Cys, Phe283Val no change
unc-122 F11C3.22) Ile503Ser, Leu15Arg n.a.
- F21F12.1 [Ala88Pro, Ala88Pro] no change
- F31C3.3 Gln526Lys, Met1581Val, Thr758Ala, Val89Leu no change
- F31C3.6 Tyr25Ser no change
maph-1.1 F32A7.5 [Gly663Val, Gly535Val, Gly663Val] no change
str-245 F32A7.7 Ala141Thr no change
- F33H2.2 Ser398Cys no change / n.a.
set-10 F33H2.7 Leu52Met no change
sur-2 F39B2.42) [Ile1486Met, Ile1488Met] n.a.
mtcu-1 F39B2.7 [Glu53Asp, Glu53Asp], [Ser24Pro, Ser24Pro] diff. change
- F49B2.3 Thr88Ala diff. change
- F49B2.71)
Arg58Gln, Asp201Gly, Phe188Leu, Ser232Arg, Val-
39Leu
n.a.
clec-116 K04H8.1 Cys104Arg, Gln223Lys no change
- K04H8.22) Ala203Glu, Asn150Asp n.a.
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- K05C4.2 [Val22Ile, Val22Ile, Val22Ile] no change
- K05C4.3 Gly319Glu, Ile114Leu, Lys107Asn, Met473Thr no change
- K05C4.42) Arg36His, Glu159Asp n.a.
- K05C4.7 [Ala267Thr, Ala267Thr] no change / n.a.
- K05C4.82) Gly32Glu, Phe95Leu n.a.
- K05C4.9 deletion diff. change
hpo-13 Y105E8A.102)
[His947Gln, His918Gln, His910Gln, His910Gln, His-
910Gln]
n.a.
- Y105E8A.131) Ala237Pro n.a.
yars-1 Y105E8A.19 Leu213Val
developmental 
arrest
- Y105E8A.20
[Glu396Val, Glu278Val, Glu278Val], [Phe503Leu, 
Phe385Leu, Phe385Leu]
no change
- Y105E8A.21 [Arg720Ser, Arg720Ser] no change
rpom-1 Y105E8A.23 [Asp216Asn, Asp216Asn], [Val56Ile, Val56Ile] no change / n.a.
- Y105E8A.25 Met7Ile diff. change
eat-18 Y105E8A.7 [Gly688Ser, Gly688Ser] no change
- Y105E8A.82) Thr262Ile n.a.
ttm-5 Y54E5A.1 Ile191Val no change
- Y54E5A.2 Ile57Leu, Ser14Pro, Tyr48Phe no change
npp-4 Y54E5A.4 [Thr354Ser, Thr354Ser] developmental 
arrest
smp-1 Y54E5B.1 Ile666Met no change
frm-1 ZK270.2
[Gly3386Trp, Gly3375Trp, Gly3375Trp, Gly3375Trp, 
Gly3375Trp], [Leu645Pro, Leu634Pro, Leu634Pro, 
Leu634Pro, Leu634Pro], [Ser3949Pro, Ser3938Pro, 
Ser3938Pro, Ser3938Pro, Ser3938Pro], [Tyr3704S-
er, Tyr3693Ser, Tyr3693Ser, Tyr3693Ser, Tyr3693S-
er]
no change
tep-1 ZK337.1
[Arg112Gly, Arg112Gly, Arg112Gly, Arg112Gly, Arg-
112Gly, Arg112Gly]
no change / n.a.
- ZK849.1 Cys313Arg no change
best-25 ZK849.42) Leu519Pro n.a.
best-26 ZK849.5 Ser58Arg diff. change
- ZK849.61) Asn58Ser, Ser28Tyr n.a.
1) Gene was not analysed due to the lack of a corresponding RNAi clone.
2) Gene was not analysed since the sequence of the RNAi clone could not be verified by Sanger se-
quencing.
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Figure 3.4. The knock-down of polymorphic genes affects Wnt signalling in either bar-1(ga80) (AH3377) 
or ewIR17; bar-1(ga80) (AH3330) animals (genome-specific modifiers). The difference in VI as compared 
to the respective empty vector controls is shown. Values were derived from bootstrapping 1000 samples. 
The number of animals analysed is indicated in brackets (RNAi clone/eV). Error bars indicate the 95% 
confidence interval. 
The knock-down of C37A5.7, F33H2.2, ZK337.1, K05C4.7 and Y105E8A.23 was not analysed, 
partially due to a bacterial contamination. We observed a developmental arrest in worms when 
we knocked down Y105E8A.19 (yars-1) or Y54E5A.4 (npp-4) in either strain, so that vulval induc-
tion could not be scored. We screened further genes and found no difference in vulval induction 
compared to the empty vector control when we knocked down the genes F09C3.4 (fbxa-103), 
F11C3.1, F21F12.1, F31C3.3, F31C3.6, F32A7.5 (maph-1.1), F32A7.7 (str-245), F33H2.7, 
K04H8.1 (clec-116), K05C4.2, K05C4.3, Y105E8A.20, Y105E8A.21, Y105E8A.7 (eat-18), 
Y54E5A.1 (ttm-5), Y54E5A.2, ZK270.2 (frm-1), ZK849.1 or Y54E5B.1 (smp-1). The silencing 
of C37A5.9 (pry-1), F39B2.7 (mtcu-1), F49B2.3, K05C4.9, Y105E8A.29 and ZK849.5 resulted 
in significant changes in vulval induction in either AH3330 or AH3377 (Table 3.8 and Fig. 3.4). 
Changes in the VI of both strains upon RNAi were not observed. 
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3.1.6 Identification of candidate genes within QTL1a affecting RAS/MAPK 
signalling 
The QTL1a region affecting RAS/MAPK signalling had been previously restricted to the geno-
mic introgression provided by ewIR5 (I: 6280001-10873000) without the overlapping region 
from ewIR2 and ewIR9 (Schmid et al. 2015 and Fig. 3.5). Since the let-60(n1046) mutant 
strain that had carried the introgression of ewIR5 was not available anymore, we re-created 
the miIL and verified it via PCR and sequencing (in terms of the let-60 locus) as well as FLP 
mapping as explained above. Similarly, recombination during the crossing resulted in lines 
that carry smaller parts of the introgressed region present in ewIR5 (Table 3.9 and Fig. 3.5). 
 
Table 3.8. Differential change in the vulval induction index of AH3330 and AH3377 upon 
RNAi.   
       
 
  Mean 95% C.I. P % Vul n 
Y105E8A.29 
ewIR17; bar-1(ga80)1) 2.53 2.25 - 2.80 0.008 40.9 22 
bar-1(ga80)1) 1.75 1.38 - 2.10 0.403 83.3 24 
C37A5.9 
ewIR17; bar-1(ga80)2) 2.97 2.92 - 3.00 0.009 2.5 40 
bar-1(ga80)2) 1.91 1.42 - 2.35 0.183 85.0 20 
ZK849.5 
ewIR17; bar-1(ga80)3) 2.77 2.60 - 2.93 0.762 35.0 20 
bar-1(ga80)3) 1.14 0.74 - 1.54 0.001 84.0 25 
F49B2.3 
ewIR17; bar-1(ga80)3) 2.85 2.71 - 2.96 0.463 21.7 23 
bar-1(ga80)3) 1.48 1.07 - 1.90 0.016 85.2 27 
F39B2.7 
ewIR17; bar-1(ga80)4) 2.79 2.57 - 2.95 0.839 23.1 21 
bar-1(ga80)4) 1.88 1.53 - 2.24 0.001 58.3 31 
K05C4.9 
ewIR17; bar-1(ga80)5) 2.86 2.73 - 2.96 0.562 11.5 26 
bar-1(ga80)4) 2.31 2.00 - 2.60 0.021 33.3 21 
eV1) 
ewIR17; bar-1(ga80) 2.89 2.76 - 3.00 - 13.0 23 
bar-1(ga80) 1.70 1.36 - 2.00 - 85.7 21 
eV2) 
ewIR17; bar-1(ga80) 2.80 2.60 - 2.95 - 20.0 20 
bar-1(ga80) 1.57 1.10 - 2.08 - 80.0 20 
eV3) 
ewIR17; bar-1(ga80) 2.84 2.68 - 2.98 - 18.2 22 
bar-1(ga80) 2.05 1.72 - 2.38 - 64.7 34 
eV4) 
ewIR17; bar-1(ga80) 2.90 2.80 - 2.98 - 20.0 20 
bar-1(ga80) 2.70 2.50 - 2.90 - 35.0 20 
eV5) 
ewIR17; bar-1(ga80) 2.89 2.77 - 3.00 - 11.5 26 
bar-1(ga80) - - - - - 
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Table 3.9. Genetic constitution of let-60(n1046) mutants introgressed with ewIR5 (chromosome I). The 
genomic location is defined by FLP marker positions and the constitution of ewIR5 is indicated as a refe-
rence. 48 lysates were mapped and stored strains are named. Black indicates Hawaiian sequence and 
grey indicates N2 Bristol sequence. Blue bars indicate heterozygousity (double peak in the sequence) and 
white bars indicate inconclusive sequencing results.   
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We determined the vulval induction index of selected lines and verified the increase in vulval 
induction by the full CB4856 introgression provided by ewIR5 (Table 3.10 and Fig. 3.5). Further-
more, vulval induction of let-60(n1046) mutant animals was increased significantly in lines car-
rying the CB4856 sequence at the marker positions ZH1-34, ZH1-01, ZH1-22 and ZH1-23 (e.g. 
AH3321). RAS/MAPK signalling was still enhanced when the CB4856 sequence was present at 
ZH1-34, ZH1-01 and ZH1-22 only (AH3324). Finally, the vulval induction index was unchanged 
in let-60(n1046) mutant lines positive for the Hawaiian sequence at positions ZH1-34 and ZH1-01 
(AH3319) or ZH1-15 only (AH3325) (Table 3.10 and Fig. 3.5) (Note that in AH3319, the genoty-
ping was inconclusive at the marker position ZH1-34, but we assumed the presence of CB4856 
sequence since double recombination seemed unlikely). These findings suggest that modifiers 
of RAS/MAPK signalling are present at and closely around the ZH1-22 marker position. Since 
previous analyses had excluded a contribution by the ewIR2 and ewIR9 introgressions (Schmid 
et al. 2015), the QTL1a region containing modifiers could be placed at I: 8416905-9135000, thus 
spanning 0.7 Mb (Fig. 3.5).
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Figure 3.5. Local refinement of the QTL1a in the let-60(n1046) mutant background. Introgression line 
analysis revealed a smaller QTL where vulval induction is increased by the CB4856 sequence. The QTL1a 
spans 0.7 Mb. Black – CB4856 introgression, grey – N2 Bristol genomic region. The sequencing and FLP 
mapping information at the marker position ZH1-34 in AH3319 was inconclusive and is marked with „?“. 
We did not genotype the ewIR9 strain at the position ZH1-22 but expect the presence of the CB4856 region 
according to the WGS data (shaded rectangle).  
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Table 3.10. Mean VI and 95% confidence intervals of let-60(n1046) mutants with and without the ewIR5 
introgression (full or partial). The values were derived from bootstrapping 1000 samples. *** indicates p < 
0.001 and ** p < 0.01.
Line / Strain Mean VI 95% C.I.
Line #37 3.37 3.17 -  3.56 
AH3362 4.24 3.86 -  4.62 
Line #10 3.29 3.12 - 3.48 
AH3323 3.52 3.25 - 3.83 
AH3326 3.76 3.50 - 4.02 
Line #42 3.47 3.28 - 3.67 
Line #29 3.50 3.23 - 3.83 
average of all 3.57 3.47 - 3.67
AH3363 4.31 4.02 - 4.62
Line #7 3.96  3.66 - 4.28 
Line #2 3.48  3.25 - 3.70 
Line #3 3.69 3.40 - 3.98
AH3320 4.24 3.94 - 4.52 
AH3322 3.92 3.61 - 4.30 
average of all 3.97*** 3.84 - 4.10
AH3319 3.65 3.43 - 3.87 
AH3325 3.50 3.28 - 3.73 
Line #22 3.59 3.40 - 3.79 
Line #30 3.50 3.28 - 3.75 
AH3324 3.95** 3.67 - 4.23 
AH3321 3.98*** 3.79 - 4.19 
ewIR5; let-60(n1046)
partial introgression
let-60(n1046) mutant 
siblings without 
introgression
ewIR5; let-60(n1046)
entire introgression
We looked for polymorphic genes in this region and found 47 genes carrying coding SNPs bet-
ween the N2 Bristol and CB4856 Hawaiian genomes (Thompson et al. 2015) (Table 3.11). We 
performed RNAi against 41 genes of which i) clones were available and ii) the sequences could 
be verified by sequencing (see Table 3.11 for details). We employed AH3326 (let-60(n1046) in 
the “pure” N2 Bristol background) and AH3363 (let-60(n1046) miIL). As we had expected, we 
found candidates affecting RAS/MAPK signalling in one background only (Table 3.12 and Fig. 
3.6) or in both backgrounds (Table 3.13 and Fig. 3.7). 
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Table 3.11. List of polymorphic genes within the QTL1a region in the let-60(n1046) mutant back-
ground. Brackets indicate that several isoforms are affected by the SNP. 
Gene
Sequence 
name
Amino acid change RNAi
- C31H5.1 Ala112Val no change
- C36B1.91) Ile107Thr n.a.
ceh-6 K02B12.1 Ser167Asn, Pro341Leu diff. change
cle-1 C36B1.1 [Val240Asp, Val240Asp] no change
cutl-7 F53B6.6 Lys562Thr no change
- D1081.101) Val182Leu, Asn105His, Glu179Lys n.a.
- D1081.4 Asn150Asp no change
- D1081.5 Leu269Ser change in both
- D1081.9 Ile178Leu no change
- F25H5.7 Val149Asp no change
- F29D10.3 Gly300Cys change in both
- F32H2.10 Phe84Ser diff. change
- F32H2.6 Ser142Leu
developmental 
arrest
- F32H2.7 Glu247Gly no change
- F36A2.13
[Ala1848Val, Ala1848Val], [Asn2045Ser, 
Asn2045Ser], [Ser2639Thr, Ser2639Thr], [Val-
2627Gly, Val2627Gly]
no change
- F36A2.2 Asn398Asp change in both
- F39H11.1 [Lys24Gln, Lys24Gln] no change
- F43G9.12 Phe478Ile sterility
- F43G9.3 Gln163Arg no change
- F53B6.4 Thr120Lys no change
- F55H12.3
Glu1733Asp, Phe2921Val, Cys973Phe, Asn-
2941His, Gln580Lys
diff. change
fasn-1 F32H2.5 Pro420Leu death at L1/L2
fcp-1 F36F2.6 Val654Ala diff. change
fer-1 F43G9.6
[Gly1454Asp, Gly1327Asp, Gly1327Asp], [Gln-
1317Lys, Gln1190Lys, Gln1190Lys], [Gln1919His, 
Gln1792His, Gln1792His]
diff. change
gls-1 C36B1.8 [Pro708Ser, Pro708Ser, Pro664Ser] no change
gon-2 T01H8.5
[Ala1115Val, Ala1176Val, Ala1075Val, Ala770Val], 
[Met668Leu, Met729Leu, Met628Leu, Met323Leu]
diff. change
- K02B12.2 Ala85Glu no change
- K02B12.5 Leu569Arg no change
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- K07A12.1 [Arg154His, Arg154His] change in both
mrps-15 K07A12.7 Thr95Ile sterility
mrt-1 F39H2.51) [Ser527Tyr, Ser527Tyr] n.a.
pqn-26 DY3.5 Leu22Ser diff. change
prmt-7 W06D4.4 [Thr617Ile, Thr617Ile] no change
- R05D11.52) [Leu158Met, Leu158Met] n.a.
- R05D11.91) Ala301Val n.a.
rad-54 W06D4.6 Ala127Thr diff. change
rskn-1 T01H8.1
[Ala439Ser, Ala445Ser, Ala406Ser, Ala388Ser, 
Ala426Ser, Ala426Ser]
change in both
sec-12 K02B12.3 Glu17Asp death at L1/L2
sup-17 DY3.7 [Phe195Leu, Phe195Leu] change in both
syx-7 F36F2.42) [Ala127Ser, Ala127Ser] n.a.
- T08G11.1
[Pro1704Gln, Pro1704Gln, Pro1704Gln], [Va-
l2807Ala, Val2807Ala, Val2834Ala]
no change
- T08G11.2 Leu131Ser no change
- T08G11.3 His491Gln no change
- W06D4.3 Cys147Phe, Cys147Ser change in both
- ZK858.5 Glu384Gln diff. change
- ZK858.6 [Pro181Leu, Pro181Leu, Pro218Leu] no change
- ZK858.7 Val297Ala change in both
1) Gene was not analysed due to the lack of a corresponding RNAi clone.
2) Gene was not analysed since the sequence of the RNAi clone could not be verified by Sanger 
sequencing. 
RNA interference of F32H2.6, F43G9.12, F32H2.5 (fasn-1), F36F2.6 (fcp-1) and K02B12.3 
(sec-12) caused developmental defects and vulval induction could not be scored. The knock-
down of F43G9.12 and K07A12.7 (mrps-15) led to sterility of the P0 generation and no pro-
geny while worms subjected to on F32H2.5 (fasn-1) or K02B12.3 (sec-12) RNAi died at the 
L1/L2 stage. Interestingly, the non-introgressed let-60(n1046) mutant strain AH3326 died as 
embryos on F32H2.6 RNAi, whereas the introgressed worms (AH3363) hatched and lived but 
arrested soon thereafter. Moreover, the reduction of F36F2.6 (fcp-1) resulted in a developmen-
tal delay of approx. one day for the non-introgressed line and a 1.5 – 2 days delay for the 
introgressed line as well as an overall sick appearance of both strains. Nevertheless, vulval 
induction was scored and was affected in AH3363 but not AH3326 (Table 3.12 and Fig. 3.6). 
A genomic background specific change in vulval induction was furthermore discovered when 
K02B12.1 (ceh-6), T01H8.5 (gon-2), F32H2.10, F55H12.3, F43G9.6 (fer-1), W06D4.6 (rad-54) or 
ZK858.5 were knocked down. 
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Table 3.12. Differential change in the vulval induction index of AH3326 and AH3363 upon 
RNAi.  
       
   Mean 95% C.I. P % Muv n 
K02B12.1 
ewIR5; let-60(n1046)1) 4.99 4.65 - 5.33 0.942 100.0 20 
let-60(n1046)1) 5.15 4.91 - 5.40 0.000 100.0 29 
T01H8.5 
ewIR5; let-60(n1046)1) 4.49 4.12 - 4.86 0.310 85.7 21 
let-60(n1046)1) 4.87 4.59 - 5.13 0.013 96.4 28 
F32H2.10 
ewIR5; let-60(n1046)2) 4.08 3.75 - 4.40 0.539 71.9 32 
let-60(n1046)2) 4.52 4.23 - 4.82 0.000 93.3 30 
F36F2.6 
ewIR5; let-60(n1046)2) 3.22 3.06 - 3.42 0.000 27.8 18 
let-60(n1046)2) 3.60 3.29 - 3.95 0.272 42.9 21 
F55H12.3 
ewIR5; let-60(n1046)3) 4.79 4.48 - 5.08 0.313 91.7 24 
let-60(n1046)3) 5.19 4.95 - 5.40 0.003 100.0 29 
F43G9.6 
ewIR5; let-60(n1046)4) 3.81 3.48 - 4.09 0.001 57.6 33 
let-60(n1046)4) 3.83 3.52 - 4.16 0.365 60.0 25 
W06D4.6 
ewIR5; let-60(n1046)5) 4.93 4.64 - 5.23 0.829 100.0 22 
let-60(n1046)5) 5.13 4.89 - 5.35 0.000 100.0 27 
ZK858.5 
ewIR5; let-60(n1046)6) 4.80 4.52 - 5.07 0.230 91.3 23 
let-60(n1046)6) 4.34 4.10 - 4.58 0.001 92.0 25 
eV1) 
ewIR5; let-60(n1046) 4.62 4.32 - 4.89 - 95.5 22 
let-60(n1046) 4.40 4.13 - 4.69 - 90.3 31 
eV2) 
ewIR5; let-60(n1046) 4.06 3.73 - 4.42 - 74.2 31 
let-60(n1046) 3.71 3.45 - 3.97 - 63.3 30 
eV3) 
ewIR5; let-60(n1046) 4.88 4.67 - 5.07 - 96.6 29 
let-60(n1046) 4.67 4.42 - 4.93 - 96.7 30 
eV4) 
ewIR5; let-60(n1046) 4.35 4.14 - 4.54 - 88.6 35 
let-60(n1046) 3.90 3.66 - 4.14 - 74.3 35 
eV5) 
ewIR5; let-60(n1046) 4.74 4.46 - 5.02 - 96.3 27 
let-60(n1046) 4.50 4.21 - 4.79 - 89.7 29 
eV6) 
ewIR5; let-60(n1046) 4.94 4.64 - 5.20 - 96.0 25 
let-60(n1046) 4.83 4.60 - 5.08 - 100.0 24 
 
RNA interference of ZK858.7, DY3.5 (pqn-26), D1081.5, T01H8.1, W06D4.3, K07A12.1, 
F29D10.3, DY3.7 and F36A2.2 altered the VI of both AH3363 and AH3326 (Table 3.13 and 
Fig. 3.7). Note that the knockdown of ZK858.7 reduced vulval induction to almost wild-type 
levels in both strains. No change was observed when C31H5.1, C36B1.1 (cle-1), F53B6.6 
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Table 3.13. Changes in the vulval induction index of AH3326 and AH3363 upon RNAi.  
       
 
  Mean 95% C.I. P % Muv n 
T01H8.1 
ewIR5; let-60(n1046)1) 5.10 4.87 - 5.28 0.010 100.0 27 
let-60(n1046)1) 5.02 4.79 - 5.23 0.000 100.0 28 
W06D4.3 
ewIR5; let-60(n1046)2) 3.00 3.00 - 3.00 0.000 0.0 40 
let-60(n1046)2) 3.00 3.00 - 3.00 0.000 0.0 40 
K07A12.1 
ewIR5; let-60(n1046)3) 3.34 3.15 - 3.58 0.000 45.0 20 
let-60(n1046)3) 3.20 3.10 - 3.37 0.000 33.3 15 
F29D10.3 
ewIR5; let-60(n1046)4) 3.80 3.56 - 4.03 0.000 71.9 32 
let-60(n1046)4) 4.10 3.82 - 4.38 0.004 86.7 30 
D1081.5 
ewIR5; let-60(n1046)4) 3.99 3.77 - 4.12 0.000 86.7 30 
let-60(n1046)4) 3.76 3.53 - 4.02 0.000 63.3 30 
DY3.7 
ewIR5; let-60(n1046)4) 3.83 3.61 - 4.06 0.000 74.3 35 
let-60(n1046)4) 3.63 3.42 - 3.83 0.000 66.7 30 
F36A2.2 
ewIR5; let-60(n1046)4) 3.90 3.48 - 4.35 0.000 65.0 20 
let-60(n1046)4) 3.93 3.69 - 4.17 0.000 76.9 26 
DY3.5 
ewIR5; let-60(n1046)5) 4.64 4.39 - 4.89 0.037 96.4 28 
let-60(n1046)5) 4.34 4.08 - 4.62 0.006 88.5 26 
ZK858.7 
ewIR5; let-60(n1046)6) 3.03 3.00 - 3.10 0.000 3.2 31 
let-60(n1046)6) 3.03 3.00 - 3.10 0.000 3.3 30 
eV1) 
ewIR5; let-60(n1046) 4.61 4.32 - 4.90 - 95.5 22 
let-60(n1046) 4.41 4.12 - 4.69 - 90.3 31 
eV2) 
ewIR5; let-60(n1046) 4.74 4.48 - 4.98 - 96.3 27 
let-60(n1046) 4.50 4.22 - 4.78 - 89.7 29 
eV3) 
ewIR5; let-60(n1046) 4.34 4.24 - 4.54 - 88.6 35 
let-60(n1046) 3.89 3.67 - 4.13 - 74.3 35 
eV4) 
ewIR5; let-60(n1046) 4.82 4.62 - 5.03 - 100.0 30 
let-60(n1046) 4.53 4.27 - 4.79 - 91.4 35 
eV5) 
ewIR5; let-60(n1046) 4.34 4.11 - 4.54 - 88.6 35 
let-60(n1046) 3.90 3.67 - 4.12 - 77.1 35 
eV6) 
ewIR5; let-60(n1046) 4.06 3.76 - 4.40 - 74.2 31 
let-60(n1046) 3.72 3.47 - 3.97 - 63.3 30 
 
(cutl-7), D1081.4, D1081.9, F25H5.7, F32H2.7, F36A2.13, F39H11.1, F43G9.3, F53B6.4, 
C36B1.8 (gls-1), K02B12.2, K02B12.5, W06D4.4 (prmt-7), T08G11.1, T08G11.2, T08G11.3 
or ZK858.6 were knocked down. 
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AH3363 (ewIR5; let-60(n1046)) 
ΔVI upon RNAi treatment in AH3326 and AH3363
Figure 3.6. The knockdown of polymorphic genes affects RAS/MAPK signalling in either let-60(n1046) 
(AH3326) or ewIR5; let-60(n1046) (AH3363) animals (genome-specific modifiers). The difference in VI as 
compared to the respective empty vector controls is shown. Values were derived from bootstrapping 1000 
samples. The number of animals analysed is indicated in brackets (RNAi clone/eV). Error bars indicate the 
95% confidence interval. 
We have started the verification of the RNAi results by using corresponding mutants. Here, 
we focused on the modifiers that exhibited genome-specific, “differential” effects (i.e. where 
either the CB4856 Hawaiian or the N2 Bristol allele showed altered vulval induction upon RNAi) 
and have human orthologues. We have crossed balanced mutants carrying a deletion in gon-2 
(VC1463) or ceh-6 (VC2666) to the let-60(n1046) mutant animals, but have not had the time to 
analyse their VI. Further mutants of fer-1, fcp-1, ZK858.5 and rad-54 exist but have not been 
crossed. The verification of F55H12.3 and F32H2.10 would include prior mutagenesis (e.g. via 
CRISPR) to obtain an appropriate mutant.
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ΔVI upon RNAi treatment in AH3326 and AH3363
Figure 3.7. The knockdown of polymorphic genes affects RAS/MAPK signalling in both let-60(n1046) 
(AH3326) and ewIR5; let-60(n1046) (AH3363) animals (general modifiers). The difference in VI as com-
pared to the respective empty vector controls is shown. Values were derived from bootstrapping 1000 
samples. The number of animals analysed is indicated in brackets (RNAi clone/eV). Error bars indicate the 
95% confidence interval. 
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3.1.7 Discussion
Previous studies have helped in gaining insight into how mis-regulated signalling pathways such 
as WNT and RAS/MAPK predispose to or initiate a certain disease (Giles et al. 2003; Prior et al. 
2012) and thereby represent basic pathological determinants. However, little is known about the 
contribution of so called „modifier genes“ that influence signalling strength, networks and modes 
of crosstalk (Eichler et al. 2010; Stessman et al. 2014). In this project, we have continued the 
work described by Schmid et al. (2015) to identify such modifier genes affecting the WNT and 
RAS/MAPK signalling pathways. Their previous efforts resulted in the prediction of three QTLs 
(chromosome I, II and V) that modify RAS/MAPK signalling (Schmid et al. 2015) and two QTLs 
(chromosome I and II) containing modifiers of WNT signalling (Schmid et al., unpublished data). 
Using selected lines of an introgressed N2 Bristol / CB4856 collection that covers the entire 
genome (Doroszuk et al. 2009) we were able to not only verify the predicted QTLs on the first 
chromosome, both in terms of WNT and RAS/MAPK signalling, but also to narrow the regions 
(Tables 3.9, 3.10) and subdivide the QTL in the bar-1(ga80) background (Fig. 3.3). By perfor-
ming RNA interference on animals carrying the bar-1(ga80) or let-60(n1046) mutation in the “pure” 
N2 Bristol or the N2 Bristol / CB4856 introgressed background, we identified a number of modifiers 
that appear to be either general modifiers of the signalling pathway analysed, i.e. induction was 
affected upon RNAi in both strains, or background specific modifiers, i.e. induction was affected 
upon RNAi in either the introgressed or non-introgressed strain. Further analysis of these candi-
date genes by mutant analysis, fluorescent reporter constructs, epistasis or tissue-specificity will 
verify the RNAi data and help discovering a mechanistic link to the pathway affected. 
3.1.7.1 RNAi is partially limited to the analysis of non-synonymous SNPs
Thompson et al. (2013) identified on average one polymorphism every 412 bp between CB4856 
and N2 Bristol. It is plausible that these SNPs are not confined to coding, exonic regions of genes 
but also dispersed across 5’ or 3’ untranslated regions, regulatory elements (e.g. enhancers) or 
noncoding RNA. Although RNA interference with noncoding RNA is not impossible, it is compli-
cated by secondary structures or nuclear localisation of the RNA (Gutschner et al. 2011). The 
analysis of untranscribed DNA stretches by RNAi on the other hand is impossible due to obvious 
reasons. As a consequence, we limited our analysis to non-synonymous SNPs with the notion 
that protein function is altered between isolates and can be assessed by RNAi. However, the re-
gulatory nature of untranslated DNA should not be underestimated as it contributes to translational 
control, mRNA stability, splicing, localisation or post-transcriptional regulation by miRNAs (Mignone 
et al. 2002). Transcription factor binding sites within promoter, 3’ UTR or intronic regions determine 
temporal and spatial gene expression patterns (Beck et al. 1991; Choi et al. 2012). Indeed, a 
great fraction of the SNPs identified between CB4856 and N2 maps to such untranslated regi-
ons (Thompson et al. 2015). An analysis of such synonymous SNPs went beyond the scope of 
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this thesis but could be incorporated in future studies by including expression QTL analyses 
(eQTLs). Especially during the detailed analysis of candidate genes identified by RNAi, the 
relative importance of non-coding SNPs within the candidate gene sequence should be inter-
rogated, e.g. via CRISPR/Cas9 mediated modification. 
3.1.7.2 Functional polymorphisms can give rise to background specific modifiers 
The presence of the N2 Bristol background at the position of QTL1 in both let-60(n1046) and 
bar-1(ga80) decreased signalling strength and vice versa, the CB4856 region enhanced sig-
nalling (Schmid et al. 2015 and Fig. 3.2), which supports previous findings on natural variation 
during vulval development (Milloz et al. 2008). We had expected to encounter one or several 
of four scenarios upon knockdown of polymorphic candidate genes. Firstly, the knockdown of 
an inhibitor present in the N2 background but not or less active in CB4856 would enhance the 
VI of non-introgressed mutants. Conversely, the inactivation of an inhibitor present in CB4856 
but absent or less active in N2 should increase induction in Hawaii but not Bristol. Thirdly, the 
suppression of an enhancer acting in N2 but not (or less) in CB4856 is expected to lower the 
vulval induction of non-introgressed but not introgressed lines and finally, the opposite should 
occur for a CB4856 specific enhancer. We discovered candidates for N2 Bristol specific inhibitors 
(K02B12.1 (ceh-6), T01H8.5 (gon-2), F32H2.10, F55H12.3 and W06D4.6 (rad-54)), N2 specific 
enhancers (ZK858.5, ZK849.5 (best-26), F49B2.3, F39B2.7 (mtcu-1) and K05C4.9) and CB4856 
specific enhancers (F36F2.6 (fcp-1), F43G9.6 (fer-1) and Y105E8A.29) (Tables 3.8, 3.12 and 
Fig. 3.4, 3.6). The knockdown of C37A5.9 (pry-1) increased vulval induction in the introgressed 
bar-1(ga80) mutant strain AH3330 but not AH3377 suggesting it encodes a CB4856 specific 
inhibitor. However, our RNAi experiments with bar-1(ga80) introgressed and non-introgressed 
animals generally exhibited a considerable variability in vulval induction indexes so that the 
results request cautious interpretation. PRY-1 is the worm Axin (Korswagen 2002) and it is 
therefore likely that loss of the protein increases WNT signalling strength in both introgressed 
and non-introgressed lines.
3.1.7.3 Polymorphic genes can affect RAS/MAPK signalling irrespective of the genomic 
background
In addition to polymorphic genes that act differently depending on the genomic background they 
are placed in, we discovered more general modifiers of RAS/MAPK signalling (T01H8.1 (rskn-1), 
W06D4.3, K07A12.1, F29D10.3, D1081.5, DY3.7 (sup-17), F36A2.2, DY3.5 (pqn-26) and 
ZK858.7), i.e. RNA interference caused a change in vulval induction in both the introgressed and 
non-introgressed strain (Table 3.13 and Fig. 3.7). A direct involvement in RAS/MAPK signalling 
of RSKN-1 and SUP-17 is likely. RSKN-1 has been described as a critical downstream effec-
tor of RAS/MAPK signalling (Cha et al. 2012) and encodes a member of the RSK (ribosomal 
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S6 kinase) family of serine/threonine kinases which are targets of RAS/MAPK-ERK (Frödin and 
Gammeltoft 1999) and themselves negatively feed back on the cascade (Saha et al. 2012). 
SUP-17 is an ADAM protein, which is a metalloproteinase involved in Notch receptor cleavage 
and signalling (Wen et al. 1997) that strongly interacts with RAS/MAPK signalling during vulval 
development (Yoo et al. 2004). The product of ZK858.7 appeared to play a central role during 
RAS/MAPK signalling, since its knockdown reduced the VI to levels comparable with the wild-
type. ZK858.7 is orthologous to human tRNA methyltransferase 6 that has been implicated in 
1-methyladenosine modification on mitochondrial tRNAs (Chujo and Suzuki 2012) and frameshift 
mutations have been discovered in colon cancer (Yeon et al. 2017).
3.1.7.4 Some caveats for the comparative study of different strains
Our findings support the feasibility of using natural wild isolates and introgression lines obtained 
thereof to investigate modifiers of well-known signalling pathways. However, one might argue 
that an obvious disadvantage of this approach is the combination of different genomic back-
grounds that have evolved in the introgression lines, the N2 Bristol and mutant lines. This seems 
disturbing, since the aim is in fact to find modifiers rather than to introduce them into the system. 
Indeed, the introgression lines were obtained from crosses between N2 Bristol and CB4856 
(Doroszuk et al. 2009) and were subsequently used in crosses to include the introgression into 
yet another C. elegans strain containing a sensitising mutation. Thus, the genomic backgrounds 
of at least three C. elegans lines exposed to individual natural selection were combined to obtain 
the final experimental strain and to study natural polymorphisms. With the rapid progress and 
dropping costs in whole genome sequencing it becomes clear that strains differ more strongly in 
their genetic constitution than anticipated (Thompson et al. 2013 and T. Schmid, doctoral thesis). 
The MT2124 strain commonly used to study the let-60(n1046) mutation is a good example for a 
strong deviation from the wild-type situation, since it contains several SNPs in core components 
of the RAS/MAPK pathway itself (e.g. let-23, age-1 or gap-1). It is thus important to be aware of 
this issue when the effect of polymorphisms on a given mutant background and within a defined 
environment is studied. Clearer conclusions of the relative effect of a modifier can be drawn 
by performing allele swapping experiments using established methods like MosSCI (Frøkjær-
Jensen et al. 2008) or CRISPR/Cas9 for endogenous gene modification (Jinek et al. 2012). 
In summary, the approach proposed by Schmid et al. (2015) and others is promising in defining 
new modifiers of well-described signalling pathways and in uncovering their contribution to 
disease development. Especially by using simple short-lived model organisms, the generation 
of genetically mixed backgrounds is feasible and allows the generation of an immense amount of 
data within a relatively short period of time. In the current project, we have superficially analysed 
the effect of polymorphisms on protein function. However, the use of introgression lines can be 
and is extended to the field of genetical genomics to interrogate mRNA or protein expression 
level variation (Breitlin et al. 2008), which exemplifies the value of studying natural variation. 
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One Sentence Summary: 
Atmospheric oxygen levels modulate the RAS/MAPK signaling pathway in the Nematode C. 
elegans through a cross-talk between the DELTA/NOTCH and Hypoxia signaling pathways. 
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Maxeiner et al. 
Abstract: 
 
Animals need to adjust many cellular functions to oxygen availability. We show that the 
Nematode C. elegans adapts the activity of the conserved RAS/MAPK pathway, a key 
regulator of various functions during development and adulthood, to changes in 
atmospheric oxygen concentration. Hypoxia inhibits the cellular responses to RAS/MAPK 
activation via the hypoxia-inducible factor HIF-1, which induces the nuclear hormone 
receptor NHR-57 to counteract MAPK signaling. Furthermore, cross-talk between the 
NOTCH and hypoxia pathways modulates the sensitivity of the RAS/MAPK pathway to 
hypoxia. Lateral NOTCH signaling induces the prolyl-hydroxylase EGL-9, which promotes 
HIF-1 degradation in uncommitted precursor cells, thereby allowing RAS/MAPK-induced 
differentiation. By inducing DELTA family NOTCH ligands, RAS/MAPK signaling creates 
a positive feedback loop that keeps precursor cells competent to respond to inductive 
signals. This regulatory network between the NOTCH, Hypoxia and RAS/MAPK pathways 
permits adaptation of developmental processes to variations in oxygen concentration. 
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Main Text:  
 
The RAS/MAPK pathway regulates cell growth, differentiation, proliferation, apoptosis and 
migration in all metazoans (1). Moreover, constitutively activating mutations in HRAS, NRAS 
or KRAS are among the most frequent tumor initiating mutations in human cancer (2). In C. 
elegans, RAS/MAPK signaling is involved in several developmental processes, such as the 
specification of the excretory duct cell precursor, the differentiation and maturation of meiotic 
germ cells or the development of the hermaphrodite vulva (3-5). During vulval development, an 
EGF-like ligand (LIN-3) is secreted from the gonadal anchor cell (AC) to activate RAS/MAPK 
signaling in the adjacent vulval precursor cells (VPCs) through an EGF receptor family tyrosine 
kinase (Fig. 1A). Activation of RAS/MAPK signaling in the proximal VPCs that are near the AC 
(P5.p, P6.p & P7.p) induces the expression of Delta-like DSL ligands, which activate 
DELTA/NOTCH signaling between adjacent VPCs. NOTCH performs two distinct functions 
during vulval induction. First, NOTCH maintains the VPCs competent to respond to the 
inductive AC signal and differentiate (6). After the VPC closest to the AC, P6.p, has reached the 
highest RAS/MAPK activity and adopted the primary (1°) fate, strong activation of the NOTCH 
pathway in the neighboring VPCs P5.p and P7.p inhibits MAPK signaling and specifies the 
secondary (2°) fate in these cells (6, 7). The distal VPCs (P3.p, P4.p and P8.p), which receive 
neither the RAS/MAPK nor NOTCH signal, adopt the tertiary (3°), uninduced fate. This results 
in the induction of the three proximal VPCs and establishes a robust 3°-3°-2°-1°-2°-3° pattern of 
vulval cell fates (7). Activating mutations in the RAS/MAPK pathway lead to the induction of 
more than three VPCs and a Multivulva (Muv) phenotype, while loss-of-function mutations in 
components of the RAS/MAPK pathway cause a Vulvaless (Vul) phenotype. Thus, the average 
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number of induced VPCs, termed the vulval induction index (VI), is used to quantify signaling 
strength (e.g. VI>3 indicates hyperinduction). 
Animals have evolved cellular and behavioral responses to adapt to variations in oxygen 
concentration. At the cellular level, the hypoxia-response pathway mediates the adaptation to low 
oxygen conditions and a switch from aerobic to anaerobic metabolism (8). In ambient oxygen, 
the C. elegans hypoxia-inducible factor α HIF-1 is hydroxylated at a specific proline residue 
within the degradation domain by the prolyl hydroxylase EGL-9 (Fig. 2A). Hydroxylated HIF-1 
interacts with the von Hippel-Lindau E3 ubiquitin ligase VHL-1 complex and is degraded by the 
26S proteasome (9). HIF-1 is stabilized in low oxygen and forms a complex with the 
constitutively expressed HIFß subunit AHA-1 to promote the expression of specific target genes. 
We have previously used quantitative genetics to identify modifiers of the RAS/MAPK pathway 
by comparing two highly polymorphic C. elegans strains, N2 Bristol and CB4856 Hawaii (10). 
Notably, CB4856 Hawaii exhibits an overall elevated activity of the RAS/MAPK pathway 
compared to the N2 Bristol reference strain. Among the RAS/MAPK modifiers identified were 
F44F1.1, a calpain paralog (F44F1.3) and pfd-3, a prefoldin orthologous to human VHL binding 
protein 1 (10). Both genes had been identified in a screen for suppressors of the egl-9 prolyl 
hydroxylase egg-laying-defective phenotype (11). Together, these findings suggested that 
genetic variation of the hypoxia-response pathway might account for differences in RAS/MAPK 
signaling activity in different C. elegans isolates. 
To test this hypothesis, we used CRISPR/CAS9 editing to introduce the activating G13E let-60 
ras mutation (12) into the CB4856 Hawaii (zh122) and N2 Bristol (zh121) backgrounds and 
determined the VI of animals raised at different oxygen concentrations. CB4856 animals 
carrying the G13E mutation exhibited a higher VI than N2 animals carrying the same mutation 
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when raised between 21% (normoxia) and 3% O2 (mild hypoxia) (Fig. 1B,C). At 1% O2 the VI 
decreased in the CB4856 background, and at 0.5% O2 the VI was reduced to the same level in 
both strains. Thus, the difference in RAS/MAPK pathway activity between CB4856 and N2 may 
be due to differences in their oxygen sensitivity. Besides the canonical let-60 G13E allele 
(n1046), hypoxia (0.5% O2) also reduced the VI in animals carrying rf mutations in let-23 egfr, 
let-60 ras or lin-45 raf and an activated MAPK transgene mpk-1(gaIs37gf) (Fig. 1D). However, 
the VI of lin-1(lf), which encodes an Ets transcription factor that represses vulval induction 
downstream of MPK-1, was not affected by hypoxia. In addition to vulval development, hypoxia 
also reduced RAS/MAPK signaling in germ cells and during excretory duct cell specification. 
The germ cells of let-60 ras(ga89gf) mutants raised at the restrictive temperature exit the 
pachytene stage at an accelerated rate (4), which results in the proximal stacking of immature 
oocytes (Fig. 1E), while let-60 ras(n1046gf) animals often exhibit duplications of the duct cell 
(3) (Fig. 1F). Hypoxia partially suppressed both let-60(gf) phenotypes (Fig. 1E,F). 
The abrupt rather than gradual reduction in RAS/MAPK activity under hypoxia (Fig. 1C) 
suggested the existence of a regulatory switch activated at a threshold oxygen concentration, 
rather than a metabolic effect of hypoxia. We thus examined the genetic interaction between 
mutants in the RAS/MAPK and hypoxia-response pathways. The VI of let-60(n1046gf) mutants 
was reduced by lf mutations in egl-9 (13) or vhl-1 (14), while the hif-1(ia04) deletion allele (15) 
increased the VI (Fig. 2B,C). The larger hif-1 deletion zh111 that likely represents a null allele 
(Fig. S1) caused an even greater increase in the VI. Moreover, let-60(gf); egl-9(lf) hif-1(ia04) 
triple mutants exhibited the same increase in VI as let-60(gf); hif-1(ia04) double mutants, 
indicating that hif-1 inhibits RAS/MAPK signaling downstream of egl-9 prolyl hydroxylase (Fig. 
2A-C). egl-9(lf) also reduced the VI of mutants in other RAS/MAPK pathway components, such 
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as the guanine nucleotide exchange factor sos-1 or the raf homolog lin-45. Though, mutations in 
EGF lin-3, the EGF receptor let-23 or its adaptors were insensitive to egl-9(lf) (Fig. S2). A wild-
type but not a hydroxylase-deficient egl-9::gfp transgene (16) rescued the reduced VI of let-
60(n1046gf); egl-9(sa307lf) mutants (Fig. 2D). Interestingly, the wild-type egl-9::gfp transgene 
further increased the VI of let-60(n1046gf) single mutants, indicating that enzymatic EGL-9 
activity is rate-limiting in HIF-1 degradation under normoxia.  
Surprisingly, hypoxia reduced the VI of let-60(n1046gf); hif-1(zh111lf) mutants, while let-
60(n1046gf); egl-9(sa307lf) mutants were insensitive to hypoxia (Fig. 2E). Thus, HIF-1 
mediates only part of the hypoxic regulation of RAS/MAPK signaling. Under hypoxia, the 
monoamine oxidase amx-2 is up-regulated in the intestinal cells, where it catalyzes the oxidation 
of serotonin (10, 11). The serotonin oxidation product 5-hydroxyindoleaceticacid (5-HIAA) 
systemically inhibits RAS/MAPK signaling by antagonizing signaling through the SER-1 
serotonin receptor pathway. Since the VI of amx-2(lf); let-60(n1046gf) mutants was not reduced 
under hypoxia (Fig. 2E), the inhibition of the SER-1 pathway by 5-HIAA possibly mediates the 
HIF-1-independent effect of hypoxia on RAS/MAPK signaling. 
Although the expression of a translational hif-1::gfp reporter was undetectable under normoxia, 
in egl-9(sa307lf) or vhl-1(ok161) mutants HIF-1::GFP was expressed in all VPCs (Fig. 3A). To 
test if HIF-1 acts in the VPCs or intestine, we performed Pn.p- and intestine-specific RNAi  
(17, 18). Only Pn.p cell-specific hif-1 RNAi increased the VI of let-60(n1046gf) (Fig. 3B). Thus, 
EGL-9 and VHL-1 induce HIF-1 degradation in the VPCs to positively regulate RAS/MAPK 
signaling. The functional egl-9::gfp reporter was initially expressed in mid L2 larvae in the three 
proximal VPCs that are induced to adopt vulval cell fates (Fig. 3C). After vulval induction in 
early L3 larvae, EGL-9::GFP expression faded in the 1° P6.p descendants and increased in the 2° 
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P5.p and P7.p descendants (Fig. 3C,D). This pattern suggested that either RAS/MAPK signaling 
inhibits or lateral DELTA/NOTCH signaling activates EGL-9::GFP expression in the VPCs. 
Since EGL-9::GFP expression was reduced in let-60(rf) mutants, RAS/MAPK signaling 
promotes rather than inhibits egl-9 expression (Fig. 3C,E). Furthermore, EGL-9::GFP expression 
was lost in the VPCs of lin-12 notch(lf) mutants, while lin-12(n137gf) mutants showed equally 
strong expression in all VPCs (Fig. 3C,F,G). Thus, egl-9 is a target of the LIN-12 NOTCH 
pathway. Since RAS/MAPK signaling induces the expression of the DSL NOTCH ligands (Fig. 
1A), reducing RAS/MAPK signaling likely represses EGL-9::GFP expression indirectly. In 
contrast to RAS/MAPK pathway mutants, egl-9(lf) did not affect the vulval phenotypes of lin-12 
gf or rf mutants (Fig. S3). 
To identify gene(s) downstream of HIF-1 that mediate the repression of RAS/MAPK signaling, 
we screened genes exhibiting an at least two-fold HIF-1 dependent induction (19, 20) in a let-
60(n1046gf); egl-9(sa307lf) and a let-60(n1046gf); hif-1(zh111lf) background by RNAi (Tables 
S1,S2). Knock-down of a HIF-1 target that inhibits RAS/MAPK signaling should increase the VI 
in the egl-9(sa307lf) but not the hif-1(zh111lf) background. This approach identified nhr-57 as a 
negative regulator of RAS/MAPK signaling (Fig. 4A, Table S1). nhr-57 encodes a nuclear 
hormone receptor similar to the Drosophila estrogen-related receptor ERR2 and vertebrate 
glucocorticoid hormone receptors. The increased VI in nhr-57(tm4533lf) deletion mutants 
confirmed NHR-57 as a negative regulator of RAS/MAPK signaling (Fig. 4B). Before vulval 
induction, a translational nhr-57::gfp reporter was not detectable in the VPCs, but expressed in 
the distal, uninduced VPCs after vulval induction (Fig. 4D, E). NHR-57::GFP expression was 
absent in the descendants of the induced proximal VPCs until they had completed their last 
round of divisions and terminally differentiated. Consistent with its role as a HIF-1 target, NHR-
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57::GFP expression was up-regulated in egl-9(lf) mutants (Fig. 4D). Unlike hif-1(zh111lf), the 
VI of let-60(n1046gf); nhr-57(tm4533lf) mutants did not significantly change under hypoxia 
(Fig. 4C). Therefore, NHR-57 mediates both the HIF-1 dependent and independent regulation of 
RAS/MAPK signaling by oxygen (21).  
 
The hypoxia-response pathway thus sets a baseline for the cellular sensitivity to RAS/MAPK 
signaling when oxygen becomes limiting. However, since the activity of the prolyl hydroxylase 
EGL-9 is limiting even under normoxia, the hypoxia-response pathway exerts its inhibitory 
effect even under normoxia. Epistasis analysis indicates that the nuclear hormone receptor NHR-
57, the downstream integrator of the hypoxic response, functions at the level of or in parallel 
with the ETS family transcription factor LIN-1 (22) (Fig. 4E). Likewise, interactions of 
mammalian ETS family transcription factors with steroid receptors have been reported (23-26). 
By linking the HIF-1 degradation pathway via EGL-9 expression to DELTA/NOTCH signaling, 
the VPCs modulate their sensitivity towards the inductive RAS/MAPK signal according to their 
spatial position and differentiate depending on oxygen availability. To our knowledge, prolyl 
hydroxylases have so far not been implicated in DELTA/NOTCH-regulated developmental 
processes in other animals, though a dependence of the mammalian prolyl hydroxylase EGLN3 
on transcription downstream of NOTCH has been reported (27, 28). By inducing the expression 
of multiple DELTA family NOTCH ligands, RAS/MAPK signaling creates a positive feedback 
loop that maintains low NHR-57 levels in the proximal VPCs to keep them competent to respond 
to inductive signals. Connecting the hypoxia-response to developmental signaling pathways thus 
permits the animals to adapt their development to changing environmental conditions, resulting 
in developmental robustness and flexibility. 
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Figures 
 
Figure 1. Hypoxia suppresses RAS/MAPK signaling in different tissues.  
(A) Overview of vulval development showing the known interactions between the RAS/MAPK 
and DELTA/NOTCH pathways. (B) Vulval phenotypes of the let-60 ras G13E mutation in the 
N2 Bristol (left) and CB4856 Hawaii (right) background with varying oxygen concentrations. 
Solid lines indicate induced 1° and 2° and arrowheads uninduced 3° VPCs in L4 larvae. (C) VI 
of N2 Bristol and CB4856 Hawaii let-60 ras G13E mutants raised in varying oxygen 
concentrations. (D) Effect of hypoxia on different RTK/RAS/MAPK pathway mutants. ∆VI 
indicates the change in VI of animals raised in 0.5% compared to controls grown in 21% oxygen. 
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∆%Muv and ∆%Vul indicate the change in the percentage of animals with VI>3 and VI<3, 
respectively. The absolute VIs in 0.5% oxygen are shown in the rightmost column. (E) 
Suppression of the stacked oocyte phenotype in let-60(ga89gf) animals by hypoxia. Arrowheads 
point at the stacked oocytes formed in the proximal gonad under normoxia. (F) Suppression of 
the duct cell duplication phenotype in let-60(n1046gf) mutants by hypoxia. Arrows point at the 
two duct cell nuclei formed under normoxia. Error bars in (C) and (D) indicate the 95% 
confidence intervals, and p-values, indicated with *** p < 0.001 and ** p < 0.01, were derived 
by bootstrapping 1000 samples. In (E) and (F), error bars indicate the standard error of the mean, 
and p-values were calculated with a Fisher’s exact test. The numbers of animals scored are 
indicated in brackets. The scale bars are 5 µm.  
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Figure 2. The hypoxia-response pathway negatively regulates RAS/MAPK signaling under 
normoxia.  
(A) Schematic overview of the hypoxia response pathway. (B) Vulval phenotypes of double and 
triple mutants between let-60(n1046gf) and components of the hypoxia-response pathway under 
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normoxia. Solid lines indicate induced 1° and 2° and arrowheads uninduced 3° VPCs in the L4 
larvae. (C) Mutations in the hypoxia pathway change the VI of let-60(n1046gf) mutants. ∆VI 
indicates the change in VI of the indicated genotypes relative to let-60(n1046gf) single mutant 
siblings obtained from the crosses. ∆%Muv indicates the change in the percentage of animals 
with VI>3. The absolute VIs are shown in the rightmost column. (D) Overexpression of egl-
9::gfp increases the VI. ∆VI indicates the change in VI of animals carrying a wild-type (grey 
bars) or hydroxylase deficient (black bar) multi-copy egl-9::gfp array compared to siblings 
without array. (E) Hypoxia reduces the VI in hif-1 but not in egl-9 or amx-2 mutants. ∆VI 
indicates the change in VI of animals grown under hypoxia versus normoxia. Error bars indicate 
the 95% confidence intervals. p-values, indicated with *** p < 0.001 and ** p < 0.01, were 
derived by bootstrapping 1000 samples. The numbers of animals scored are indicated in 
brackets. The scale bar indicates 5 µm. 
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Figure 3. egl-9 is a NOTCH target that promotes HIF-1 degradation in the induced VPCs.  
(A) HIF-1::GFP expression in wild-type, egl-9(sa307lf) and vhl-1(ok161lf) larvae before vulval 
induction. Arrowheads point at the nuclei of the three proximal VPCs. (B) Pn.p cell- and gut-
specific hif-1 RNAi (see supplementary information). ∆VI indicates the change in VI in hif-1 
RNAi compared to empty vector treated control animals. Error bars indicate the 95% confidence 
interval, and p-values were derived by bootstrapping 1000 samples. (C) EGL-9::GFP expression 
in the wild-type before (mid L2, top panel) and after induction (early L3, second panel), and in 
let-60 ras(rf), lin-12 notch(lf) and lin-12 notch(gf) mutants after induction. Induced VPCs are 
underlined. The scale bar is 5 µm. (D) Schematic representation of the wild-type EGL-9::GFP 
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pattern during vulval development. (E-G) Quantification of EGL-9::GFP expression in the four 
genotypes shown in (C) after vulval induction (early L3). Error bars indicate the standard error 
of the mean, and p-values, indicated with *** p < 0.001, ** p < 0.01 and * p < 0.05, were 
calculated in a two-tailed Student’s t-test. The numbers of animals scored are indicated in 
brackets.  
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Figure 4. The HIF-1 target NHR-57 inhibits RAS/MAPK signaling through a 
DELTA/NOTCH-induced negative feedback loop. 
(A) Knock-down of nhr-57 increases the VI in an egl-9(lf) but not a hif-1(lf) background. ∆VI 
and ∆%Muv indicate the changes in VI and percentage of animals with VI>3 after nhr-57 RNAi 
compared to empty vector treated control animals. (B) The nhr-57(tm4533) deletion allele 
increases the VI of let-60(n1046gf) single and let-60(n1046gf); egl-9(sa307lf) double mutants 
but has no effect in a hif-1(zh111lf) background. ∆VI and ∆%Muv indicate the changes in VI and 
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percentage of animals with VI>3 compared to nhr-57(+) control siblings. (C) Hypoxic treatment 
decreases the VI in the hif-1(zh111) but not the nhr-57(tm4533) background. ∆VI and ∆%Muv 
indicate the changes in VI and percentage of animals with VI>3 raised in hypoxia compared to 
normoxia. Error bars indicate the 95% confidence intervals, and p-values, indicated with *** p < 
0.001 and ** p < 0.01, were derived by bootstrapping 1000 samples. The numbers of animals 
scored are indicated in brackets. (D) NHR-57::GFP expression pattern in the wild-type (left 
panels) and egl-9(lf) (right panels) background before (top panels) and after induction (middle 
panels), and at the end of vulval differentiation (bottom panels). Arrowheads and solid lines 
point at the nuclei of the induced or uninduced VPCs and their descendants, respectively. The 
scale bar is 5 µm. (E) Schematic representation of the NHR-57::GFP pattern during vulval 
development in the wild-type (top) and in an egl-9(lf) background (bottom). (F) Model 
illustrating the cross-talk of the hypoxia-response, DELTA/NOTCH and RAS/MAPK pathways 
during vulval induction. Lateral DELTA/NOTCH signaling between the proximal VPCs induces 
EGL-9 expression to maintain low HIF-1 and NHR-57 levels, thereby keeping the VPCs 
competent to respond to RAS/MAPK signaling, which in turn maintains expression of the 
DELTA family NOTCH ligands. Distal VPCs loose their competence due to higher NHR-57 
levels and adopt the 3° fate. 
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Materials and Methods 
 
C. elegans strains 
C. elegans strains were maintained at 20°C using standard procedures (1) unless stated 
differently. C. elegans Bristol refers to the wild-type N2 strain and Hawaii to CB4856 (2). The 
transgenic lines were generated as described in  
(3, 4). N2 strains carrying let-60(ga89) or egl-9(n586) were maintained at 20°C and shifted to 
25°C for mutant analysis. The following mutations and transgenes were used in this study: LG 
III: unc-32(e189) lin-12(n137n720) (5), dpy-19(e1259) lin-12(n137) (56), hT2[bli-4(e937) let-
?(q782) qIs48] (I;III) (6). LG IV: let-60(n1046) (7), let-60(zh121) (this study), let-60(zh122) 
(this study), let-60(ga89) (8), let-60(n2021) (7), lin-1(n304) (9), lin-3(e1417) (10), lin-45(sy96) 
(11). LG V: egl-9(sa307) (12), hif-1(ia04) (13), hif-1(zh111) (this study), nhr-57(tm4533) 
(Mitani lab). LG X: vhl-1(ok161) (14), rde-1(ne219) (15), Transgenes: gaIs47[lin-31::mpk-
1(gf); lin-31::D-mek(gf)] (16), iaIs38[egl-9p::egl-9::tag + unc-119(+)] (17), iaEx101[egl-
9p::egl-9(H487A)::tag + unc-119(+)](17), duIs[Pelt-2::rde-1(+); pRF4] (18), zhEx418[lin-
31::rde-1;myo-2::mCherry] (19), saIS14[lin-48p::gfp] (20), opIs206[Phif-1::hif-1::gfp::hif-1 
3’UTR + unc-119(+)] (21), zhEx605[Pnhr-57::nhr-57::gfp:: nhr-57 3’ UTR + unc-119(+)] 
(this study).   
 
RNAi and microscopy 
RNAi was performed as described in Kamath et al. (2002) (22). Animals were synchronized by 
bleaching and raised on bacteria expressing dsRNA. The empty vector plasmid L4440 was used 
as a negative control and dsRNA against rpn-6.1 as a positive control. Vulval induction was 
scored in the F1 generation. Animals were anesthetized in in a drop of 5mM tetramisole and 
analysed using differential interference contrast (DIC) and fluorescence microscopy.  
 
Hypoxic treatment   
Hypoxic chambers were adapted from Fawcett et al. (2002) (23). Briefly, a glass bowl with 
flange served as container for small NGM plates. A customized lid was made, which consists of 
an acrylic glass plate surrounded by a metal ring equipped with an immersion to fit in an O-ring. 
Two holes in the acrylic glass served as the gas in- and output apertures. A third larger hole 
accommodates an oxygen measuring device (GOX 100). A hypoxic environment was generated 
via oxygen replacement by N2 until the desired O2 concentration was obtained. NGM plates 
containing mixed stage C. elegans were incubated for three to five days and analyzed at the 
microscope.  
 
Generation of hif-1(zh111) 
Co-CRISPR was employed as described in Arribere et al. (2014) (24). 25 ng/µl dpy-10 sgRNA 
pJA58 was co-injected into N2 Bristol animals with 25 ng/µl of a sgRNA targeting hif-1, GAT 
AGA AAA GTG AGT CCT AA, 500 nM of dpy-10(cn64) repair template AF-ZF-827 and 50 
ng/µl of pDD162. Candidate worms were selected from plates harboring a large number of Rol 
progeny and analyzed by PCR. The zh111 deletion spans 2464 bp and removes exons three to 
five (region upstream: ATT TCA AAA AAT TTT TGA CA. Region downstream: CTA AGT 
TAA AAA AAC AAC AG). 
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Generation of let-60(zh121) and let-60(zh122) 
CRISPR/Cas9 was employed as described in Friedland et al. (2013) (25). The sgRNA sequence 
AAT GAC GGA GTA CAA GCT TG was inserted into plasmid #46169 (PU6::unc-
119_sgRNA) via site-directed mutagenesis. The let-60 genomic locus was partially amplified 
using the primers AAG GAG CAA ATC GAA CAG AC and ATC CAT TTT ATT AGG CAC 
GCA C and cloned into p-GEM®-T easy. The silently mutated PAM and the G13E mutation 
were obtained using the primers TGA GTG CTG ATT TAC CAA CTC CTC CAT CTC CAA 
CTA CCA CAA GCT TGT ACT CCG TC and AAG CTT GTG GTA GTT GGA GAT GGA 
GGA GTT GGT AA ATC AGC ACT CAC CAT TCA ACT CAT C. N2 Bristol or CB4856 
Hawaii animals were injected with 50 ng/µl sgRNA plasmid, 50 ng/µl pDD162, 50 ng/µl repair 
template and 5 ng/µl pCFJ104. The progeny was screened for the Multivulva phenotype and 
candidate animals were verified by PCR and sequencing.   
 
Translational nhr-57 reporter 
A 1206 bp fragment upstream of the nhr-57 transcriptional start site was amplified together with 
the coding genomic region (without the stop codon) using the primers cta aca act tgg aaa tga aat 
CAC CAA CAC CTT CTA CAC AGC TGC and gtt ctt ctc ctt tac tca tTT GTC CAT CAA TGA 
TTT TAT AGA TTT TGT CG. The gfp sequence was amplified from pPD95.75 using the 
primers ATG AGT AAA GGA GAA GAA C and gag atc tgg ttc aaa tag CTA TTT GTA TAG 
TTC ATC CAT GC.  459 bp of the nhr-57 3’ UTR were amplified using the primers GCT ATT 
TGA ACC AGA TCT CTT C and cag tac ggc cga cta gta gGA ATA AAT CAT CCC AAA GCC 
GTT TTT G. A vector backbone containing a CB-unc-119(+) rescue as well as the AmpR gene 
was amplified using the primers ATT TCA TTT CCA AGT TGT TAG CG and CTA CTA GTC 
GGC CGT ACT GAG GTG TTG TCG CTT TTA TTG GG. The four fragments were combined 
into a 10.170 kb plasmid (pSMa32) using Gibson Assembly®. N2 animals were injected (due to 
a mutation in the CB-unc-119(+) gene) with 5 ng/µl pSMa32, 2.5 ng/µl pCFJ104 and 100 ng/µl 
pBS. Transformants were isolated based on the presence of the co-injection marker.  
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Supplementary Figures 
 
Fig. S1. Comparison of the zh111 and ia04 deletions in the hif-1 locus. 
(A) Schematic representation of the hif-1 locus with the five isoforms shown in grey. The 
canonical deletion allele ia04 is depicted in light blue and the larger zh111 deletion is shown in 
dark blue. Note that the zh111 deletion affects all isoforms. (B) The zh111 allele has a stronger 
effect on the VI in the let-60(n1046) background than ia04. Error bars in (B) indicate the 95% 
confidence intervals, and p-values, indicated with *** p < 0.001 and ** p < 0.01, were derived 
by bootstrapping 1000 samples. 
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Fig. S2. Genetic interaction between egl-9(lf) and RAS/MAPK pathway mutations. 
∆VI indicates the change in VI of the indicated genotypes in the egl-9(lf) background compared 
to single (or double) mutant siblings obtained from the crosses. ∆%Muv and ∆%Vul indicate the 
changes in the percentage of animals with VI>3 and VI<3, respectively. The absolute Vis of the 
double (or triple) mutants are shown in the rightmost column. Error bars indicate the 95% 
confidence intervals. p-values, indicated with ** p < 0.01, were derived by bootstrapping 1000 
samples. The numbers of animals scored are indicated in brackets.  
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Fig. S3. Genetic interaction between egl-9(lf) and lin-12 notch mutations. 
The absolute VIs of lin-12(gf) and lin-12(lf) mutants in the egl-9(lf) background compared to egl-
9(+) single mutant siblings obtained from the crosses are shown. %Muv and %Vul indicate the 
percentage of animals with VI>3 and VI<3, respectively. Error bars indicate the 95% confidence 
intervals. p-values were derived by bootstrapping 1000 samples. The numbers of animals scored 
are indicated in brackets. 
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Sequence Name Gene Name Genotype VI 95% C.I. P % Muv n
let-60(n1046); egl-9(sa307)1 3.09 3.00 - 3.20 0.005 14 22
let-60(n1046); hif-1(zh111)1 4.28 4.10 - 4.51 0.650 90 44
let-60(n1046); egl-9(sa307)1 3.20 3.10 - 3.35 0.102 30 20
let-60(n1046); hif-1(zh111)1 n.a. n.a. n.a. n.a. n.a.
let-60(n1046); egl-9(sa307)1 3.18 3.05 - 3.34 0.072 23 22
let-60(n1046); hif-1(zh111) n.a. n.a. n.a. n.a. n.a.
let-60(n1046); egl-9(sa307)3 3.58 3.38 - 3.77 0.000 69 26
let-60(n1046); hif-1(zh111)3 4.70 4.47 - 4.94 0.901 100 32
let-60(n1046); egl-9(sa307)1 3.28 3.11 - 3.46 0.199 33 27
let-60(n1046); hif-1(zh111) n.a. n.a. n.a. n.a. n.a.
let-60(n1046); egl-9(sa307)1 3.27 3.05 - 3.55 0.236 25 20
let-60(n1046); hif-1(zh111) n.a. n.a. n.a. n.a. n.a.
let-60(n1046); egl-9(sa307)1 3.11 3.00 - 3.24 0.014 13 23
let-60(n1046); hif-1(zh111)1 4.03  3.65 -  4.45 0.302 70 20
let-60(n1046); egl-9(sa307)1 3.08 3.00 - 3.22 0.006 9 23
let-60(n1046); hif-1(zh111) n.a. n.a. n.a. n.a. n.a.
let-60(n1046); egl-9(sa307)1 3.10 3.03 - 3.21 0.008 21 19
let-60(n1046); hif-1(zh111) n.a. n.a. n.a. n.a. n.a.
let-60(n1046); egl-9(sa307)1 3.04 3.00 - 3.11 0.000 9 23
let-60(n1046); hif-1(zh111)1 4.46 4.07 - 4.86 0.797 86 22
let-60(n1046); egl-9(sa307)1 3.12 3.00 - 3.28 0.034 10 20
let-60(n1046); hif-1(zh111)1 4.10 3.73 - 4.45 0.430 80 20
let-60(n1046); egl-9(sa307)2 3.17 3.05 - 3.33 0.028 19 21
let-60(n1046); hif-1(zh111) n.a. n.a. n.a. n.a. n.a.
let-60(n1046); egl-9(sa307)2 3.51 3.33 - 3.71 0.838 55 29
let-60(n1046); hif-1(zh111)2 4.22 3.95 - 4.48 0.007 87 30
let-60(n1046); egl-9(sa307)2 3.31 3.14 - 3.52 0.243 38 21
let-60(n1046); hif-1(zh111) n.a. n.a. n.a. n.a. n.a.
let-60(n1046); egl-9(sa307)3 3.04 3.00 - 3.13 0.281 4 23
let-60(n1046); hif-1(zh111)3 3.96 3.74 - 4.19 0.002 67 55
let-60(n1046); egl-9(sa307)3 3.20  3.10 -  3.30 0.049 40 20
let-60(n1046); hif-1(zh111)3 4.32 4.08 - 4.55 0.184 95 20
let-60(n1046); egl-9(sa307)2 3.50 3.28 - 3.77 0.756 47 32
let-60(n1046); hif-1(zh111)2 4.61 4.31 - 4.90 0.412 92 26
let-60(n1046); egl-9(sa307)2 3.45 3.27 - 3.64 0.683 50 28
let-60(n1046); hif-1(zh111)2 4.51 4.09 - 4.89 0.286 86 22
let-60(n1046); egl-9(sa307)2 3.47  3.18 - 3.80 0.676 36 25
let-60(n1046); hif-1(zh111) n.a. n.a. n.a. n.a. n.a.
let-60(n1046); egl-9(sa307)3 3.16 3.00 - 3.36 0.784 14 22
let-60(n1046); hif-1(zh111)3 4.35 4.12 - 4.62 0.244 96 26
let-60(n1046); egl-9(sa307)2 3.48 3.33 - 3.65 0.822 61 33
let-60(n1046); hif-1(zh111)2 4.65 4.31 - 4.98 0.480 90 29
let-60(n1046); egl-9(sa307)2 3.55 3.33 - 3.79 0.882 57 21
let-60(n1046); hif-1(zh111) n.a. n.a. n.a. n.a. n.a.
let-60(n1046); egl-9(sa307)2 3.31 3.15 - 3.52 0.262 35 31
let-60(n1046); hif-1(zh111)2 4.35 3.98 - 4.72 0.084 83 23
let-60(n1046); egl-9(sa307)4 3.03 3.00 - 3.08 0.000 5 20
let-60(n1046); hif-1(zh111)4 4.14 3.91 - 4.34 0.005 86 29
let-60(n1046); egl-9(sa307)2 3.49 3.33 - 3.66 0.794 61 38
let-60(n1046); hif-1(zh111)2 4.98 4.72 - 5.25 0.027 97 30
let-60(n1046); egl-9(sa307)4 3.58 3.38 - 3.83 0.050 58 26
let-60(n1046); hif-1(zh111)4 4.93 4.64 - 5.24 0.902 97 29
let-60(n1046); egl-9(sa307)2 3.07 3.00 - 3.17 0.000 11 27
let-60(n1046); hif-1(zh111)2 4.71 4.40 - 4.98 0.627 97 30
let-60(n1046); egl-9(sa307)4 3.52 3.30 - 3.80 0.870 41 27
let-60(n1046); hif-1(zh111)4 5.15 4.89 - 5.39 0.005 100 23
let-60(n1046); egl-9(sa307)2 3.29 3.11 - 3.52 0.241 28 32
let-60(n1046); hif-1(zh111)2 4.23 3.95 - 4.55 0.008 83 29
let-60(n1046); egl-9(sa307)2 3.51 3.31 - 3.73 0.806 46 39
let-60(n1046); hif-1(zh111)2 4.80 4.43 - 5.15 0.757 90 20
let-60(n1046); egl-9(sa307)2 3.38  3.22 - 3.58 0.475 44 25
let-60(n1046); hif-1(zh111)2 4.69 4.42 - 4.95 0.576 97 31
let-60(n1046); egl-9(sa307) n.a. n.a. n.a. n.a. n.a.
let-60(n1046); hif-1(zh111) n.a. n.a. n.a. n.a. n.a.
let-60(n1046); egl-9(sa307)1 3.40 3.14 - 3.67 - 38 21
let-60(n1046); hif-1(zh111)1 4.17 3.71 - 4.66 - 68 19
let-60(n1046); egl-9(sa307)2 3.39 3.24 - 3.53 - 41 59
let-60(n1046); hif-1(zh111)2 4.65 4.44 - 4.85 - 98 56
let-60(n1046); egl-9(sa307)3 3.08  3.00 - 3.15 - 15 20
let-60(n1046); hif-1(zh111)3 4.48 4.23 - 4.73 - 95 22
let-60(n1046); egl-9(sa307)4 3.34 3.18 - 3.52 - 43 28
let-60(n1046); hif-1(zh111)4 4.64 4.29 - 4.94 - 100 24
eV -
eV -
T25E12.4
eV -
eV -
K10H10.4
W07A12.6
Y44A6C.1
T05B4.2
C04F2.1
M01H9.3
C56E6.2
F22B5.7
C01B4.1
C29F9.5
C36A4.9
F45D11.16
W04E12.4
F53F4.5a
K08E3.1
C01B12.1
T07H3.4
C13D9.4
C14E2.5
C28H8.8
C50E3.9
F13B9.6
F56C3.3
-
Y38C1BA.3
Y38H6C.2
CC8.2
-
oac-54
-
nhr-57
dkf-2
-
-
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R04D3.1
R52.2
T05B9.2
T06G6.2
zyg-9
str-257
-
acs-19
-
cyp-14A4
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tyr-2
sqt-2
srh-79
srsx-11
-
-
-
cutl-29
-
-
-
-
-
sra-24
clec-21
col-109
srw-65
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Table S1. RNAi screen to identify HIF-1 targets inhibiting vulval development. 
Knock-down of selected HIF-1 target genes in let-60(n1046gf); egl-9(sa307lf) and let-
60(n1046gf); hif-1(zh111lf) mutants that had an effect in a primary screen using let-60n1046gf); 
egl-9(sa307lf) mutants only. The empty vector negative controls are shown at the bottom, and for 
each RNAi experiment the matching control is indicated with the superscript numbers. Note that 
some genes were not analyzed in the let-60(n1046gf); hif-1(zh111lf) strain, since there was no 
effect in let-60(n1046gf); egl-9(sa307lf) mutants. Furthermore, the knock-down of CC8.2 caused 
lethality and could not be analyzed. p-values were derived by bootstrapping 1000 samples.  
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Table S2. HIF-1 targets without an effect on vulval development. 
List of HIF-1 target genes that were knocked down in let-60(n1046gf); egl-9(sa307lf) animals 
and did not change the VI as estimated from the number of Muv animals on the plates. 
 
Sequence Name Gene Name
K08C7.5 fmo-2
F22B5.4 -
F42A10.4a efk-1
F59B10.4 -
C24B9.9 dod-3
F44B9.1a dpf-6
C31G12.2 clec-245
Y38E10A.23 -
R10D12.1 -
F56A3.3a npp-6
C34D4.14 hecd-1
K04H4.2 -
C04A2.1 tbc-6
F02E8.6 npc-1/ncr-1
F45D11.1 -
K02E7.6 -
F16G10.10 -
Y48G8AL.6 smg-2
C01G6.8a cam-1
F57B9.1 -
F21D12.3 -
T08G3.6 -
Y46G5A.6 -
M05D6.5 -
C34B7.3 cyp-36A1
M03A1.1a vab-1
Y55F3BR.4 lgc-33
C32D5.12 -
Y19D10A.5 -
C05D12.1 -
C05E4.2 str-20
C10G11.3 srh-51
C42D4.13 -
C42D4.2 -
C50E10.6 sre-54
F20D6.1 -
F25G6.5 stdh-4
F57G8.1 srh-180
H27D07.6 srh-87
R09B5.3 cnc-2
R09E10.2 -
R186.6 mpst-7
T04A11.10 sru-17
T06E4.8 -
T07C5.5 nhr-26
T17H7.1 -
W02A2.3 pqn-74
ZK938.6 chil-9
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3.3 Additional experiments not included in the manuscript
3.3.1 Introduction
While the first project focussed on describing regions of quantitative traits positioned on the first 
chromosome that modify WNT or RAS/MAPK signalling, we investigated in more detail selected 
candidate genes found during the RNAi screen on QTL1b in the let-60(n1046) mutant back-
ground within a second project. 
The QTL1b region was positioned at I: 12433756-13863711 (N2 Bristol, WormBase WS195) 
as estimated from the overlapping genomic CB4856 region present in ewIR10 and ewIR17 that 
had been determined by FLP mapping and partial sequencing (Schmid et al. 2015). The region 
spans 1.43 Mbp and contains 142 polymorphic modifier genes, of which 107 had been screened 
by RNAi (Schmid et al. 2015). The knockdown of W02D9.4, B0019.1 (amx-2), F17B5.4, F44F1.1 
and F44F1.4 increased the VI exclusively in the let-60(n1046) background which proposed the 
presence of negative regulators (more) active in the N2 Bristol but not or less active in the CB4856 
background. RNA interference with C54C8.2 (bgnt-1.8), T07D10.1, T07D10.3, T06G6.9 (pfd-3), 
W02A11.5 (bath-34), Y18D10A.13 (pad-1), C47B2.6 (gale-1), ZK1225.5, Y40B1B.5 (eif-3.J) and 
K03D10.1 (kal-1) led to the reduction in VI in the ewIR17; let-60(n1046) miIL only, suggesting 
that positive regulators (more) active in the Hawaii background are present. The VI was decre-
ased in both backgrounds upon knockdown of T26E3.6, F28C12.4 (sra-20), T06G6.7 (srw-88), 
W02A11.13 (toe-4), Y18D10A.2, Y18D10A.9, F08A8.5, CC4.3 (smu-1), F44F1.6, M01E5.6 
(sepa-1), Y40B1A.1, Y6B3B.4, W04A8.6 and Y36D3A.5 (tfg-1) indicating more general regulators 
of RAS/MAPK signalling. To investigate genes exhibiting functional differences due to polymor-
phisms we focussed our studies on the candidate genes which had an effect in one background 
only. From the set of genes we decided to start our analysis on pfd-3 and F44F1.1 (see Table 7.2 
in the Appendix for polymorphisms).
PFD-3 is a putative prefoldin that is orthologous to human von Hippel-Lindau binding protein 
1 (VBP1). The von Hippel-Lindau protein (VHL) acts in the oxygen-sensing pathway and is in-
volved in the proteasomal degradation of hydroxylated hypoxia-inducible factors (HIFs) (Nord-
strom-O‘Brien et al. 2010). Alterations in the von Hippel-Lindau tumour suppressor (VHL) are 
associated with the von Hippel-Lindau disease that predisposes to central nervous system ha-
emangioblastomas, renal cysts and renal cell carcinoma (Barontini and Dahia 2010). VBP1 intra-
cellular localisation depends on VHL (Tsuchiya et al. 1996) and the cooperation of VBP1 and VHL 
was found to be crucial in the efficient poly-ubiquitination and subsequent proteasome-mediated 
degradation of HIV-1 integrase (Mousnier et al. 2007). These findings suggest the involvement 
of VBP1 in the VHL pathway, although no correlation with renal tumourigenesis has been obser-
ved (Clifford et al. 1999). F44F1.1 was initially found as a calpain-like sequence (Syntichaki et 
al. 2002) and was later defined as a pseudogene with reduced or no functionality (WormBase 
release WS225). F44F1.1 is paralogous to F44F1.3, which is an orthologue of human calpain 
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15. Calpains are Ca2+-activated regulatory proteases that have been implicated in a number of 
developmental events, such as cell differentiation, proliferation as well as signal transduction 
and apoptosis (Sorimachi et al. 1997; Sato and Kawashima 2001), the development of the ner-
vous system, in respiratory diseases, breast cancer and further pathological cases (Huang and 
Wang 2001). Both polymorphic genes, F44F1.1 and pfd-3, have been identified in a screen for 
suppression of the egg-laying defective phenotype in the egl-9 mutant in addition to lin-10, vhl-1 
and hif-1 (Gort et al. 2007). VHL-1, HIF-1 and EGL-9 are the C. elegans homologues of VHL, 
HIF-1A and EGLN3, respectively, that act in the conserved hypoxia response pathway (Jiang et 
al. 2001; Epstein et al. 2001). These and the above mentioned findings suggested a functional 
link between conserved RAS/MAPK and hypoxic signalling events that is influenced by natural 
variation. Thus, we set out to investigate the interaction of these pathways in more detail.
3.3.2  Verification of candidate genes modulating RAS/MAPK signalling during 
vulval induction
We started our analysis by verifying the candidate genes F44F1.1 and pfd-3 that had been disco-
vered in the RNAi screen performed by Schmid et al. (2015). We crossed the F44F1.1(ok1765) 
allele into the let-60(n1046) mutants and found that the deletion in F44F1.1 decreased vul-
val induction to an average index of 3.67, 95% CI [3.57, 3.78] (Fig. 3.8A) compared to the 
let-60(n1046) single mutant sibling with an average induction of 4.00, 95% CI [3.87, 4.12]. The 
opposite had been found in the RNAi experiments, where the knockdown of F44F1.1 had incre-
ased vulval induction in the let-60(n1046) mutant background (Fig. 3.8B). Since F44F1.1 and 
F44F1.3 exhibit some similarity in their genomic sequence as well as their RNAi clone sequen-
ces, we performed RNAi against F44F1.3 and included the F44F1.3(ok1878) deletion mutant 
into our studies. However, RNAi against F44F1.3 had no effect on either introgressed or non-
introgressed lines (Fig. 3.8C). Furthermore, we were not able to verify the ok1878 deletion in 
the mutant we had obtained from the Caenorhabditis elegans Genetic Center (CGC), i.e. there 
was no deletion in the F44F1.3 gene (as tested by PCR). Thus, since RNAi frequently shows 
off-target effects, especially for similar gene sequences, we regarded the data we had obtained 
using the F44F1.1(ok1765) mutant as more relevant for our studies. 
The knockdown of pfd-3 had resulted in the reduced VI in the miIL (Schmid et al. 2015). As 
there was no mutant commercially available, we employed CRISPR/Cas9 in a joined effort 
with K. Jovic and T. Schmid to obtain a deletion mutant. Following the protocol as described 
in Friedland et al. (2013), we used four different sgRNAs flanking the pfd-3 coding sequence 
(CDS) and a repair template lacking the entire CDS that we had obtained through prior in-
sertion of BglII restriction sites and enzymatic digestion (Fig. 3.8D). We obtained mutants 
harbouring deletions of different sizes that led to sterility when homozygous and that we had 
lost before we could balance the mutation.
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Figure 3.8. (A) A deletion in F44F1.1 significantly reduces the VI of let-60(n1046) mutants. (B) The knock-
down of F44F1.1 increases the VI of non-introgressed but not introgressed let-60(n1046) mutant lines. The 
difference in the percentage of Muvs is indicated and the mean VI and number of animals are indicated as 
RNAi treated / empty vector (eV). (C) The knockdown of F44F1.3 affects neither the VI of introgressed nor 
the one of non-introgressed animals. The difference in the percentage of Muvs is indicated and the mean 
VI and number of animals are indicated as RNAi treated / empty vector. p values were derived from from 
bootstrapping 1000 samples, where *** p < 0.001 and ** p < 0.01 and the number of animals analysed is 
indicated in brackets. Error bars indicate the 95% confidence interval. (D) Scheme of CRISPR/Cas9 medi-
ated endogenous mutagenesis within the pfd-3 locus. Via site-directed mutagenesis, two BglII sites were 
inserted into the repair template to flank the CDS. The CDS was removed via enzymatic restriction digest. 
OKJ - primers used for cloning, sgRNA - sgRNAs used to cut the genomic sequence, BglII - position of 
BglII restriction sites. 
3.3.3  EGL-9 affects RAS/MAPK signalling at the level or downstream of SEM-5/
GRB2 or SOS-1/SOS1
Our results indicating that EGL-9 is a positive regulator of RAS/MAPK signalling in the vulva 
(see chapter 3.2) were obtained in a let-60(n1046gf) mutant background. To exclude allele-
specific effects and to study at which step in the RAS/MAPK cascade EGL-9 acts, we per-
formed epistasis experiments. We used the lin-3(e1417) (Hwang 2004), let-23(sy1) (Aroian 
and Sternberg 1991), lin-2(n397) (Horvitz and Ferguson 1985), lin-7(e1413) (Simske et al. 
1996), lin-10(e1439) (Whitfield et al. 1999), sem-5(n2019) (Clark et al. 1992), sos-1(s1031) 
(Chang et al. 2000) and lin-45(sy96) (Sternberg et al. 1993) alleles and crossed them to the 
egl-9(sa307) mutant. We found that a loss of EGL-9 decreased the VI of animals mutant for 
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lin-45 or let-60 combined with sos-1 (only the double mutants are viable) but not for any of the 
other alleles (Fig. 3.9A). It is possible that EGL-9 acts at the level of SOS-1 which is however 
masked by the presence of the let-60(n1046) allele. To exclude any allele-specific effects stem-
ming from the egl-9(sa307) mutant, we included into our analysis a temperature-sensitive allele 
of egl-9, n586. In support of our data we found that the egl-9(n586) allele suppressed the VI of 
let-60(n1046) animals with an increase in temperature, most strongly at the restrictive temperature 
of 25 °C (Fig. 3.9B). We conclude that EGL-9 acts either at the level of SEM-5 or SOS-1 or in 
parallel to promote RAS/MAPK signalling strength in the vulva.
3.3.4  EGL-9 and CDK-5 are presumably not involved in the localisation of LET-23
Figure 3.9. Difference in VI values of mutants of the RAS/MAPK pathway with and without the egl-9(sa307) 
or egl-9(n586ts) allele. The difference is shown for double mutant animals compared with their respective 
single mutant siblings. p values were derived from bootstrapping 1000 samples, where *** p < 0.01, ** p < 
0.01 and * p < 0.05. (A) The mean VI is indicated for the double mutant. The number of animals analysed is 
indicated in brackets (double mutant / single mutant sibling). Error bars indicate the 95% confidence inter-
val. Note that the sos-1(s1031) was analysed in combination with the let-60(n1046) allele due to lethality in 
the single mutant. (B) With a rise in temperature, the egl-9(n586) allele suppresses the VI of let-60(n1046) 
mutants. The mean values are shown with the 95% confidence intervals as error bars. 
The epistasis analysis indicated that egl-9 acts at the level or downstream of either SEM-5/GRB2 
or SOS-1/SOS1. Others had found that lin-10 RNAi suppressed the egg-laying defective pheno-
type of egl-9 mutants (Gort et al. 2007). Moreover, Park et al. (2012) had described a mecha-
nism, in which EGL-9 competes with CDK-5 for the post-translational modification of LIN-10 
to regulate trafficking of the glutamate receptor GLR-1 (Fig. 3.10A, B). They proposed that 
proline hydroxylation of LIN-10 sterically inhibits serine phosphorylation by CDK-5 and thereby 
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indirectly supports the function of LIN-10 in receptor recycling back to the cell membrane. 
During hypoxia, when EGL-9 becomes inactive, LIN-10 is phosphorylated and less active in 
receptor recycling, thus signalling through GLR-1 is decreased. Based on these findings, 
we asked whether EGL-9 and CDK-5 are similarly involved in LET-23 trafficking by 
competing for LIN-10 modification in the VPCs (Fig. 3.10C, D). 
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Figure 3.10. Role of EGL-9 in receptor trafficking. In neurons, EGL-9 competes with CDK-5 for LIN-10 
post-translational modification in addition to its role in HIF-1 modification. (A) In normoxia, prolyl hydroxyla-
tion of LIN-10 is thought to promote receptor recycling and signalling. (B) In hypoxia, hydroxylation does not 
take place but LIN-10 is phosphorylated at serine and recycling is diminished. Since LIN-10 localised LET-23 in 
the VPCs, a similar function of EGL-9 and oxygen could control LET-23 trafficking and signalling. According 
to the data, EGL-9 would promote LET-23 plasma membrane localisation through LIN-10 modification (C) 
whereas hypoxia reduces signalling through preventing the hydroxylation and allowing CDK-5 mediated 
phosphorylation of LIN-10 (D). (E) The loss of CDKA-1 does not alter RAS/MAPK activity in let-60(n1046) 
mutant animals, whereas loss of CDK-5 increases RAS/MAPK signalling. (F) During hypoxia, the VI of 
animals mutant for cdk-5 is reduced significantly. p values were derived from bootstrapping 1000 samples, 
where *** p < 0.001. Error bars indicate the 95% confidence interval and the number of animals analysed 
is indicated in brackets.  
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We started by crossing the predicted null allele ok626 of cdk-5 (Juo et al. 2007) into 
let-60(n1046gf) mutant animals and determining the VI. If CDK-5 is involved in LET-23 trafficking 
similarly to its function in GLR-1 trafficking, we would expect that vulval induction in the double 
mutant at normoxia can be increased. Indeed, loss of CDK-5 increased the VI of let-60(n1046gf) 
animals (Fig. 3.10E). However, vulval induction of these double mutants was decreased upon 
hypoxic exposure conflicting the results in neurons, where cdk-5(ok626lf) mutants were in-
sensitive to hypoxia (Fig. 3.10F) (Park et al. 2012). Finally, a loss of CDKA-1 (also known as 
p35), the activator of CDK-5 (Juo et al. 2007), had no effect on vulval induction (Fig. 3.10E). 
We continued by introducing a translational LET-23::GFP reporter (Haag et al. 2014) into 
the egl-9(sa307lf) and cdk-5(ok626lf) mutant backgrounds and by quantifying fluorescence 
intensity. In line with the findings in neurons (Juo et al. 2007; Park et al. 2012), there was no 
visible change in the cdk-5(ok626lf) mutant (Fig. 3.11A). In egl-9(sa307lf) mutants carrying the 
reporter, we observed a diffuse signal in the VPCs (Fig. 3.11A). However, this signal was pre-
sent also in the egl-9(sa307lf) mutant without reporter and seemed dependent on hif-1, since 
there was no such signal in egl-9(sa307lf) hif-1(ia04) mutant animals (data not shown). Park 
et al. (2012) had described that GLR-1 receptor mislocalisation was independent of hif-1, thus 
we expected to see a LET-23 mislocalisation phenotype in egl-9(sa307lf) hif-1(ia04) mutant 
animals, which we did not. Because of the diffuse fluorescence in egl-9 mutant animals, which 
we classified as mutant specific auto-fluorescence, we quantified LET-23::GFP by determining 
the apical to basal ratio as described in Haag et al. (2014). We did not detect any changes in 
the fluorescence intensity ratio (Fig. 3.11B). 
Figure 3.11. Localisation of LET-23::GFP. (A) Receptor localisation is prominent at the membrane and 
unchanged in animals mutant for cdk-5 or egl-9. Note the diffuse fluorescence in egl-9(sa307) mutant 
animals that is specific to the mutant and hif-1 dependent (see text for details). (B) Quantification of apical 
to basal LET-23::GFP intensity values. Loss of EGL-9, HIF-1 or CDK-5 has not effect on the apical/basal 
ratio. As a control, intensity was measured in lin-3(1417) mutant animals, in which LET-23 internalisation is 
reduced and the apical/basal ratio similarly reduced (Haag et al. 2014). p values were derived from a two-
tailed student’s t-test and *** p < 0.001. Error bars indicate the standard error of the mean. The number of 
animals analysed is indicated in brackets. The scale bar indicates 10 µm.  
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To circumvent the auto-fluorescence and investigate intracellular LET-23 localisation in egl-9 mu-
tants, we generated animals carrying an extra-chromosomal translational LET-23::mCherry 
reporter construct. The expression pattern of the reporter was comparable to the GFP version, 
although accumulation of mCherry in punctae was visible as had also been observed by others 
(Shcherbo et al. 2007) (Fig. 3.11A and 3.12A). The LET-23::mCherry reporter did not show any 
intracellular accumulation in the absence of EGL-9 (Fig. 3.12B) as opposed to GLR-1 (Park et 
al. 2012). 
Figure 3.12. Expression of LET-23::mCherry and LIN-10::GFP constructs in the Pn.px stage. Localisation 
of a LET-23::mCherry construct resembles the expression of LET-23::GFP (A). As for LET-23::GFP, there 
is no change in localisation in egl-9(sa307) mutants (B). In the red fluorescence channel, the autofluores-
cence is not detectable. A LIN-10::GFP extrachromosomal array is visible in the VPCs intracellularly both 
in wild-type (C) and egl-9(sa307) (D). The scale bar indicates 10 µm.   
Finally, we analysed the expression of an extra-chromosomal translational LIN-10::GFP re-
porter that was kindly provided by Rocheleau lab. LIN-10::GFP was present in a punctate 
pattern throughout the VPC body (Fig. 3.12C). Expression was overall variable in intensity 
and in the number or fate identity of VPCs, e.g. sometimes stronger in P5.p (Fig. 3.12D). In the 
egl-9(sa307lf) mutant background, we did not observe any changes in the localisation or inten-
sity of the LIN-10::GFP construct within a given VPC. Note that the more diffuse signal in the 
mutant does not originate from the reporter but from the auto-fluorescence as explained above. 
In conclusion, our genetic and fluorescent reporter analyses do not support the model proposed 
by Park et al. (2012) in terms of vulval development. Rather, hydroxylation seems to actively 
promote RAS/MAPK signalling in the VPCs without affecting LET-23 receptor trafficking. 
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3.3.5  Loss of EGL-9 does not impair sex myoblast migration or division
During vulval development, RAS/MAPK signalling downstream of LET-23/EGFR is important 
to confer vulval cell fates (Sternberg and Horvitz 1986). On the other hand, RAS/MAPK activity 
downstream of EGL-15/FGFR is involved in the correct formation of the sex muscles that contri-
bute to egg-laying (DeVore et al. 1995; Burdine et al. 1998). The egg-laying system of C. elegans 
is composed of the vulva, sex muscle cells and neurons (White et al. 1976; Sulston and Horvitz 
1977) so that defects in egg-laying can be attributed to either component. The hermaphro-
dite-specific neurons (HSNs) release serotonin to act on the vulval muscles and to stimulate 
egg-laying (Horvitz et al. 1982) and exogenous serotonin can rescue the egg-laying defects of 
HSN-ablated defective animals (Waggoner et al. 1998). Animals mutant for egl-9 do not show 
any abnormalities in vulval development (present study) and were found to be resistant to exo-
genous serotonin in terms of egg-laying (Trent et al. 1983), which argues against defects in the 
neuronal circuit that controls egg-laying behaviour. The sex muscles, i.e. the vulval and uterine 
muscles, originate from two sex myoblasts that are born at the late L3 stage and migrate towards 
the developing vulva in response to egl-17/FGF (Burdine et al. 1998). Both myoblasts divide 
three times to produce the 16 descendants giving rise to the sex muscles (eight vulval muscle 
cells and eight uterine muscle cells) (Corsi et al. 2002). We thus asked, whether the egg-laying 
defective phenotype of egl-9 mutants is associated with defects in RAS/MAPK signalling in 
response to EGL-17/FGF. To this aim, we employed the transcriptional Phlh-8::GFP reporter 
that is expressed in the descendants of the sex myoblasts to monitor division and migration 
(Harfe et al. 1998). We did not observe any of the severe defects in the migration or division of 
Phlh-8::GFP expressing cells in egl-9(sa307) mutant animals (Fig. 3.13) as had been described 
in animals mutant for components of the FGF signalling pathway (Burdine et al. 1998): The two 
sex myoblasts were positioned correctly close to the vulva and subsequent divisions resulted in 
16 daughter cells (eight shown in the focal plane of Fig. 3.13C, F). In conclusion, EGL-9 does not 
seem to be crucial during sex myoblast migration or positioning via FGF and RAS/MAPK activity.
Figure 3.13. Expression of Phlh-8::GFP in the migrating sex myoblasts. The sex myoblasts migrate from 
the tail towards the vulva, undergo three rounds of cell division (two shown here) and produce the sex 
muscles (A-C). Neither migration nor division is impaired in egl-9(sa307) mutant animals (D-F). The scale 
bar indicates 10 µm.   
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3.3.6  A new hif-1(zh111) deletion allele is stronger than the hif-1(ia04) allele
The ia04 allele had been described as a null allele, because i) HIF-1 protein was not detecta-
ble in the mutant and ii) the 1231 bp deletion was found to cause a frameshift mutation and a 
premature stop (Jiang et al. 2001; Budde and Roth 2010). (Note that the deletion is annotated 
incorrectly on Wormbase (WS260) and deletes instead the sequence between 5’-TCCACTGG-
CTCCTCCTACTC-3’ (upstream) and 5’-AGGATTAGAAAATTGGAGAG-3’ (downstream) as we 
had verified by Sanger sequencing). We and others (M. de Bono, personal communication) are 
not convinced of the complete loss-of-function nature of the allele for several of the following 
reasons. The hif-1 genomic locus encodes five isoforms, one of which is not affected by the 
ia04 deletion and had been identified to be expressed (EST information available from the 
Kohara lab) (Fig. 3.14A). This isoform lacks the DNA binding domain but can be regulated 
by oxygen and comprises one of the PAS domains that interact with HIF-1ß (Jiang et al. 1996) 
(Fig. 3.14B). Furthermore, to detect HIF-1 protein by Western blotting, Budde et al. (2010) had 
obtained an antibody by using the N-terminus of C. elegans HIF-1 that is not present in the shor-
test isoform, since the transcriptional start site is further downstream in the genomic locus (Fig. 
3.14A). Additionally, there is a polymorphism in the hif-1 locus that impairs the first splice donor in 
this shorter HIF-1 isoform and leads to a truncated protein (72 vs. 503 amino acids) (WormBase, 
WS260) (Fig. 3.14A, black arrowhead). This polymorphism is present in a number of wild isolates, 
among which CB4856 (Thompson et al. 2013). Based on these observations, we knocked down 
hif-1 in the let-60(n1046gf); hif-1(ia04rf) mutants and found that vulval induction was slightly but 
significantly decreased (Fig. 3.14C). Next, we employed CRISPR/Cas as described in Arribere et 
al. (2014) to obtain a larger deletion in hif-1 as well as to introduce the splice site polymorphism 
present in CB4856 into the N2 background. While we did not succeed in obtaining the latter 
strain, we obtained a 2464 bp deletion (zh111) that removes parts of all isoforms (Fig. 3.14A). We 
crossed the hif-1(zh111) allele to let-60(n1046gf) and found that vulval induction was even more 
increased as by the hif-1(ia04) allele (Fig. 3.14D), supporting our hypothesis of a residual HIF-1 
function in the hif-1(ia04). Unfortunately, we were not able to verify the absence of HIF-1 protein 
in the mutant as Budde et al. (2010) had proposed, since the commonly used CeHIF-1 antibody 
was not available anymore.
3.3.7 The canonical hypoxia response pathway affects RAS/MAPK signalling in 
the vulva during normoxia
Our results indicate that EGL-9 and VHL-1 enhance RAS/MAPK signalling in a sensitised 
background, whereas HIF-1 inhibits signalling (see also chapter 3.2). To further test whether 
egl-9, vhl-1 and hif-1 act in the same pathway to impinge on RAS/MAPK activity, i.e. coopera-
tively in the hypoxia response pathway rather than separately, we constructed triple mutants 
for epistasis analysis. Vulval induction was increased by a deletion in hif-1 in a manner epi-
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static to the vhl-1(ok161) or egl-9(sa307) deletions (Fig. 3.15). In addition, we found that the 
VI of let-60(n1046); egl-9(sa307); vhl-1(ok161) triple mutants was decreased as compared to 
let-60(n1046) single mutants, but not further when compared to either let-60(n1046); egl-9(sa307) or 
let-60(n1046); vhl-1(ok161) mutant animals (Fig. 3.15). We conclude from this epistasis that 
EGL-9, VHL-1 and HIF-1 act together not only to control expression of oxygen responsive ge-
nes but also to modify RAS/MAPK activity during normoxia.
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Figure 3.14. (A) Schematic representation of the hif-1 genomic locus. The locus encodes five isoforms and 
four are partially deleted in the ia04 allele. The larger zh111 deletion obtained by CRISPR/Cas9 removes 
parts of all isoforms. The arrow indicates the P621 site of EGL-9 hydroxylation that is not present in one 
isoform. The arrowhead points to the splice donor site that contains a SNP in a number of isolates including 
CB4856 and impairs splicing. (B) the protein domains of the five HIF-1 isoforms are indicated. The shortest 
isoform, that is impaired in CB4856, does not contain the DNA binding domain but one of the PAS protein 
interaction domains. (C) RNAi of hif-1 increases the VI of let-60(n1046) animal and decreases the VI of 
let-60(n1046); hif-1(ia04) mutants. (D) The VI of let-60(n1046) mutants is increased when combined with 
the hif-1(ia04) allele and more strongly increased when combined with the hif-1(zh111) allele. p values were 
derived from bootstrapping 1000 samples, where *** p < 0.001 and ** p < 0.01. Error bars indicate the 95% 
confidence interval and the number of animals analysed is indicated in brackets.  
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Figure 3.15. Epistasis analysis between LET-60 and the core hypoxia response pathway. Loss of EGL-9 
or VHL-1 decreases the VI and the loss of HIF-1 increases the VI in a manner epistatic to both EGL-9 and 
VHL-1. The differences in VI are indicated in comparison to the respective let-60(n1046) single mutant 
sibling. p values were derived from bootstrapping 1000 samples, where *** p < 0.001. Error bars indicate 
the 95% confidence interval and the number of animals analysed is indicated in brackets (double or triple 
mutant / let-60(n1046) sibling). The mean VI value refers to the double / triple mutant.  
3.3.8 Loss of EGL-9 does not affect vulval cell fates
We had found that vulval induction was changed by the loss of EGL-9 or HIF-1 in animals 
carrying mutations in members of the RAS/MAPK cascade but not in animals mutant for 
lin-12 (gf or lf) (see also chapter 3.2). It could be assumed that alterations in signalling result 
in a different pattern or intensity of downstream marker genes, such as the 1° cell fate marker 
egl-17::gfp (Burdine et al. 1998) or the 2° cell fate marker lip-1::gfp (Berset et al. 2001). We 
tested this hypothesis by crossing these reporters into the egl-9(n586lf) temperature-sensitive 
mutant background. We raised animals at the non-restrictive (15 °C - 20 °C) and the restric-
tive temperature (25 °C) when vulval induction is reduced (Fig. 3.9B). For both markers 
analysed, we did not notice any difference in either localisation or fluorescence intensity in 
the absence of EGL-9 (Fig. 3.16). From these findings, we conclude that egl-9 is involved in 
fine-tuning rather than instructing RAS/MAPK signalling strength or that it acts in a parallel 
pathway. 
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Figure 3.16. Vulval cell fates are not changed in egl-9(n586ts) mutant animals. The localisation of 
EGL-17::GFP is not changed in egl-9(n586ts) mutant animals raised at the permissive temperatu-
res 15 °C (A) and 20 °C (E) or the restrictive temperature 25 °C (I) and most prominent in P6.p and 
descendants. 1, 2 and 4 cell stages are shown. Similarly, the localisation of LIP-1::GFP is unchanged 
in egl-9(n586ts) mutant animals raised at the permissive temperatures 15 °C (C) and 20 °C (G) or the 
restrictive temperature 25 °C (K) and most prominent in P5.p and P7.p and descendants. 1, 2 and 4 cell 
stages are shown. The scale bar indicates 10 µm. 
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3.3.9 Hypoxia affects the RAS/MAPK signalling pathway downstream of 
LET-23/EGFR and upstream of LIN-1/ETS
We have shown that hypoxia inhibits RAS/MAPK signalling in the vulva i) upstream of or in parallel 
with the ETS family transcription factor LIN-1 (Beitel et al. 1995) (see chapter 3.2) and ii) in part 
independently of hif-1 (see chapter 3.2 and Fig. 3.17). We further found that hypoxic inhibition of 
RAS/MAPK activity depends on egl-9 and vhl-1 in the let-60(n1046) mutant background, since 
induction was not further changed upon hypoxia in presence of either deletion allele (Fig. 3.17). 
Moreover, we did not see any effect of hypoxia in animals where LET-23 is severely mislocalised, 
i.e. in animals mutant for lin-2, lin-7 or lin-10 (Haag et al. 2014). In contrast, there was an interme-
diate reduction in the VI of let-23(sy1) mutant animals (see chapter 3.2) in which LET-23 activity is 
reduced due to decreased basolateral localisation but not abolished (Simske et al. 1996). Finally, 
hypoxia did not suppress the Muv of animals mutant for lin-15, which acts upstream of let-23 and 
in parallel to lin-3 to inhibit vulval induction (Huang et al. 1994; Clark et al. 1994) and there was no 
effect on the VI of animals mutant for BAR-1/ß-catenin or LIN-12/Notch. Together, these results 
strongly suggest that hypoxia acts specifically on the RAS/MAPK signalling cascade, genetically 
upstream of or in parallel to LIN-1 but downstream of LET-23.
Figure 3.17. Difference in VI of hypoxia treated animals compared with animals raised in normoxia. p 
values were derived from bootstrapping 1000 samples, where *** p < 0.001. The mean VI is indicated for 
the hypoxic situation. The number of animals analysed is indicated in brackets (hypoxia / normoxia). Error 
bars indicate the 95% confidence interval. 
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3.3.10 During normoxia HIF-1 and EGL-9 are dispensable in the germline but 
HIF-1 is required for the hypoxic reduction of RAS/MAPK activity
Hypoxic exposure suppressed RAS/MAPK activity during vulval development, meiotic germ 
cell progression and the specification of the excretory duct cell precursor in the embryo (see 
chapter 3.2 draft). We had further observed that both EGL-9 and HIF-1 are required in the 
vulva during normoxia and that RAS/MAPK activity is reduced during hypoxia partially inde-
pendently of HIF-1. Analogously, we tested the requirement for EGL-9 and HIF-1 in the germ-
line, both during normoxia and hypoxia. Neither did the loss of EGL-9 reduce the percentage 
of stacked oocytes in let-60(ga89ts) animals raised at the restrictive temperature nor did the 
loss of HIF-1 increase the phenotype (Fig. 3.18). Since the phenotype of let-60(ga89) mutant 
animals is > 90% penetrant and strong at 25 °C and may prevent the detection of any further 
enhancement, we tested the hif-1(zh111) allele at 23 °C but did not see any effect compared 
to the single mutant (data not shown). Hypoxic treatment reduced the percentage of stacked 
oocytes at 25 °C significantly in let-60(ga89) as well as in let-60(ga89); egl-9(sa307) mutants 
(see chapter 3.2 and Fig. 3.18) but not in let-60(ga89); hif-1(zh111) mutant animals (Fig. 3.18) 
suggesting a requirement of functional HIF-1 upon hypoxia. Together, these results propose 
that firstly, HIF-1 regulates RAS/MAPK signalling in the germline during hypoxia and secondly, 
that EGL-9 does not regulate HIF-1 stability during normoxia suggesting the presence of an 
alternative HIF-1 hydroxylase acting in the germline. 
Figure 3.18. (A) Percentage of stacked oocytes of let-60(ga89gf) mutant animals carrying either the hif-
1(zh111lf) or egl-9(sa307lf) deletion allele that were raised at the restrictive temperature (25 °C) and in normoxia 
or hypoxia. Error bars indicate the standard error of the mean and p-values were calculated in a Fisher’s exact 
test where *** p < 0.001. The numbers of animals scored are indicated in brackets. (B)-(D) Example images 
of let-60(ga89gf), let-60(n1046); egl-9(sa307lf) and let-60(ga89gf); hif-1(zh111lf) mutants raised at 25 °C and 
normoxia (B, C, D) or hypoxia (B’, C’, D’). Triangles indicate stacked oocytes. The scale bar indicates 5 µm.
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3.4 Biarsenical labelling of tetracysteine-tagged proteins is promising 
in C. elegans
3.4.1 Introduction
The imaging of proteins in living cells is a powerful tool to study aspects such as dynamics, traf-
ficking, protein-protein interactions and many more. Fluorescent tags like GFP and variants are 
widely used to visualise protein expression or localisation (Day and Davidson 2009). However, the 
considerable size of these fluorescent proteins (approx. 27 kDa) can interfere with protein function 
or stability (Giepmans et al. 2006) and issues with photostability and cytoplasmic accumulation 
have been encountered (Shcherbo et al. 2007). Another limitation is the lack of multiplexing, once 
a protein has been modified with a specific fluorescent tag. Griffin et al. (1998) introduced a new 
technique whereby proteins are labelled with a small tetra-cysteine tag consisting of the six-amino 
acid motif CCPGCC. Here, a small fluorescein derivative, such as fluorescein arsenical hairpin 
binder (FlAsH) or a red-shifted variant resofurin arsenical hairpin binder (ReAsH), is used in a non-
fluorescent complex with ethanedithiol (EDT2). The freed compound can bind to the tetra-cysteine 
motif upon which fluorescence becomes visible (Hoffmann et al. 2010). FlAsH (MW 664) and 
ReAsH (MW 545) are comparable in size to MitoTracker® (MW 500-600) and similarly membrane 
permeable. The tetra-cysteine-based biarsenical labelling system has been applied successfully to 
study protein localisation and turnover in pulse-chase experiments (Gaietta et al. 2002; Pattnaik 
and Panda 2009), protein-protein interactions by using the dyes for FRET (Hoffmann et al. 2005), 
for electron microscopy (Gaietta et al. 2002), affinity purification (Thorn et al. 2008) or SDS-PAGE 
(Kottegoda et al. 2008). Although biarsenical labelling has proven difficult in the Golgi apparatus 
or the extracellular space, hence in oxidising environments, successful imaging has been reported 
with the prior use of reducing agents that keep cysteine thiols accessible for the dyes (Gaietta et al. 
2006). The versatility of the system convinced us to test the method in C. elegans with a prospect 
of visualising a presumptive LIN-3/EGF gradient produced by the AC during vulval development 
that has, as of to date, only been visualised indirectly (Yoo et al. 2004). 
3.4.2 Preliminary results
In a first step, we inserted the CCPGCC tetra-cysteine tag (TC-tag) at the C-terminus of func-
tional reporter plasmids. We used the sequence 5’- TGC TGC CCA GGA TGC TGC -3’ that we 
had codon-optimised for C. elegans as described (Redemann et al. 2011). We employed reporter 
plasmids that are widely used as co-injection markers (Frøkjær-Jensen et al. 2008; Arribere 
et al. 2014; Dickinson et al. 2015), specifically the Pmyo-2::mCherry::unc-54 3’ UTR and 
Pmyo-3::gfp::unc-54 3’ UTR as well as a plasmid containing a 6.3 kb fragment of lin-3 (Hajnal 
lab). The visual output (mCherry or GFP expression and a Muv respectively) provides infor-
mation on the functionality of the TC-tagged transgenes. We micro-injected worms to obtain 
animals carrying one of the reporters as an extra-chromosomal array and were able to isolate 
3. Projects
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animals with TC-tagged lin-3 and Pmyo-2::mCherry but not yet Pmyo-3::gfp. We adapted pro-
tocols used to stain with MitoTracker® (Rimann and Hajnal 2007; Morf et al. 2013), since the 
size of the dye is comparable to both FlAsH and ReAsH. We applied working concentrations 
of 5 µM, 7.5 µM and 10 µM for several hours or overnight. We did not detect considerable 
amounts of background staining with either construct, when we used the BAL washing buffer 
from the kit (ThermoFisher). However, there was no specific fluorescence where we would 
have expected the presence of LIN-3 protein (not shown). For the Pmyo-2::mCherry construct, 
the FlAsH staining in the pharynx of array carrying worms was detectable as fluorescence and 
was specific to animals carrying the array (Fig. 3.19 and not shown), which proposes that the 
dye had bound specifically to the mCherry expressed in the pharynx. In further experiments, 
we will similarly apply ReAsH on worms that carry extra-chromosomal arrays of Pmyo-3::gfp 
that is expressed in body wall muscles (Frøkjær-Jensen et al. 2008). 
Figure 3.19. FlAsH-EDT2 staining of Pmyo-2::mCherry in the pharynx. (A) In control animals treated wi-
thout the compound, no fluorescence is detectable with the FITC filter set („green“, left), although the 
Pmyo-2::mCherry construct is expressed and visible with the TRITC filter set („red“, right). (B) FlAsH-EDT2 
(left) stains the pharynx of animals carrying the Pmyo-2::mCherry array (right).
3.4.3 Further steps in the establishment and usage of biarsenical dyes
To our knowledge, biarsenical staining has not been applied on C. elegans and only via injec-
tion on D. melanogaster eyes in vivo (Venken et al. 2008). Our very preliminary data indicate 
that biarsenical dyes can permeate the cuticle of the worm to stain proteins expressed from 
extra-chromosomal arrays and are therefore promising tools as an alternative to GFP-based 
live imaging. In further experiments, we will test whether we see a similar fluorescence of 
ReAsH in Pmyo-3::gfp transgenic worms as we had seen for FlAsH in Pmyo-2::mCherry car-
rying animals. Moreover, we will tag other fluorescent reporter genes using the tetra-cysteine 
motif to analyse the spatial concurrence of biarsenical dye and fluorescent protein and im-
prove on the protocol. We did not observe LIN-3 staining and will repeat the experiments with 
more lin-3::TC carrying animals at various stages of development. However, since LIN-3 is 
Pmyo-2::mCherry
- FlAsH-EDT2
TRITCFITC TRITCFITC
+ FlAsH-EDT2A B
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secreted (Hill and Sternberg 1992), prior application of reducing agents may be necessary. 
In conclusion, biarsenical labelling of TC-tagged proteins appears feasible and promising in 
C. elegans, since i) the dyes seemed able to cross the cuticle and membranes, ii) we did not 
detect perturbing levels of background staining, iii) TC-tagged proteins can be generated and 
introduced with minimal effort and iv) viability as well as the development of the worms were 
not affected.
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Studies on oxygen deprivation distinguish between the absence of and a reduction in O2 (anoxia 
vs. hypoxia). A precise transition does not exist and the terms appear clearly defined only within 
a given study. However, anoxia and hypoxia cause profoundly different defects and should thus 
be evaluated according to well-defined phenotypes rather than the oxygen percentage employed 
within an experiment in order to prevent confusion and misinterpretation. C. elegans is surpri-
singly resilient against hypoxia and dies only upon prolonged anoxia (> 24h), which is in stark 
contrast to most other organisms and thought to be accomplished by diffusion (Shen and Powell-
Coffman 2003). Here, hypoxia referred to an oxygen concentration below 21% and anoxia to the 
lack of molecular oxygen (0%). In contrast, another study described genes that confer resistance 
to hypoxia based on their suppression of lethality in an oxygen concentration of < 0.3% (Mabon 
et al. 2008). To complicate things further, still others distinguish between “moderate” and “seve-
re” hypoxia. As a matter of fact, the strength of hypoxic insult may determine certain phenotypes 
rather than hypoxia per se. The metabolic rate (as judged from CO2 production) has been shown 
to be unchanged at an oxygen concentration as low as 3.6%, slightly reduced down to 2% and 
severely compromised below (Van Voorhies and Ward 2000). As smooth as the transition bet-
ween hypoxia and anoxia may be, there are phenotypes clearly defining one or the other situ-
ation. In the absence of oxygen (0%), movement, feeding, developmental progression as well 
as cell divisions cease in worms – a situation known as „suspended animation“ that involves an 
arrest in the cell cycle (Padilla et al. 2002). Hypoxic treatment (> 0% O2 and < 21% O2), on the 
other hand, does not involve such severe phenotypes and wild-type but not hif-1 mutants appa-
rently develop normally (Shen and Powell-Coffman 2003). We have analysed the influence of 
hypoxia on RAS/MAPK signalling in several tissues of the worm and refer to hypoxia as a reduc-
tion in oxygen concentration to 0.5%, which we could measure with an oxygen sensor (GOX 100, 
Greisinger) mounted inside the hypoxic chambers. However, according to the manufacturer, the 
sensor has an error of 0.1%, which is considerable in this range. To circumvent the falsification 
of our results by anoxic suspended animation pathways, we only evaluated those experiments, 
during which worms developed and moved more or less normally (which verified the absence of 
4 
Discussion
4.1 General considerations
4.1.1 Anoxia and hypoxia are ambiguous terms
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suspended animation and thus anoxia) but during which the progeny of hif-1 mutants was not 
viable (as is characteristic of hypoxic treatment). For the description of our experiments, we used 
0.5% oxygen as an approximation of the concentration applied and considered the phenotypes 
described as more important. With this approach, we were able to obtain reproducible results 
and thus emphasise the experimental bias towards oxygen-dependent phenotypes rather than 
oxygen percentages or generic terms like anoxia and (moderate, severe, strong etc.) hypoxia.
4.1.2 „Isogeneity“ and „wild-type“
When studying a certain cellular or developmental event, the first step most often involves the 
acquisition of an appropriate mutant. Especially for popular model organisms, researchers have 
made an effort in collecting newly isolated mutations in commonly accessible databases which 
substantially simplifies research. Based on common agreement, mutations are engineered in 
and backcrossed to a reference strain or “wild-type” to create “isogenic” lines. However, particu-
larly in the case of model organisms with a short generation time that are kept within a constant 
and distinct laboratory environment, evolution at a population level occurs to select individuals 
with (small) advantages in fitness and establishes an evolutionary distance to the initial wild-type 
(Caberoy et al. 2003; Folg and Bradley 2005; Gasch et al. 2016). Note that such microevolution 
of model organisms is unconsciously enforced by favouring their easy-to-handling characteris-
tics. The presence of a mutation can put a selective pressure on specific genes, e.g. to suppress 
an increased lethality associated with that mutation. Hence, initially isogenic lines become more 
heterogenic, meaning they differ in the constitution of their genomic background. As much as 
microevolution is accelerated in simple short-lived model organisms, it can be at least limited 
by performing regular backcrosses and should be standard practice for organisms that can be 
stored frozen like C. elegans – in theory. In practice, this is rarely done due to the associated 
additional effort and/or a sheer underestimation of the issue. The fact that a certain mutation of 
interest is analysed within a non-isogenic environment may account for unexpected, highly va-
riable and even contradictory results and it is the interaction of a trait with its individual genomic 
and environmental background that produces a measurable phenotype. It is therefore reaso-
nable that the term “wild-type” is not (entirely) valid, since it signifies a reference strain that has 
undergone laboratory specific genetic adaptation. In the case of C. elegans, as of today the 
“wild-type” reference strain N2 Bristol (Brenner 1974) has already experienced almost 44 years 
of adaptation which is a considerable amount of time for an organism with a life cycle of only 
three days. A prominent and disturbing example of adaptation is presented by the lin-2(n397) 
mutant that exhibits a strongly reduced vulval induction index due to a severe mislocalisation of 
LET-23/EGFR (Horvitz and Ferguson 1985; Hoskins et al. 1996; Kaech et al. 1998). During the 
course of experiments within the scope of this thesis, the mutant was thawed and backcrossed 
repeatedly (and frozen immediately thereafter), as the acquisition of random mutations through 
several generations suppressed the Vul phenotype considerably. An analogous example is given 
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by the variability in signalling strength that is manifested in a broad range of VIs in sensitised 
mutants. This is however not solely caused by environmental fluctuations but depends on the set 
of unrelated or pathway related mutations present in the genome of a strain (Battu et al. 2003; 
Schmid et al. 2015) and introduced into others upon crossing (Fig. 3.4, 3.6 and 3.7). When stu-
dying alterations in signalling strength in response to a mutation, it is thus of utmost importance 
to i) analyse several lines carrying the mutation of interest in order to compensate for differences 
in the genomic background and ii) to consistently compare the effect of a mutation introduced by 
mating to the respective control sibling lines rather than to any original strain in order to stay in 
the same range of unrelated background modifications.
4.1.3 Western blots to measure pERK/ERK and pMEK/MEK ratios are incon-
clusive
From our genetic data, we had concluded that HIF-1 acts to repress RAS/MAPK signalling whe-
reas VHL-1 and EGL-9 enhance its activity (see chapter 3.2 and Fig. 3.9, 3.14, 3.15). Hence, 
we expected to detect elevated ratios of diphosphorylated (dp) MPK-1/ERK to total MPK-1/ERK 
as well as elevated phosphorylated (p) MEK-2/MEK to total MEK-2/MEK levels in hif-1(zh111) 
mutant animals and the opposite in egl-9(sa307) or vhl-1(ok161) mutants. To test this hypothe-
sis, we had performed SDS-PAGE and Western blotting on L4 larvae as described (Nakdimon 
et al. 2012; Schmid et al. 2015). We chose the let-60(n1046) mutant as a reference and the 
amx-2(ok1235); let-60(n1046) mutant animals as a control where we expected increased levels 
of phosphorylated ERK or MEK (Schmid et al. 2015). To our surprise, however, we were not 
able to reproduce the results of either publication: Whereas Nakdimon et al. (2012) detected no 
dpMPK-1 band in N2, the band for the wild-type was obvious on all our blots (data not shown). 
Second, there was no increase in dpMPK-1/total MPK-1 or pMEK/total MEK in the let-60(n1046) 
mutant sample as compared to the wild-type and third, there was no increase in dpMPK-1 or pMEK 
in amx-2(ok1235); let-60(n1046) mutants as compared to let-60(n1046) mutant animals (data not 
shown). Lastly, there was no difference in dpMPK-1 or pMEK in our let-60(n1046); egl-9(sa307) 
or let-60(n1046); hif-1(zh111) mutants in comparison with the let-60(n1046) single mutants. 
Generally speaking, the quantification of the bands representing (di)phosphorylated and total 
protein was highly variable as had been observed earlier (T. Schmid, personal communication). 
RAS/MAPK signalling is important not only during vulval development (Kornfeld 1997), but also 
during duct cell fate specification (Abdus-Saboor et al. 2011) and meiotic cell cycle progression 
(Church et al. 1995). In relation to the germline, the vulval tissue is rather small and the ERK 
and MEK levels we had measured in our egl-9, hif-1 and vhl-1 mutants may have represented 
the situation in the germline and masked the levels present in the VPCs. If this was the case, 
the variability in quantification could have stemmed from natural fluctuations in RAS/MAPK 
activity, which is supported by our genetic data that had revealed no effect of either HIF-1 or 
EGL-9 on RAS/MAPK signalling in the germline (see chapter 3.2). 
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Still, this would not explain why we were not able to reproduce the published data. To circumvent 
this issue and in addition to analyse MPK-1 dynamics, we intended to introduce a MAPK FRET 
based biosensor previously reported to be functional in cell culture as well as C. elegans ASER 
neurons (Tomida et al. 2012; Fritz et al. 2013). However, we did not succeed in employing the 
sensor neither in the VPCs nor in the germline (for a detailed analysis and discussion, the reader 
is referred to the Master Thesis by S. Boetschi). Since its initial description, there has been a 
burst in MAPK biosensors and future experiments relating to the projects presented here should 
include a recently published C. elegans sensor that relies on the ratio of cytoplasmic to nuclear 
intensities (ERK-nKTR). Here, phosphorylation in response to active RAS/MAPK inhibits a nuc-
lear localisation signal and enhances a nuclear export signal (de la Cova et al. 2017).
4.2 Project related considerations
The findings of Schmid et al. (2015) and ours suggest the presence of several polymorphic 
modifiers affecting the WNT and RAS/MAPK pathways during C. elegans vulval development. 
Intriguingly, although the members of these two signalling pathways exhibit some degree of 
polymorphic divergence, coding SNPs are rare (Thompson et al. 2013 and Table 7.2). This fact 
underscores the essential functions of the WNT and RAS/MAPK pathways during development 
and a low tolerance for aberrations. A high tolerance for sequence variation in non-essential 
modifying genes is represented by polymorphic genes containing many coding as well as 
non-coding SNPs (Tables 3.7, 3.11, 7.1 and 7.2). Cumulatively, they can considerably change 
signalling strength as exemplified in the degree of Vul and Muv phenotypes that strongly depend 
on the genomic background. 
When we consulted the list of polymorphic genes that we had identified in the RNAi screens, we 
were surprised to find some extent of pathway correlation within the candidates, in particular to 
oxygen sensing. It seems indeed plausible that several signalling modules (here RAS/MAPK and 
oxygen pathways) are influenced by the same polymorphic gene in order to facilitate an adap-
tation to a specific environmental condition encountered by genetically divergent individuals. 
These candidates were rskn-1, which plays a role in anoxia-associated death (Mabon et al. 
2008), interacts with mpk-1 and is an ortholog of human ribosomal protein S6 kinase polypep-
tide 1 (Simonis et al. 2009), pqn-26, a prion like Q/N-rich domain protein which suppresses the 
egg-laying defective phenotype of egl-9 mutants when knocked down (Gort et al. 2007) (both 
within QTL1a in the let-60(n1046) mutant background (Fig. 3.7 and Table 3.13) and best-26, 
an orthologue of human bestrophin genes (calcium-activated chloride channels) that also sup-
pressed the egl-9 mutant phenotype (Gort et al. 2007) (within the QTL1B in the bar-1(ga80) mu-
4.2.1  Highly polymorphic genes may modify low polymorphic pathways
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tant background (Fig. 3.4 and Table 3.8). Finally, F44F1.1 and pfd-3 were found to modify RAS/
MAPK signalling, to suppress the egg-laying defects caused by the lack of EGL-9, and PFD-3 is 
orthologous to VHL binding protein 1 (Gort et al. 2007; Schmid et al. 2015).   
Previously, a difference in oxygen preference of CB4856 and N2 has been ascribed to an oxy-
gen-sensing globin glb-5, which is modified by the neuropeptide receptor npr-1 and both of which 
are polymorphic (de Bono and Bargmann 1998; Persson et al. 2009). These polymorphisms 
contribute to the behavioural differences between CB4856 and N2. CB4856 and other wild iso-
lates tend to burrow more extensively into the agar the less food is present, whereas N2 roams 
on the surface of NGM plates and is thus exposed to higher oxygen concentrations (Hodgkin and 
Doniach 1997 and our observations). Further, the presence of CB4856 sequence can increase 
RAS/MAPK and WNT signalling strength. Based on theses relationships, it could thus be hypo-
thesised that RAS/MAPK or WNT signalling strength and oxygen signalling are tuned in concert, 
i.e. according to oxygen availability, such that burrowing strains need to upregulate fundamental 
pathways (like RAS/MAPK or WNT) to ensure a correct development despite a reduced meta-
bolic performance. If this hypothesis was true, then the VI of CB4856 animals sensitised with the 
let-60(n1046) mutation should be lower in individuals which had grown inside the agar compared 
with individuals that had grown on the surface. This notion is supported by our hypoxia experi-
ments, in which the VI of CB4856 animals carrying the let-60(n1046gf) mutation was decreased 
in hypoxia (see chapter 3.2). Alternatively, a lower VI in the standard N2 strain (as compared to 
CB4856) might be the result of extensive adaptation to the laboratory and exclusive life on the 
surface with increased oxygen saturation.   
Although we have not directly investigated the role of the polymorphic genes mentioned above 
neither in modifying RAS/MAPK signalling nor in affecting the hypoxia response pathway, we 
would expect their contribution to both based on the tight interaction between the two pathways 
as well as with oxygen availability (see chapter 3.2). In this respect, we had decided for a more 
unconventional approach by studying the relationship between two less polymorphic pathways 
(RAS/MAPK and the hypoxia response) that had emerged from their shared polymorphic modi-
fiers rather than studying the direct link to these modifiers. Future studies could therefore focus 
more deeply on this branch.
4.2.2  Pseudogenes – genomic remnants but not necessarily non-functional
Initially, the identification of F44F1.1 as a polymorphic modifier of RAS/MAPK signalling (Schmid 
et al. 2015) came as a surprise. As a paralog of F44F1.3, F44F1.1 may have originated from 
gene duplication with subsequent mutational events and was formerly defined as a calpain-like 
sequence (Syntichaki et al. 2002) but then dismissed as pseudogene with unknown (if any) func-
tion (WormBase WS225). Pseudogenes need not be non-functional, since RNA can be produced 
that may regulate related sequences (Tutar 2012). Somewhat supportive of such a function is 
the fact that F44F1.1 does not exhibit SNPs between CB4856 and N2 that would presumably 
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not strongly affect the functionality of a non-coding RNA, but rather a deletion that would indeed 
impair its ability in post-transcriptional modification. Previous studies have proposed that pseudo-
genes regulate their own “parental” paralogous sequences either directly by pseudogene-gene 
pairing or indirectly by acting as microRNA decoys (Poliseno et al. 2010). The latter mechanism 
has been described for the PTEN and KRAS loci and excitingly, the PTEN pseudogene locus 
(PTENP1) is frequently lost in human cancer (Poliseno et al. 2010) while the KRASP1 locus was 
found to be duplicated in neuroblastoma, retinoblastoma and hepatocellular carcinoma (Plantaz 
et al. 1997; Zimonjic et al. 1999; van der Wal et al. 2003). F44F1.3 is an orthologue of human 
atypical calpain 15 (Shaye and Greenwald 2002). Calpains are calcium-dependent cysteine-type 
endopeptidases involved in cell differentiation, proliferation and cell signalling events (Sorimachi 
et al. 1997; Sato and Kawashima 2001). A link between F44F1.3, its possibly regulatory pseu-
dogene F44F1.1, hypoxia and the RAS/MAPK pathway is provided by the following findings. 
Firstly, F44F1.1 suppressed the egg-laying defects of egl-9 mutant worms (Gort et al. 2007). 
Secondly, calpain expression and activity is enhanced during hypoxic insult (Zhang et al. 1998) 
and thirdly, calpains degrade HIF-1A in an O2 independent but Ca
2+ dependent manner (Zhou 
2006). Other studies described an involvement of ERK mediated calpain 2 activation in cell 
adhesiveness (Glading et al. 2000). Although we were not able to verify the deletion in F44F1.3 
and did not manage to engineer a mutant due to time limitations, we have observed a reduction 
in the VI of let-60(n1046) mutant worms carrying the F44F1.1(ok1765) deletion allele indicating 
an involvement of a calpain pseudogene in RAS/MAPK signalling output. It would be interesting 
to investigate the function of F44F1.1 as a pseudogene and regulator of F44F1.3 further, e.g. by 
analysing F44F1.3 mRNA levels in F44F1.1(ok1765) mutants vs. wild-type and to study the role 
of F44F1.3 in the RAS/MAPK signalling pathway.
4.2.3 EGL-9 function is not restricted to HIF-1 modification
When studying signalling pathways and networks within cells, the relevance of post-translational 
modification of pathway components is frequently underestimated although it can profoundly al-
ter protein localisation, function or degradation (Krishna and Wold 1993). An impressive example 
is the hypoxia response pathway that relies to a large part on post-translational modifications 
(PTM). As a type of PTM, prolyl hydroxylation within LXXLAP motifs promotes the proteasomal 
degradation of hypoxia inducible factors (HIFA) and is mediated by prolyl hydroxylation domain 
proteins (PHDs) (Bruick 2001). Prolyl hydroxylation within proline-rich sequences changes the 
function of a number of proteins, such as the stability of collagen, the formation of elastin fibrils 
and, perhaps surprising, the stability of Argonaute 2 (Myllyharju 2003; Gorres and Raines 2010). 
LXXLAP motifs as found in HIFA are present in other proteins where they are similarly modified 
by PHDs. This is the case for the large subunit of the RNA polymerase II complex (Kuznetsova 
et al. 2003), activating transcription factor 4 (ATF4) (Koditz et al. 2007), ß2-adrenergic receptor 
(Xie et al. 2009) or non-muscle actin (Luo et al. 2014). Thus, identifying proteins with a LXXLAP 
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motif is a promising approach to not only detect and understand the role of prolyl hydroxylation 
for a given candidate but also to decipher HIFA independent mechanisms during hypoxia. Such 
a candidate could help discover details of the HIFA independent reduction of RAS/MAPK signal-
ling strength we had observed in worms raised under hypoxia and that seemed to require intact 
AMX-2 (see chapter 3.2). Using the SIB ExPASy Bioinformatics Resource Portal (Artimo et al. 
2012) proteomes can be readily scanned for motifs of interest and we interrogated the C. elegans 
proteome for the presence of LXXLAP motifs. 46 such proteins exist, with a human conservation 
of the motif only in H28O16.1 and ddx-35 (Table 4.1). ddx-35 is an ortholog of human DHX35 
with probable ATP-dependent RNA helicase activity (Shaye and Greenwald 2011). Mutations 
in ddx-35 that impair its function have not been engineered. H28O16.1 encodes the alpha 
subunit of mitochondrial ATP synthase (Shaye and Greenwald 2011), is involved in the induc-
tion of the unfolded protein response (UPR) (Runkel et al. 2014) and is induced by serotonin 
(Gomez-Amaro et al. 2015). Could H28O16.1 thus be involved in the HIF-1 independent inhi-
bition of RAS/MAPK signalling in the vulva during hypoxia, when serotonin levels rise (Pocock 
and Hobert 2010) and enhance expression of amx-2 (Gort et al. 2007) as well as H28O16.1? 
Due to time restrictions, we have no (preliminary) results relating to this hypothesis but we will 
examine this possibility in future experiments and have started to create translational GFP repor-
ters of H28O16.1 and similarly planned constructs of ddx-35 (mutated and wt LXXLAP motifs). 
Furthermore, if ddx-35 and H28O16.1 are indeed targets of hydroxylation by EGL-9, it would be 
interesting to study their function in normoxia and hypoxia and to verify their prolyl hydroxylation 
within the LXXLAP motif (via e.g. drug treatment (DIP, CoCl2), mass spectrometry, Co-IPs or 
in vitro hydroxylation assays).
Table 4.1. C. elegans genes containing at least one LXXLAP motif. In the case of human conservati-
on, the motif sequence is indicated. 
Gene name
Sequence 
name
Human conservation Motif C. elegans Motif H. sapiens
unc-89 C09D1.1 no LvvLAP  
vps-39 T08G5.5 no LlqLAP
- T19H5.4 no LsqLAP  
- B0303.11 no LtmLAP
- ZK1290.11 no LagLAP  
- F44B9.2 no LaaLAP
- C06E1.9 no LfsLAP  
- B0495.5 no LraLAP
- C05B5.4 no LyeLAP  
- K07C5.4 no LfrLAP
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- T19B4.3 no LieLAP  
- H28O16.1 yes LqfLAP LqyLAP
- F35C8.5 no LpiLAP  
chd-3 T14G8.1 no LnfLAP
cor-1 R01H10.3 no LstLAP  
dapk-1 K12C11.4 no LvcLAP
ddx-35 Y67D2.6 yes LyeLAP LteLAP
epi-1 K08C7.3 no LnkLAP
- R09B5.11 no LteLAP  
- ZK1058.3 no LnpLAP
- F41C3.4 no LdrLAP  
hif-1 F38A6.3 yes LscLAP LemLAP, LtlLAP
hpk-1 F20B6.8 no LriLAP  
ceh-38 F22D3.1 no LasLAP
ceh-21 T26C11.6 no LeeLAP  
hmp-1 R13H4.4 no LekLAP
mes-1 F54F7.5 no LrtLAP  
mon-2 F11A10.4 no LasLAP
tyra-2 F01E11.5 no LisLAP  
ostb-1 T09A5.11 no LfiLAP
ptc-1 ZK675.1 no LlnLAP  
ptr-9 F54G8.5 no LklLAP
irx-1 C36F7.1 no LalLAP  
lin-45  Y73B6A.5 no LanLAP
cdc-25.1  K06A5.7 no LwdLAP  
dpy-31 R151.5 no LvsLAP
pro-1 R166.4 no LfqLAP  
rfc-4 F31E3.3 no LqsLAP
rhy-1 W07A12.7 no LlrLAP  
rpl-4 B0041.4 no LlkLAP
uba-2 W02A11.4 no LnmLAP  
sdc-3 C25D7.3 no LheLAP
slc-17.3 C02C2.4 no LlsLAP  
strd-1 Y52D3.1 no LyyLAP
unc-103 C30D11.1 no LlrLAP  
ptp-3 C09D8.1 no LllLAP
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4.2.4 Is EGL-9 the sole HIF-1 hydroxylase in C. elegans?
To assess tissue-specificity of EGL-9 and HIF-1 function during RAS/MAPK signalling, we have 
used the let-60(ga89) allele and analysed the percentage of stacked oocytes in double mutants at 
both normoxia and hypoxia (see chapter 3.2 and Fig. 3.18). Interestingly and in contrast to the vul-
val tissue, the absence of EGL-9 did not suppress the phenotype. Since the ga89 allele exhibits a 
strong phenotype at 25 °C and may complicate the detection of mutations enhancing the stacking 
of oocytes, we tested the absence of HIF-1 at both 25°C (Fig. 3.18) and 23 °C (not shown), but 
similarly did not detect a change in the phenotypical outcome. These results indicated that neither 
EGL-9 nor HIF-1 regulate RAS/MAPK activity in the germline during normoxia. As opposed to 
this, RAS/MAPK activity was strongly reduced in the germline of hypoxia treated animals in both 
let-60(ga89) and let-60(ga89); egl-9(sa307) mutants but not in let-60(ga89); hif-1(zh111) mutant 
animals, which suggested a HIF-1 dependent effect in the absence of oxygen. 
These results raised the possibility of a hydroxylase other than EGL-9 that modifies HIF-1 (at 
least in the germline), though this has not been reported as of yet. Rather, the prevailing under-
standing is that human HIFA proteins are subject to prolyl hydroxylation by one of three closely 
related PHDs (also known as EGLN1, 2 and 3) (Bruick 2001) and to asparaginyl hydroxylation by 
factor inhibiting HIF (FIH-1) (Lando 2002; Hewitson et al. 2002). Apparently, C. elegans encodes 
a single HIF-PHD (EGL-9) (Jiang et al. 2001; Epstein et al. 2001). A FIH gene has not been de-
scribed in the worm, but the worm genome encodes a low sequence similarity FIH-1 homolog, 
a JuMonJi (transcription factor) Domain protein jmjd-5 (The C. elegans Sequencing Consortium 
1998) that contains an iron and 2-oxoglutarate coordinating JmjC domain with hydroxylase activity 
(Trewick et al. 2005; Klose et al. 2006). Other prolyl hydroxylases modify collagen but have been 
shown not to influence HIFA stability (Jaakkola et al. 2001). C. elegans produces six collagen 
prolyl hydroxylase proteins, dpy-18, phy-2, phy-3, phy-4, C14E2.4 and Y43F8B.4 (Myllyharju 
2003), a procollagen lysyl hydroxylase let-268 (The C. elegans Sequencing Consortium 1998) 
and C17G10.1 which is an ortholog of human 2-oxoglutarate and iron dependent oxygenase 
domain containing 1 (OGFOD1) (Shaye and Greenwald 2011). Consistent with the findings of 
Jaakkola et al. (2001) the absence of DPY-18 or PHY-2 does not impair HIF-1 degradation 
(Epstein et al. 2001). Lastly, although OGFOD1 is most closely related to HIF-PHDs it proba-
bly does not regulate HIFA stability but rather acts as a ribosomal oxygenase (Singleton et al. 
2014; Pugh and Ratcliffe 2017). 
In conclusion and to our surprise, relatively little has been done to interrogate the hydroxylation 
of HIFA by oxygenases other than EGLN. The C. elegans germline in particular represents a 
promising tissue to investigate this option in more detail. Specifically, jmjd-5 and C17G10.1 as 
non-collagen modifying hydroxylases are encouraging candidates. 
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4.2.5 EGL-9 and NHR-57 may competitively act to control vulval competence
During vulval induction, growth factor signalling via the LET-23 and LIN-12 pathways establishes 
distinct cell fates to ensure the formation of a functional egg-laying organ (Kornfeld 1997; Yoo 
et al. 2004). In order to respond to these growth factors, vulval precursor cells need to obtain 
competence, which is established by Hox gene expression and WNT signalling (Clark et al. 1993; 
Eisenmann et al. 1998) and seems defined within a temporal window (Wang and Sternberg 
1999). Of the twelve ventral epidermal cells, only P3.p-P8.p comprise the vulval equivalence 
group and divide once irrespective of inductive signalling (Kornfeld 1997). Uninduced cells lose 
their competence soon after this first division, fuse to the hypodermal syncytium and differentiate 
as 3° VPCs. In wild-type animals, induction by LIN-3 from the AC takes place prior to this first 
division and favours a 1° vs 2° cell fate in P6.p. By expressing LIN-3 from a heat-shock promoter 
at precisely controlled timepoints, Wang and Sternberg (1999) found that VPCs are competent 
to respond to LIN-3 from the beginning of the first cell division until shortly after division (Wang 
and Sternberg 1999). If they overexpressed LIN-3 after VPCs had divided, all VPCs adopted the 
uninduced 3° fate. They further found that the daughters of NOTCH expressing 2° VPCs (P5.p 
and P7.p) are able to respond to LIN-3 and adopt a 1° fate which contrasts the time-wisely more 
restricted LIN-3 responsiveness and suggests that 2° cells remain competent for a longer period. 
In agreement with these observations, others had proposed a function of NOTCH in maintaining 
competence by delaying cell fate determination (Coffman et al. 1993; Artavanis-Tsakonas et al. 
1995). Specifically, NOTCH signalling promotes the G1/S transition thereby inhibiting differen-
tiation (Joshi et al. 2009). The coupling of NOTCH signalling with cell cycle progression is an 
elegant way to temporally adjust cell fate acquisition and indeed, NICD degradation in the VPCs 
has been shown to coincide with the G2 phase (Nusser-Stein et al. 2012). Therefore, if VPCs 
receive both unsufficient LIN-3 and LIN-12 signals, they exit from the cell cycle and differentiate 
as 3° (Ambros 1999). LIN-12 probably prolongs vulval fate competence to help ensure that a 1° 
fate is established, since 1° descendants but not 2° cells can sometimes give rise to a partially 
functional vulva (Sulston and White 1980; Greenwald and Seydoux 1990). This notion is consis-
tent with the finding that once the 1° fate has been established, a VPC cannot be reverted to 2° 
or 3° (Ambros 1999). Similarly, compromised RAS/MAPK signalling does not necessarily cause 
all VPCs to adopt the uninduced cell fate but frequently confers a 2° fate to extend the time when 
a 1° fate can still be acquired (Katz et al. 1995; Katz et al. 1996). 
Our results extend the current knowledge on VPC cell fate acquisition and prolongation of com-
petence and suggest that EGL-9 aids in these processes. We discovered that EGL-9 is a NOTCH 
target promoting induction and that the HIF-1 target NHR-57 mediates the inhibitory effect we 
observed in egl-9 mutant animals (see chapter 3.2). Hence, these results add more complexity 
to vulval fate acquisition and control of cell competence by introducing the environmental compo-
nent oxygen. In wild-type animals, a translational nhr-57::gfp reporter is expressed in the ventral 
epidermal cells that do not exhibit egl-9::gfp expression (see chapter 3.2), i.e. in the Pn.p cells 
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outside of the vulval equivalence group. Therefore, NHR-57 may act to limit vulval competence in 
competition with EGL-9 which promotes competence. We assume that early during development 
and in P6.p, where expression of egl-9 (as judged from egl-9::gfp expression) is weak, NHR-57 
may act to moderate competence to prevent a manifestation of stochastic fluctuations in signal-
ling. At the onset of induction, LIN-3 signalling may override this decreased competence to confer 
a vulval fate and initiate lateral signalling via LIN-12 in order to promote egl-9 expression and the 
enhancement as well as the prolongation of vulval competence. While the VI of let-60(n1046) 
mutant animals was increased by a nhr-57(tm4533) mutation, presumably due to the loss of 
NHR-57 function in uninduced cells (see chapter 3.2), the translational nhr-57::gfp construct 
did not suppress the VI (data not shown). Possibly, since the construct is still subject to HIF-1 
mediated transcriptional control, an overexpression from an extra-chromosomal array may not 
suffice for protein accumulation (as suggested by the lack of a GFP signal in vulval cells of wild-
type or let-60(n1046) mutant animals). As opposed to this, nhr-57 expressed from a non-HIF-1 
regulated promoter is expected to suppress RAS/MAPK activity and we are currently working 
on a bar-1 driven reporter to test this hypothesis. 
Figure 4.1. NHR-57 and EGL-9 modulate vulval development. (A) Expression of an extrachromoso-
mal nhr-57::gfp construct in egl-9(sa307) mutant animals is prominent in nonvulval cells and visible in 
the VPCs as well as in the AC (indicated by a triangle). (B) In the wild-type, the apical junctions of the 
vulval competence group are visible, because they do not fuse with hyp7. (C) AJM-1::GFP expression 
in egl-9(sa307) mutants is unchanged. The scale bars indicate 10 µm.
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The epistasis analysis predicts that NHR-57 inhibits vulval induction in parallel with LIN-1/ETS 
and this is in accordance with our findings that the GFP reporter expression of the RAS/MAPK 
and NOTCH downstream effectors egl-17 and lip-1 is unchanged in egl-9 mutant animals (Fig. 
3.16). All of the genes within this new regulatory module – hif-1, egl-9, nhr-57 and vhl-1 – exert 
a regulatory and fine-tuning rather than an essential function during vulval development, since 
mutations in any of the genes do not cause obvious phenotypes in an otherwise wild-type situati-
on (in terms of vulval development). Likewise, a loss of EGL-9, which causes increased NHR-57 
expression in the VPCs (Fig. 4.1A), does not lead to the adoption of excessive 3° cell fates and 
the fusion with the syncytial hypodermis as assessed using an apical junction marker ajm-1::gfp 
(Diogon et al. 2007) (Fig. 4.1B, C). Expression of nhr-57 in the Pn.p cells is presumably not 
solely regulated by egl-9 and hif-1 as reporter fluorescence in egl-9 mutant animals is strongly 
enhanced in the non-competent P(1-3).p and P(9-12).p cells in relation to the vulval competence 
group (P(3-8).p) (Fig. 4.1A and see below). We assume that the usage of oxygen in modulating 
and timing cell competence serves to limit energetically unfavourable signalling pathway activity, 
especially in less important tissues like the vulva, when oxygen availability is compromised and 
to preserve essential cellular functions with an absolute necessity of oxygen.
NHR-57 is an ortholog of members of the human nuclear hormone receptors, among which are 
the glucocorticoid and retinoic acid receptors that act as transcription factors or by regulating the 
same (Shaye and Greenwald 2011; Varricchio and Migliaccio 2014). Among the possible ortho-
logues, only the glucocorticoid receptor NR3C1 (nuclear receptor subfamily 3 group C member 
1) was found to accumulate during hypoxia and participate during erythropoiesis (Bauer et al. 
1999; Mense et al. 2006; Elvidge et al. 2006; Varricchio and Migliaccio 2014). While NR3C1 
was found expressed during CD8 T cell and cardiomyocyte differentiation, it maintained prolife-
ration in response to stress such as hypoxia (Bauer et al. 1999; Cabral-Teixeira et al. 2015; Yu 
et al. 2017). In addition to an activation by steroid hormone binding, CDKs and MAPK regulate 
transcriptional activity of NR3C1 through phosphorylation (Krstic et al. 1997) and others descri-
bed a physical interaction between NR3C1 with ETS2 proteins to synergistically regulate shared 
cellular events (Mullick et al. 2001). Intriguingly, NR3C1 mutations compromising its expression 
are present in patients suffering from major depression and serotonin positively regulates NR3C1 
expression (Mitchell et al. 1990; Mitchell et al. 1992; Laplante et al. 2002; Kumsta et al. 2009; 
Zhang et al. 2012). This fact is of particular interest, since we propose that RAS/MAPK signalling 
is reduced during hypoxia in a HIF-1 independent but presumably serotonin dependent manner 
(see chapter 3.2). Against our initial expectations such a HIF-1 independent regulation could still 
converge on the same transcription factor, NHR-57, by employing increased serotonin levels 
present during hypoxia (Pocock and Hobert 2010) and promote nhr-57 expression to suppress 
RAS/MAPK activity. Finally, the gene encoding the glucocorticoid receptor contains many coding 
and noncoding polymorphisms in the human population that have been associated with various 
diseases (Bray and Cotton 2003; Varricchio and Migliaccio 2014). Similarly, the nhr-57 locus re-
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veals twelve noncoding SNPs between CB4856 and N2 that may affect function (Thompson et 
al. 2013). In summary, many studies have focused on the presumable nhr-57 ortholog NR3C1 
and have suggested the involvement of the protein during hypoxia, cell differentiation and proli-
feration, serotonin signalling and RAS/MAPK signalling outputs – characteristics relating to our 
present data and hypothesis and that may facilitate in gaining a deeper insight into how exactly 
NHR-57 acts to control vulval induction.
4.2.6 Crosstalk between HIFA and MAPK
In this thesis, we describe how HIF-1 as a transcription factor and hypoxia as an important 
environmental component control the output of RAS/MAPK signalling. As a matter of fact, the 
interaction of HIFA and hypoxia with MAPK has been described earlier. HIF-1 post-translational 
modification does not only include hydroxylation by PHD proteins (Epstein et al. 2001) but also 
positively regulating phosphorylation by MAPK, as exemplified in transformed cell lines exhibi-
ting elevated RAS/MAPK levels (Richard et al. 1999). Interestingly, one of the four HIF-1 iso-
forms of C. elegans contains neither a hydroxylation nor a P-X-[S/T]-P MAPK phosphorylation 
motif (Clark-Lewis et al. 1991) as determined from its amino acid sequence (The C. elegans 
Sequencing Consortium 1998), raising the possibility of a poorly modifiable stable isoform 
comparable to constitutive HIF1B. On the other hand, hypoxia has been shown to activate RAF 
by hyper-phosphorylation it on the other hand to activate negative feedback signalling (Seko 
et al. 1996; de la Cova and Greenwald 2012). Further HIF-1 was shown to interact with LIN-2 
in yeast two-hybrid experiments (Li et al. 2004) and described as an ERK target gene (Berra et 
al. 2000). The activation of HIF-1 by a gain in RAS/MAPK activity could explain our findings that 
the loss of HIF-1 affected vulval induction of let-60(n1046) mutants during normoxia, when HIF-1 
protein is normally degraded. To assess the extent, to which elevated RAS/MAPK activity incre-
ases HIF-1 protein levels, we had crossed a HIF-1::GFP translational reporter (Sendoel et al. 
2010) into the let-60(n1046) mutants. However, we did not observe any increase in fluorescence 
when EGL-9 was functional, suggesting that oxygen regulated degradation of HIF-1 had elimina-
ted potentially elevated protein levels that may have originated from overactive RAS/MAPK sig-
nalling. Though, it might be that the fluorescent reporter construct was not visible in the mutants, 
because expression was in general rather weak also in egl-9 mutant animals. Unfortunately, we 
could not perform SDS-PAGE and Western blotting to detect HIF-1 protein in these mutants as 
the antibody was not available. Nevertheless, future experiments may include the biochemical 
analysis of HIF-1::GFP levels in let-60(n1046) or lin-12(n137n720) mutant animals as well as 
hypoxia to confirm or analyse respectively whether HIF-1 protein accumulates as had been 
suggested previously.
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4.2.7 Further experiments
This last paragraph is dedicated to a summary of some of the experiments that were not conduc-
ted because of timely constraints but may be part of follow-up studies. 
We have identified several polymorphic candidate polymorphic modifier genes within the QTLs 
affecting WNT and RAS/MAPK signalling that await verification by mutant analysis and a detailed 
description. In addition, the hypothesis and involvement of a pseudogene-gene interactive me-
chanism by F44F1.1 and F44F1.3 on RAS/MAPK activity could be evaluated. 
In the second project, we have investigated the requirement for HIF-1 and EGL-9 in RAS/MAPK 
signalling during vulval development and the germline both during normoxia and hypoxia and 
found considerable differences in pathway regulation. Thus, the role of the two proteins du-
ring duct cell fate specification in normoxia and hypoxia should be analysed and compared to 
the other tissues. Next, we had started analysing the egg-laying defective phenotype of egl-9 
mutants in more detail. RAS/MAPK activity is required for the uterine uv1 fate to establish the 
vulva-uterine connection and enable egg-laying (Chang et al. 1999). It is therefore plausible to 
interrogate uv1 fate acquisition in egl-9 mutants. Moreover and as mentioned above, H28O16.1 
and nhr-57 may act in concert with AMX-2 to suppress RAS/MAPK activity in the vulva during 
hypoxia and in a HIF-1 independent manner. The analysis of mutants and fluorescent reporters 
(of amx-2, H28O16.1 and nhr-57) in normoxia, hypoxia, upon treatment with the egl-9 inhibiting 
drugs CoCl2 or DIP (Romney et al. 2011; Padmanabha et al. 2015) and in egl-9 mutant animals 
will provide more information and open up possibilities for subsequent analyses. It should be 
mentioned at this point that drug treatment using CoCl2 or DIP is indeed a feasible method for 
our investigations as both drugs strongly suppressed the VI of let-60(n1046) mutant animals but 
had no effect in a wild-type background (data not shown, for method see 5.3.7). Our results also 
strongly suggest the presence of an alternative hydroxylase acting on HIF-1 in the germline and 
investigating the involvement of the few hydroxylases encoded in the C. elegans genome (e.g. 
jmjd-5, C17G10.1) appears straightforward. Finally, we have just started to understand the regu-
latory role of the hypoxia response pathway and one of its prime targets NHR-57 in vulval cell fate 
acquisition and competence and future should and will tell, which NHR-57 targets or interacting 
proteins act downstream and how exactly cell fate acquisition is controlled. 
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The plasmid sequences can be found on the accompanying CD ROM. 
pSMa01, 02 and 07 were not part of the projects described in this thesis and are described in 
the previous Master thesis. For a detailed description of experiments performed with pSMa05, 
pSMa06, pSMa09 and pSMa10 the reader is referred to the Master thesis by S. Boetschi and 
to the report by J. Grolleman. The usage of pSMa11-14 is described in the Master thesis of A. 
Henggeler. SLiCE cloning was established in our lab by J. Grolleman and is described in the 
respective report.
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Material and Methods
5.1 DNA methods
5.1.1 Plasmids
pSMa03
sgRNA1 targeting hif-1. Site-directed mutagenesis using OSMA87 and OSMA88 to 
insert sgRNA into pUC57. Sequence: GATAGAAAAGTGAGTCCTAA.
pSMa04
sgRNA4 targeting hif-1. Site-directed mutagenesis using OSMA93 and OSMA94 to 
insert sgRNA into pUC57. Sequence: TTCGAATATACACGCCCTTT.
pSMa05
Pbar-1::ERKyce::unc-54 3’ UTR in pCFJ150. Obtained by Gateway cloning using pIN08, 
ERKyce_pos221_pDONR and pCH17.
pSMa06 Pdlg-1 in pDONRP4-P1r. Pdlg-1 was amplified using OSMA102 and OSMA103.
pSMa08
sgRNA5 targeting hif-1 P621. Site-directed mutagenesis using OSMA96 and OSMA97 
to insert sgRNA into pUC57. Sequence: ATATGATGCAAATGGACGAG.
pSMa09
pie-1 3’ UTR in pDONRP2r-P3. pie-1 3’ UTR was amplified using OSMA144 and 
OSMA145.
pSMa10
Ppie-1::ERKyce::pie-1 3’ UTR in pCFJ150. Construct obtained by Gateway cloning using 
pCM1.127, ERKyce_pos221_pDONR and pSMa09.
pSMa11
pDONRP2r-P3 containing let-23(partial)::mCherry. mCherry was inserted by Gibson 
cloning: mCherry was amplified using OSMA179 and OSMA180 with overhangs into 
pJE05. OSMA181 and OSMA182 were used to amplify pJE05 without GFP and the frag-
ments were fused. 
pSMa12
Plet-23::let-23::mCherry::let-23 3’ UTR in pCFJ150. Obtained by LR reaction (Gateway 
cloning) with pSMa11, pJE06 and pJE07.
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pSMa13
pDONRP2r-P3 containing let-23(partial)::SECFP. SECFP was inserted by SLiCE clon-
ing: SECFP was amplified using OSMA195 and OSMA197 with overhangs into pJE05. 
OSMA182 and OSMA196 were used to amplify pJE05 without GFP and the fragments 
were fused.
pSMa14
pDONRP2r-P3 containing let-23(partial)::YPet. YPet was inserted by SLiCE clon-
ing: YPet was amplified using OSMA195 and OSMA198 with overhangs into pJE05. 
OSMA182 and OSMA196 were used to amplify pJE05 without GFP and the fragments 
were fused. 
pSMa15
N-terminally tagged lin-3 with tetracysteine sequence (TGTTGCCCAGGTTGCTGT). 
Inserted by site-directed mutagenesis using OSMA183 and OSMA184.
pSMa16
sgRNA1 targeting nhr-57. Sequence cloned into pMW46. Sequence: TGTAGTGTGTGC-
CATCAGTT.
pSMa17
sgRNA2 targeting nhr-57. Sequence cloned into pMW46. Sequence: TTAGGAGATGGT-
TATCACTT.
pSMa18
sgRNA4 targeting nhr-57. Sequence cloned into pMW46. Sequence: GAAC-
TATTTCTTCAAACGA.
pSMa19
sgRNA5 targeting nhr-57. Sequence cloned into pMW46. Sequence: GGCTAAAAA-
GATATAAGCTT.
pSMa20
Tester for sgRNAs3, 4, 5 targeting nhr-57. Cloned into pMW79. Sequence: GGCTA-
AAAAGATATAAGCTTAGGTCACAATTTTCAGCGTTCCGTGGAACTATTTCTTCAAAC-
GATGG.
pSMa21
sgRNA1 targeting LXXLAP motif in H28O16.1. Cloned into pMW46. Sequence: TGCC-
GCTCCACTCCAATTCT.
pSMa22
sgRNA4 targeting LXXLAP motif in H28O16.1. Cloned into pMW46. Sequence: TATG-
GAGCCAAGAATTGGAG.
pSMa23
sgRNA3 targeting LXXLAP motif in H28O16.1. Cloned into pMW46. Sequence: CAGAG-
TATGGAGCCAAGAAT.
pSMa24
sgRNA5 targeting LXXLAP motif in H28O16.1. Cloned into pMW46. Sequence: AGC-
CAAGAATTGGAGTGGAG.
pSMa25
sgRNA2 targeting LXXLAP motif in ddx-35. Cloned into pMW46. Sequence: GC-
CAATTCGTAAAGCCATTC.
pSMa26
sgRNA1 targeting LXXLAP motif in ddx-35. Cloned into pMW46. Sequence: GTGC-
CAAATTCGTAATAGTG.
pSMa27
sgRNA3 targeting LXXLAP motif in ddx-35. Cloned into pMW46. Sequence: GCCT-
GAATGGCTTTACGAAT.
pSMa28
Repair template with mutated LXXLAP motif in H28O16.1, cloned into pCR™-Blunt II-
TOPO®. Amplified with OSMA234 - OSMA235 and mutated with OSMA236/237. 
pSMa29
sgRNA5 targeting nhr-57. Sequence cloned into pMW46. Sequence: TCA-
CAATTTTCAGCGTTCCG.
pSMa30
Pmyo-2::mCherry::unc-54 3’ UTR (Q29), C-terminally tagged with codon-optimised 
tetracysteine tag (TGCTGCCCAGGATGCTGC). Tag was inserted by site-directed muta-
genesis using OSMA283 and OSMA284. 
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pSMa31
Pmyo-3::gfp::unc-54 3’ UTR, C-terminally tagged with codon-optimised tetracysteine 
tag (TGCTGCCCAGGATGCTGC). Tag was inserted by site-directed mutagenesis using 
OSMA292 and OSMA293.
pSMa32
Pnhr-57::nhr-57::gfp::nhr-57 3’ UTR in vector backbone with AmpR and CB-unc-119(+) 
(Note that the CB-unc-119(+) sequence contains a coding SNP). 
pSMa33
Pbar-1::nhr-57::gfp::nhr-57 3’ UTR in vector backbone with AmpR and CB-unc-119(+) 
(Note that the CB-unc-119(+) sequence contains a coding SNP).
Amplification of DNA sequences was performed with Phusion® High-Fidelity DNA Polymerase 
(NEB) or LongAmp® Taq DNA Polymerase (NEB) according to the manufacturer’s protocol using 
the following PCR mixes and cycle programs. 
Phusion® High-Fidelity DNA Polymerase (NEB)
5.1.2 PCR
Cycles Temperature Time
1x 98 °C 30 sec
30x 98 °C 10 sec
58 °C 30 sec
72 °C 30 sec / kb
1x 72 °C 5 - 10 min
12 °C ∞
Component 20 µl reaction
5X Phusion HF or GC buffer* 4 µl
2 mM dNTPs 2 µl
2 mM forward primer 2 µl
2 mM reverse primer 2 µl
Template DNA variable
Phusion DNA Polymerase 0.2 µl
ddH2O to 20 µl
*Phusion HF buffer was used for the amplification from plasmid DNA and Phusion GC buffer was 
used for the amplification from genomic DNA.
LongAmp® Taq DNA Polymerase (NEB)
Cycles Temperature Time
1x 94 °C 2 min
30x 94 °C 30 sec
58 °C 30 sec
65 °C 50 sec / kb
1x 65 °C 10 min
12 °C ∞
Component 20 µl reaction
5X LongAmp Taq buffer 4 µl
2 mM dNTPs 2 µl
2 mM forward primer 2 µl
2 mM reverse primer 2 µl
Template DNA variable
LongAmp DNA Polymerase 0.8 µl
ddH2O to 20 µl
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PCRs were performed in 0.2 ml Multiply® Pro Tubes (Sarstedt) or 96-well plates cut accor-
ding to the number of reactions. The BioRad MyCycler Thermocycler was used. 2 – 4 µl PCR 
product was mixed with PCR-loading dye and loaded onto 1% agarose gels supplied with 
0.2 – 0.5 µg/ml ethidium bromide. 1 kb or 2-log ladders (Invitrogen) were used as reference. 
Gels were run at 120 V for approximately 30 min and the DNA bands were visualised with 
UV trans illumination.
5.1.3 Oligonucleotides
The primers listed below were ordered from Microsynth AG (www.microsynth.ch) and kept at 
-20 °C in 100 µM stock solution in TE. For PCR reactions, the primers were diluted with ddH2O 
to 2 µM. A working concentration of 10 µM was used for sequencing. The primers listed below 
are indicated from 5’ to 3’. Primers OSMA1 – OSMA25 were part of previous studies and not 
mentioned here.
F44F1.1
OSMA 26 CAGTTGAGTCTTTTACCCCG
OSMA 27 GATCCAGAAAACAGTCAGCC
OSMA 30 GAACACGAATCCGAACAAATC
OSMA 31 GTCAAAGGAATGGGAATGGTG
F44F1.3
OSMA 28 CAAAGACAGGCACTAAAATGAG
OSMA 29 CTGAGAAGAAGAAGTTTGTGC
OSMA 85 GGACTATATTTCTCGGTGAT
OSMA 86 GGAAGATTGCCAGTAAGAAT
pfd-3
OSMA 32 GTGTCGATAATGCTCAAACT
OSMA 33 ACAAATTCCTCTCTGAACCC
OKJ 1 TCTAATCACATCACCTGTCACAC
OKJ 2 CGAAAATCAATATCCCAAAGCCC
OKJ 3 GCAAATCTA AATGTTTGCGGACAGTCTATCAGCACGGTTTTA GAGC-
TAGAAATAGCAAGTTA
OKJ 4 CTAGCTCTAAAACCGTGCTGATAGACTGTCCGCAAACATTTA GAT TTG-
CAATTCAATTATATAG
OKJ 5 GCAAATCTAAATGTTTGTCATATTCGACCATTACGTGTTTTAGAG 
CTAGAAATAGCAAGTTA
OKJ 6 CTAGCTCTAAAA CACGTAATGGTCGAATATGACAAACATTTA GATTTG-
CAATTCAATTATATAG
OKJ 7 CTTTTTCCCCGGAAGATCTACGCTCAATTTTTAC
OKJ 8 TGAGCGTAGATCTTCCGGGGAAAAAGAAAATTCC
123
DNA methods
OKJ 9 CCGTTTTTCGCCCGAAAGATCTCTTGAAATCCCC
OKJ 10 ATTTTAAAGGGGATTTCAAGAGATCTTTCGGGCG
OKJ 11 AAATTAAAGGCGCATAAGGG
OKJ 12 CCGATTTCGTTTTTTTCCACC
OKJ 13 AGGTCGTCTAGTGTCTTTTAG
OKJ 14 AAATTGAACCCGAAACCCTC
OKJ 15 CGTCTATCCATATTCTCAGC
OKJ 16 AACCATGCTCTCCAATTTTG
OKJ 17 ACG GAA GTC AAT TTT GAA GC
OTS 326 GCAAATCTAAATGTTTGAAAAAACGCAAAAAATTCGGTTTTAGAG 
CTAGAAATAGCAAGTTA
OTS 327 CTAGCTCTAAAACCGAATTTTTTGCGTTTTTTCAAACATTTA GATTTG-
CAATTCAATTATATAG
OTS 328 GCAAATCTAAATGTTTGCCGCTCTCGCTGTCAATAAGTTTTA GAGC-
TAGAAATAGCAAGTTA
OTS 329 CTAGCTCTAAAACTTATTGACAGCGAGAGCGGCAAACAT TTAGATTTG-
CAATTCAATTATATAG
OTS 121 AGTTGGGATTTTTTTGTGCTCC
OTS 122 TGGCTGCTGAGATGTTGATTTTC
egl-9
OSMA 34 CCAATTCCACCTACTGTTTC
OSMA 35 CAGTAAATGTGGTCAGATCG
OSMA 36 CAGATCATCGAAACAGAAGG
OSMA 42 GCCACGTCGTTCATTTTATC
OSMA 43 GCGTAGGGAGATGGAAGAGA
OSMA 113 GTTATTGTCTCGCTTTTGCC
OSMA 114 CCAATTCCACCTACTGTTTC
OSMA 171 CATCATCAGTGTCTTCCCCTC
OSMA 172 CTTGCTCTCACGTATTTCTGC
OSMA 229 GATATCAGTAGACTCGCTCAAGTTTTGAGTC (cDNA)
OSMA 230 GATGATCCGGATATTCAGATCATCGAAACAGAAG (cDNA)
OSMA 231 GAGTCGCTCAATTTCTTTCGCGGTAAATTTG (cDNA)
OSMA 232 GTCGGCAGAGATGTCAACTCTATCTTCATCTG (cDNA)
OSMA 233 GTGGAGAGAGATACTCCCGAGTCAGTAGATTC (cDNA)
hif-1
OSMA 48 CACTTACAATGGCTCGAAAC
OSMA 49 GTAACATCTTCTCCGTTTTC
OSMA 87 GCAAATCTAAATGTTTGATAGAAAAGTGAGTCCTAAGTTTTAGAGC-
TAGAAATAGCAAGTTA
OSMA 88 CTAGCTCTAAAACTTAGGACTCACTTTTCTATCAAACATTTAGATTTG-
CAATTCAATTATATAG
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OSMA 89 CGTTTGCAAAAGTAAAATGAGCAGGGACTCTGAATACCTAG-
ATAGAAAAGGGAGTCCTAAAGCGCGTGTATATTCGAAAACTTTTTCAAATCA-
GATTTATAG
OSMA 90 GTCCTTTTTGTCCTTTCGTC
OSMA 91 GCAAATCTAAATGTTTTAGGACTCACTTTTCTATCTGTTTTAGAGC-
TAGAAATAGCAAGTTA
OSMA 92 CTAGCTCTAAAACAGATAGAAAAGTGAGTCCTAAAACATTTAGATTTG-
CAATTCAATTATATAG
OSMA 93 GCAAATCTAAATGTTTTTCGAATATACACGCCCTTTGTTTTAGAGC-
TAGAAATAGCAAGTTA
OSMA 94 CTAGCTCTAAAACAAAGGGCGTGTATATTCGAAAAACATTTAGATTTG-
CAATTCAATTATATAG
OSMA 95 GATCTTCAATGGGAAGAGCCTGATTTATCGTGCTTGGCAGGATTC-
GTTGACACTTATGATATGATGCAAATGGACGAGGGCTTACCAC-
CAGAGCTTCAAGCTCTTTACGACTTGCCTGACTTTAC
OSMA 96 GCAAATCTAAATGTTTATATGATGCAAATGGACGAGGTTTTAGAGC-
TAGAAATAGCAAGTTA
OSMA 97 CTAGCTCTAAAACCTCGTCCATTTGCATCATATAAACATTTAGATTTG-
CAATTCAATTATATAG
OSMA 115 CAAAACTGTCTGAAAACACC
OSMA 116 GAAAATGAATGAGACGAGAGC
OSMA 122 CAATCTTGCCCCATTCATAC
OSMA 123 GTATCTGATGGTGAAAGGGC
OSMA 127 GAGCTCCAACAAAAAGAAGGG
OSMA 128 CTGAACAACAAAGAGCGGTC
OSMA 129 GCGAATGCATTACAACTAGG
OSMA 130 CTTCACCTCTCTCAATTTTCAG
OSMA 131 GTTTCCCTCGTTTCATATGAC
OSMA 132 CTAGGCTGTTGTTCATTTTGC
OSMA 224 CAATCACACCAACCTCAGCTTCAC
OSMA 225 CTGTTGCTGTCCTTGCCAATATGTC
OSMA 289 CTCACGGAGGTATGAGGACAACGG
OSMA 290 GAGGAATGCCGCATGTTCCGATCC
vhl-1
OSMA 50 CGTATGGGGAATGGAATTGC
OSMA 51 CTGTCCTGTAATTCAACTTTCC
ahr-1
OSMA 77 CTCTTTTTATCGCCATCCTTC
OSMA 78 GGAATTGATGGGATTGTTGG
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mos1 / ttTi5605
OSMA 62 GAATAGGTGGTAATCGGATGG
OSMA 63 CCCATCTACCGACCTTCTGA
OSMA 64 CATTCCCTACTTGTACACCT
OTS 172 CGGAAACCAAAGGACGAGAG
OTS 173 TGTTTTTGATTGCGTGCGTT
OTS 194 ATCTTTTCTGGCTCTGCTTCTTC
OTS 195 CCTCTTAATGCGTTGTTTCTCTC
pha-1
OSMA 117 CGTTGCTCGATGATTTCTCC
OSMA 118 CAAAATTTTCCCGGTTGTCG
OSMA 119 GAAAAGAGAATCGAACTGTGG
rrf-3
OSMA 120 CAATGGAGCGAACATACATC
OSMA 121 CACATTTTCTCGTTCAAGCC
let-23
OSMA 124 CAAAGAAGTTCAGCAGTCAGC
OSMA 125 CCAGCGACCAAATCCATTAG
OSMA 126 GAAATTTTGTGAAGAAGGGCAG
let-858
OSMA 146 GGGGACAGCTTTCTTGTACAAAGTGGCAATTTTCAAATTTTAAATACTGAATA
OSMA 147 GGGGACAACTTTGTATAATAAAGTTGCTTTCTTTGCTTATTTTTTACTAGTT
cdka-1 / p35
OSMA 175 GTCAACAGGAATAGAGCAAGAG
OSMA 176 CGTGCGATATCCAAATAAGTG
lin-10
OSMA 159 GATTTGTTACGAGGATGTGCAG
OSMA 160 CTGGAAATTAGGCGAAGTGATG
OSMA 161 CTCTCTCTTTTTGCTCAGCC
lin-7
OSMA 162 CTTGATCGGTTTTTGGGAGC
OSMA 163 GAGGAGATGAAGGGATACGAG
5. Material and Methods
126
unc-119
OSMA 165 GCACACCCCTTTTATGAACG
OSMA 166 CGGGTCTCGTTTGGATTATTG
OSMA 167 CAGTTGTTTCTCGAATTTGGC
lin-3
OSMA 189 GTTCTTCCCACCCCTTATG 
OSMA 190 CTGGAGACGATGAAAAACG 
OSMA 191 GATGAGCATGACAATGAGA 
OSMA 192 CGACACAACTCCACATTCAAC 
OSMA 206 GCTGATGTTGAAGATTGCTG
OMMO 135 TGGTCCCTTGAATGGTTTGTC
OMMO 136 CTGTTCGGGAGCACTACGTT
OJE 129 GACTAACAACCAATCTACAG
OAH 138 GAAATCGAGGAGTTGAACTGGC 
lin-45
OSMA 199 GTTGCCTCATCATTAATCGC
OSMA 200 GATGATGGGATTTCGATGTG
unc-32
OSMA 211 CTGAGCACTTCACCAATTCC
OSMA 212 GGTATGTGGTCCTAGGCAAG
OSMA 213 CACGACAAGCTACAGGATAG
mpk-1
OSMA 226 CACCCCTGAATTGAACTACG
OSMA 227 GTTTCTCTCTTTTCTACCACG
OSMA 229 CCGGAAAATCGAAAACTTAC
H28O16.1
OSMA 234 GCCGAAGAAATGGTTGAGTTC
OSMA 235 CTACACGGGATACAGACAGAC
OSMA 236 GAGTATCGTGGGATGAATTCCACTGGAGCGGCATCGG
OSMA 237 CTCCAGTGGAATTCATCCCACGATACTCTGGATGCG
OSMA 242 CTTGTGCCGCTCCACTCCAATTCT
OSMA 243 AAACAGAATTGGAGTGGAGCGGCA
OSMA 244 CTTGCAGAGTATGGAGCCAAGAAT
OSMA 245 AAACATTCTTGGCTCCATACTCTG
OSMA 246 CTTGTATGGAGCCAAGAATTGGAG
OSMA 247 AAACCTCCAATTCTTGGCTCCATA
OSMA 248 CTTGAGCCAAGAATTGGAGTGGAG
OSMA 249 AAACCTCCACTCCAATTCTTGGCT
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OSMA 260 CTTGCTCCGATGCCGCTCCACTCCAATTCTTGGCTCCATACTCTGGATGCG
OSMA 261 CCCTCGCATCCAGAGTATGGAGCCAAGAATTGGAGTGGAGCGGCATCGGAG
ddx-35
OSMA 238 GTATTTTGCGTACTTTTGGGGC
OSMA 239 GCGCGGAATATAGTCATGTTG
OSMA 240 GTAATAGTGTCCACCGAACTCGAGATGCCATTCAGGCTCAATAAC
OSMA 241 GAATGGCATCTCGAGTTCGGTGGACACTATTACGAATTTGGC
OSMA 250 CTTGGTGCCAAATTCGTAATAGTG
OSMA 251 AAACCACTATTACGAATTTGGCAC
OSMA 252 CTTGGCCAATTCGTAAAGCCATTC
OSMA 253 AAACGAATGGCTTTACGAATTGGC
OSMA 254 CTTGGCCTGAATGGCTTTACGAAT
OSMA 255 AAACATTCGTAAAGCCATTCAGGC
OSMA 262 CTTGCCTTCGGTGCCAAATTCGTAATAGTGTGGAGCCAATTCGTAAAGC-
CATTCAGGCTCAATA
OSMA 263 CCCTTATTGAGCCTGAATGGCTTTACGAATTGGCTCCACACTATTACGAATTTG-
GCACCGAAGG
nhr-57
OSMA 266 GCGTACGTGATTAGTGGAAC
OSMA 267 CTCTGGAACCTCACAAATTTC
OSMA 294 CTCTCCATACCTTTTTCATTTCCC
OSMA 295 CTGGAACTCGGTGACTATGAC
OSMA 296 CACGTTTGGGACATTTGAAG
OSMA 297 GCATTTCTCACGTAGACTTCCTGG
OSMA 298 GTCATAGTCACCGAGTTCCAG
OSMA 299 CACAGCTGCTCAACGCAAATCCAG
OSMA 300 GACGTAACTTATTTGAGCGGG
OSMA 301 GTAGTTTGTGGCTCTTGGTGTC
tyr-2
OSMA 287 GCTTCAGCCTATTCCAGTTC
OSMA 288 GATTAAGGTGGAGTTAGCGTG
let-60
OTS 38 TCATTCTCCGTCGTCTTC
OTS 39 CATTTTTTTCAGTTCCAGCC
OTS 49 CCAAACTTCTGACTCATC
OMMO 127 CCCTTTGCTGTCTCACTGACT
OMMO 128 CATTTTTTTCAGTTCCAGCC
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bar-1
OTS 33 AGATAGACACACACACACAA
OTS 36 GAGCATTGTTGCATGTTGGA
OSMA 327 CTAACAACTTGGAAATGAAATCTTAGCAAAGCCGTGTCAAAACCC
OSMA 328 GTTCGCGAGCCACCAACATTAGGTTCGGATCCAGGTCCATCCCAGTTTTC
dpy-10
AF-ZF 827 CACTTGAACTTCAATACGGCAAGATGAGAATGACTGGAAACCGTACCGCAT-
GCGGTGCCTATGG
AF-ZF 831 GTCAGATGATCTACCGGTGTGTCAC
AF-ZF 832 GTCTCTCCTGGTGCTCCGTCTTCAC
rde-1 
OMW 207 CGACTTGCTTGCCAAACACTGATG
OMMO 247 ATCCACGAATCACTGGTGTC
OMMO 248 GTCGAGATTGACAGAACGAC
OEL 1 GGCATGCGATTCTCGAATGATGAC
cdk-5
OSN 108 AAGAGCATCCACAGTTTCGTAG
OSN 109 CAGTTCGTTGAATATTGAGTAGC
OSN 110 ATCGATTCTTCCTGCTGGATTGC
lin-2
OJE 61 CGCCTATGAAATCTCAGTTT
OJE 62 CGCGCATTTTCATAATTGCG
dpy-19
OMW 223 GCAGTAGAGAATGGAATCAGATCC
OMW 224 CTTGCATTTCTGTACCGCCCATTC
amx-2
OTS 149 AGGCTCAGGGTACATTTTAG
OTS 150 GTCGTTTCGGTTAATGATGG
sos-1
OAH 295 CAAGCAATTCAAGCAACTGG
OAH 296 TGTCTTTCTCGTGGCGAGACC
sem-5
OAS 605 GATCACCTGATGAGTTGTCTTTCAAG
OAS 606 CAGCAATACTTCTGCGTCATTTCTTG
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ttr-11
OSN 7 GGTTCTTGAAATTCGACGCTC
OSN 8 TAAGTCCGTCCACAAACTGGC
mCherry
OEH 86 ATGGTCTCAAAGGGTGAAGAAG
OEH 87 CTTATACAATTCATCCATGCCAC
gfp
OSMA 81 CTTTTCACTGGAGTTGTCCC
OSMA 82 CCATGTGGTCTCTCTTTTCG
OJE 6 TTTGTATAGTTCATCCATGCC
OMW 280 GAAGTCAAGTTTGAAGGTGATACCC
Pegl-9::egl-9::tag
OSMA 264 CACCACCTCCTTCCACAAAC
OSN 73 GCATCACCTTCACCCTCTCC
opIs206[Phif-1::hif-1::gfp::hif-1 3’ UTR]
OSMA 79 GGGACAACTCCAGTGAAAAG
OSMA 80 CCACACAGTGCCAACTACTC
pSMa05 (Pbar-1::ERKyce::unc-54 3’ UTR)
OSMA 111 TAGCCAATTTCACACCTTTG
OSMA 112 CTATTTTTTCTCTTCATCCGGC
pSMa06 (Pdlg-1 in pDONRP4-P1r) 
OSMA 102 GGGGACAACTTTGTATAGAAAAGTTGAGCTGTACGACAGTTGCACATTCGG
OSMA 103 GGGGACTGCTTTTTTGTACAAACTTGGCTTCCTTCCTTCGGTGAGGCGTTC
pSMa09 (pie-1 3’ UTR in pDONRP2r-P3) and 
pSMa10 (Ppie-1::ERKyce::pie-1 3’ UTR)
OSMA 142 GGGGACAACTTTGTATAGAAAAGTTGGATCATTATTTCACTGATTTTCTTCAT
OSMA 143 GGGGACTGCTTTTTTGTACAAACTTGGCTGGAAAAGAAAATTTGATTTTTAA
OSMA 144 GGGGACAGCTTTCTTGTACAAAGTGGGATTTTGCCGTATTTTCCATATTTTGT
OSMA 145 GGGGACAACTTTGTATAATAAAGTTGCATATTCGAATACACTTCCAGAGTCG
OSMA 148 CGAAAGCGAAACAGAGACAG
OSMA 149 GAAGGTCGCTTTTTGGTCG
OSMA 150 GGTGTCGATTTACGAGCTTG
OSMA 151 GTAGGCAGCAGAATGTGTG
OSMA 152 GAGAAAACTACAGACACGGG
OSMA 153 CATTCAGCTTTTTTTGAGTCCG
OSMA 154 GCCTTTAAACCAACCGTAACC
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OSMA 155 GTTCACCCTTTTTCTCCAATG
OSMA 156 CCCAATCCGCTCTTTCTAAG
OSMA 168 CGCTAAAAACACTAATCACACG
OSMA 169 CTTTTGACGCCATTTTTTCTCG
OSMA 170 GGTAGTGCAAAGAAGCTTAAGG
pSMa11 (let-23(partial)::mCherry in pDONRP2r-P3) and
pSMa12 (Plet-23::let-23::mCherry-let-23 3’ UTR)
OSMA 179 CCGGTAGAAAAAATGGTCTCAAAGGGTGAAGA
OSMA 180 CTCTTCTGATGTTTCCTTATACAATTCATCCATG
OSMA 181 GAGACCATTTTTTCTACCGGTACCCTCCAAGG
OSMA 182 GAAACATCAGAAGAGGCTGAAG
OSMA 185 CGGAGCCTTTTGATTGTAAG 
OSMA 186 CCCAACAAATTTTCACCCAAC
OSMA 187 GTTTATGCGTTTCAAGGTGC 
OSMA 188 CTCGGATGGACCTGTTATGC 
OSMA 201 GAAGGCTGCGAACAAATTGATG
OSMA 202 GCCCTTCTTCACAAAATTTC
OSMA 203 GGAAAGGAAATTGGAGTCTG
pSMa13 (let-23(partial)::SECFP in pDONRP2r-P3)
OSMA 195 CCGGTAGAAAAAATGGTTTCTAAGGGAGAGG
OSMA 196 AACCATTTTTTCTACCGGTACCCTCCAAG
OSMA 197 CTCTTCTGATGTTTCGAGCTCATCCATTCCAAGGGTG
pSMa14 (let-23(partial)::YPet in pDONRP2r-P3)
OSMA 195 CCGGTAGAAAAAATGGTTTCTAAGGGAGAGG
OSMA 196 AACCATTTTTTCTACCGGTACCCTCCAAG
OSMA 198 CTCTTCTGATGTTTCAGCAGCGGTAAGGAACTCAAGAAG
pSMa15 (lin-3::TC)
OSMA 183 GTTTCAGAATCGTGTCTCTGTTGCCCAGGTTGCTGTCCTTCGTGGTTTCGT-
CAAGAACGTA
OSMA 184 AAACCACGAAGGACAGCAACCTGGGCAACAGAGACACGATTCTGAAACTTT-
TATTGATATTTG
OSMA 193 CTTAAACCGGCGGTTCGGAAGG
OSMA 194 CCGCCGGTTTAAGAGTCGACG
pSMa30 (Pmyo-2::mCherry::tetracysteine::unc-54 3’ UTR)
OSMA 283 ATGGATGAATTGTATAAGTGCTGCCCAGGATGCTGCTAGTACCCAGCTTTCTT-
GTACAAAG
OSMA 284 GAAAGCTGGGTACTAGCAGCATCCTGGGCAGCACTTATACAATTCATCCATGC-
CACCTGTCGAG
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pSMa31 (Pmyo-3::gfp::tetracysteine::unc-54 3’ UTR)
OSMA 292 CATGGATGAACTATACAAATGCTGCCCAGGATGCTGCTAGCATTCGTAGAATTC-
CAACTGAGCGCCGGTCGC
OSMA 293 GTTGGAATTCTACGAATGCTAGCAGCATCCTGGGCAGCATTTGTATAGTTCATC-
CATGCCATGTGTAATCCC
pSMa32 (Pnhr-57::nhr-57::gfp::nhr-57 3’ UTR)
OSMA 302 CTAACAACTTGGAAATGAAATCACCAACACCTTCTACACAGCTGC
OSMA 303 GTTCTTCTCCTTTACTCATTTGTCCATCAATGATTTTATAGATTTTGTCG
OMMO 76 ATGAGTAAAGGAGAAGAAC
OSMA 304 GAGATCTGGTTCAAATAGCTATTTGTATAGTTCATCCATGC
OSMA 305 GCTATTTGAACCAGATCTCTTC
OSMA 306 CAGTACGGCCGACTAGTAGGAATAAATCATCCCAAAGCCGTTTTTG
OMW 443 CTACTAGTCGGCCGTACTGAGGTGTTGTCGCTTTTATTGGG
OMW 405 ATTTCATTTCCAAGTTGTTAGCG
pSMa33 (Pbar-1::nhr-57::gfp::nhr-57 3’ UTR)
OSMA 326 ATGTTGGTGGCTCGCGAACGAAAATATTG
OSMA 327 CTAACAACTTGGAAATGAAATCTTAGCAAAGCCGTGTCAAAACCC
OSMA 328 GTTCGCGAGCCACCAACATTAGGTTCGGATCCAGGTCCATCCCAGTTTTC
Restriction enzymes from Roche or NEB were used and digests were carried out according to the 
manufacturer’s protocol. To remove parental plasmids after site-directed mutagenesis, the sam-
ple was digested with DpnI for 3 – 4 h prior to transformation. Digested fragments were purified 
from residual buffer and enzyme either by PCR purification using the GenElute PCR Clean-Up 
Kit (Sigma-Aldrich) or by gel extraction using the QIAquick® Gel Extraction Kit (Qiagen). Digested 
and purified fragments were checked on an agarose gel.
5.1.4 Restriction enzyme digest
Component Volume per reaction
10X restriction enzyme buffer 2 µl
Template DNA variable
Restriction enzyme 0.2 µl
ddH2O to 20 µl
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DNA fragments obtained by PCR or plasmid digest were sub-cloned into the pCR™-Blunt 
II-TOPO® vector (Invitrogen) according to manufacturer’s protocol and further modified 
where necessary. For Gateway® cloning (Invitrogen), purified PCR products were inser-
ted into the respective pDONR™ vector through the BP reaction. The MosSCI expression 
vectors were obtained by performing the Gateway® LR reaction with the destination vector 
pCFJ150.
5.1.5 Ligation of DNA into vector plasmid
Chemically competent cells (DH10B or Top10) stored at -80°C were thawed on ice for 10 min. 
For a re-transformation of plasmids, 0.5 μl of the construct were added to 100 μl cells. In case of 
ligation products, 20 μl of the ligation mix were used. The cells were left on ice for 10 min. The 
cells were heat-shocked at 42 °C for 1.5 min on a Thermocycler (Eppendorf), after which they 
were left to recover on ice for 2 min. 800 µl 2x TY medium without ampicillin were added and the 
cells were incubated at 37 °C for 30 – 60 min. Of bacteria transformed with a retransformation 
product, 50 μl were streaked onto agar plates containing 50 μg/ml antibiotic. Cells transformed 
with ligation products were pelleted in the micro-centrifuge for 2 min at 3500 rpm and the super-
natant was discarded up to 100 μl. The cells were resuspended and distributed on agar plates 
with antibiotic (50 μg/ml). Either plates were incubated overnight at 37 °C or over the weekend at 
room temperature to allow the growth of colonies.
5.1.6 Transformation of E. coli
In order to test the presence of a specific DNA sequence in previously transformed cells, a quick 
miniprep was performed. Single clones were picked from agar plates into 2 ml 2X TY containing 
50 μg/ml antibiotic and left to shake at 225 rpm and 37 °C overnight. The bacterial cultures were 
transferred to 1.5 ml Eppendorf Tubes® and pelleted in the micro-centrifuge for 2 min at 4000 rpm. 
The supernatant was discarded and per sample, 350 μl STET buffer were added. The pellet was 
dissolved by vigorous vortexing. To lyse the cells, 25 μl lysozyme solution (10 mg/ml in TE buffer) 
were added and the sample was inverted several times. The lysozyme was inactivated by the 
incubation at 95 °C for 1 min on a heating block. The cell lysate was centrifuged for 8 min at 4 °C 
and 14000 rpm and the cell remnants were removed with a toothpick. The DNA was precipitated 
by adding 30 μl NaAc (3M, pH = 5.2) and 300 μl isopropanol (100%). The samples were inverted 
several times and again centrifuged for 8 min at 4 °C and at 14000 rpm, after which the supernatant 
was discarded. To remove remaining isopropanol, the sample was centrifuged briefly and left to dry 
before the DNA pellet was resuspended in 40 μl TE buffer and allowed to dissolve at 40 – 50 °C 
using a heating block. For sequencing, 2 µl were used. 
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Midipreps were performed with the QIAGEN Plasmid Plus Kit (Qiagen), which was adapted 
slightly. A bacterial clone was incubated overnight while shaking at 225 rpm in 100 ml 2X TY me-
dium containing 50 μg/ml antibiotic. The bacterial culture was centrifuged at 6000 g for 15 min. 
The bacterial pellet was resuspended in 4 ml Buffer P1. 4 ml Buffer P2 were added and the 
sample was inverted several times. The mixture was incubated at room temperature for three 
minutes, during which the QIAFilter Cartridge was prepared. Subsequently, 4 ml Buffer P3 were 
added and mixed again thoroughly to neutralise the lysis. The lysate was poured into the barrel 
of the cartridge and incubated at room temperature for 10 min. Using the plunger, the cleared 
lysate was transferred into a 15 ml falcon tube containing 2 ml binding buffer BB. The sample 
was mixed and poured onto a filter column (using an extender). The liquid was drawn through the 
column by suction. The column was washed by applying 700 µl ETR buffer and suction. A second 
washing step was performed using 700 µl PE buffer and suction. To remove residual EtOH, the 
column was placed into a 2 ml tube and centrifuged at 14’000 rpm for 2 min. The column was 
inserted into a fresh 1.5 ml Eppendorf Tube® and 100 µl TE buffer were added onto the centre 
of the filter. After a brief incubation, the DNA was eluted by centrifuging at 14’000 rpm for 2 min. 
Since the quality of this sample was not yet satisfying, we additionally precipitated the DNA in 
the following way. Twice the volume of 100% ice-cold EtOH and 1/10 of the volume of NaAc 
(3M, pH = 5.2) was added and the sample left at -20 °C for 30 – 60 min. The sample was cen-
trifuged at 14’000 rpm for 20 min, the supernatant was removed carefully and the initial volume 
(100 µl) of TE was added. The concentration of the DNA was measured using the NanoDrop™ 
and adjusted to 1 µg/µl.
5.1.8 Midiprep
5.1.9 Site-directed mutagenesis
To insert specific mutations on a plasmid, overlapping primers of minimally 50 bp were designed 
(according to the Richard lab, https://openwetware.org/ (OpenWetWare 2017)). The mutation(s) 
of interest were positioned in both primers and at least four bases from the 5‘-terminus as well as 
at least eight bases from the 3‘-terminus. Each primer contained eight or more non-overlapping 
bases at the 3‘-terminus. Finally, both primers were placed such that they started and ended with 
a G or C. Mutagenesis was carried out in the BioRad MyCycler with the conditions below.
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Cycles Temperature Time
1x 98 °C 30 sec
30x 98 °C 10 sec
58 °C 30 sec
72 °C 30 sec / kb
1x 72 °C 5 - 10 min
12 °C ∞
Component 25 µl reaction
5X Phusion HF buffer 5 µl
10 mM dNTPs 2 µl
forward primer 100 ng
reverse primer 100 ng
Template DNA 100 ng
Phusion DNA Polymerase 0.2 µl
ddH2O to 25 µl
After the PCR the sample was digested with DpnI (NEB) to remove the methylated template 
plasmid and transformed into chemically competent DH10B or Top10 E. coli.
5.1.10 DNA sequencing
DNA sequence data was obtained through in-house Sanger sequencing. For this purpose, 
500 – 1000 ng plasmid DNA or 10 – 20 ng per 100 bp DNA obtained via PCR and 1 µM se-
quencing primer were delivered.  
5.1.11 DNA micro-injection
The injection mix containing 150 ng of DNA in 20 µl was cleaned using a filter column (Coxtar, 
SPIN-X Centrifuge Tube Filter, 0.45 µm Cellulose Acetate) and injected into the gonads of young 
adult hermaphrodites sticking to 2.5% agarose pads and covered in Halocarbon oil (700) as de-
scribed previously in (Mello et al. 1991). Injected animals were rescued with M9 buffer onto fresh 
plates seeded with OP50 E. coli and screened for transgenic progeny after a few days. 
5.1.12 Ballistic transformation
As an alternative to micro-injection or in case of big DNA constructs, worms were transformed by 
gene bombardment to obtain low-copy integrations. 
Equipment
Biolistic PDS-1000/He from BioRad
rupture discs 1100 psi
macrocarriers 
macrocarrier holders
stopping screens
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Settings
Gap distance: 1/4’’ 
vacuum: 27/28 inches Hg
Target shelf: second shelf from the bottom
To facilitate the screening of transformants, a worm strain defective in crawling (DP38, 
unc-119(ed3)) and a cloning vector containing the genomic unc-119 sequence was used. 
Worms were enriched by liquid culture. For this purpose, two confluent 6 cm NGM plates were 
added to 100 ml S-medium and supplied with 300 µl MgSO4 (1M), 300 µl CaCl2 (1M), 1 ml KCi-
trate (pH = 6), 1 ml trace metals, 100 µl cholesterol (5 mg/ml), 1 ml Pen/Strep (100X) and 100 µl 
nystatin (1000X). As a food source, highly concentrated Na22 E. coli were used. The bacteria were 
enriched overnight in a rich medium as listed below and concentrated ~ 40x. The worm culture was 
kept at 20 °C on a shaker at 150 rpm to ensure oxygenation. 
Component Amount / volume
Bacto tryptone 24 g
Yeast extract 48 g
Glycerol (50%) 16 ml
ddH2O to 2l
autoclave, cool to 60 °C, then add
KH2PO4 (pH = 6) 1 ml
When worms had grown to confluency and a lot of L4 to young adult worms were present, the 
culture was centrifuged at 1000 – 2000 rpm for 1 min, washed twice with M9 buffer and distribu-
ted evenly on two 10 cm NGM plates. To prevent the movement of the worms, the plates were 
dried on ice with the lid open. 
Prior to the collection of the worms, the gold beads were prepared (this step can be done up to 
one week before). For two bombardments, 16 – 17 mg gold beads were weighed into siliconised 
Eppendorf Tubes® (0.3 – 3 microns, Chempur) and 1 ml of 70% EtOH was added. The beads 
were mixed thoroughly in a homogenizer, briefly centrifuged and the supernatant was removed. 
The beads were then washed three times by adding 1 ml of ddH2O, mixing in the homogenizer 
and removing the supernatant after a brief spin. The streaks of gold were gently streaked down 
with the pipette tip. Finally, 170 µl of 50% glycerol were added. Optionally, the beads can be kept 
3 – 4 weeks at room temperature at this point. The beads were again mixed well using the ho-
mogenizer and distributed into two siliconised Eppendorf Tubes® (85 µl / tube). The beads were 
coated while being vortexed continuously, with a one min break in between the additions. 32 µl 
spermidine, 4 µg DNA and 80 µl CaCl2 (2.5M) were added and the final mixture was vortexed for 
five min. The beads were centrifuged briefly and the supernatant was removed from the centre. 
The beads were resuspended in 300 µl 70% EtOH and the gold streaks sticking to the tube wall 
were pushed down. The supernatant was removed again after spinning and 80 µl 100% EtOH 
5. Material and Methods
136
were added. The beads were vortexed for further five min. 
The macrocarriers were cleaned using pressurised gas and inserted into the holder. 10 µl of 
coated DNA beads were spread evenly on each macrocarrier and left to dry. The rupture disc 
(1350 psi) was prepared by dipping it in 100% isopropanol and drying with pressurised gas. The 
bombardment disc was assembled, inserted into the apparatus and the plate(s) with the dried 
worm culture was bombarded. 
The bombarded worms were left to recover for 1 – 2 h at room temperature. They were washed 
down with M9 into 15 ml falcon tubes, centrifuged at 1000 rpm for 1 min and the supernatant 
was removed leaving 4 ml. With a cut pipette tip, the worms were distributed onto 25 NGM plates 
(10 cm) next to the food at the edge of the plates. After approximately one week, crawling worms 
were searched and cloned to check for insertions.
5.1.13 Lysis of worms
Genomic DNA of worms was obtained by lysing 1 – 10 young adult hermaphrodites in 6 – 10 µl 
lysis mix. The lysis was performed in 0.2 ml Multiply® Pro Tubes (Sarstedt) in a PCR machine 
(BioRad MyCycler). 
Temperature Time
60 °C 1 hour
95 °C 10 min
12 °C ∞
Component Volume (for 10 µl)
10X lysis buffer 1 µl
Proteinase K (10 mg / ml) 0.6 µl
ddH2O 8.4 µl
5.1.14 Genotyping PCR assays
The genotyping of strains was performed by amplifying the genomic locus partially using NEB 
LongAmp Taq DNA Polymerase. The presence of a deletion was confirmed via gel electrophore-
sis and SNPs were verified via DNA sequencing after precipitation of the PCR product.
Locus Primer pair Size (mut) / (wt)
Sequencing 
Primer
F44F1.1(ok1765) OSMA26 / OSMA27 1.8 kb / 2.9 -
egl-9(sa307)
OSMA35 / 36
OSMA171 / 172 
1.0 kb / 1.2 kb
1.1 kb / 1.4 kb 
-
egl-9(n586) OSMA113 / OSMA114 0.6 kb OSMA113
egl-9(ia60) OSMA113 / OSMA114 0.6 kb OSMA113
hif-1(ia04)
OSMA48 / OSMA49
OSMA122 / OSMA123
0.5 kb / 1.7 kb
3.1 kb / 4.5 kb 
-
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hif-1(zh111)
OSMA122 / OSMA123
OSMA224 / OSMA225
1.0 kb / 4.5 kb 
2.0 kb / 4.4 kb 
-
vhl-1(ok161) OSMA50 / OSMA51 0.6 kb / 1.9 kb -
ahr-1(ia3) OSMA77 / OSMA78 1.9 kb / 3.0 kb -
Phif-1::gfp::hif-1(3’ UTR) OSMA79 / OSMA80 0.9 kb -
gfp OSMA81 / OSMA82 0.8 kb -
pha-1(e2123) OSMA117 / OSMA118 1.1 kb OSMA119
rrf-3(pk1426) OSMA120 / OSMA121 2.2 kb / 4.5 kb -
let-23(sy1) OSMA124 / OSMA125 1.0 kb OSMA126
cdka-1/p35(gm335) OSMA175 / OSMA176 4.0 kb / 5.7 kb -
amx-2(ok1235) OTS149 / OTS150 0.5 kb / 2.3 kb -
let-60(n1046) OTS38 / OTS39 0.8 kb OTS49
let-60(ga89) OTS38 / OTS39 0.8 kb OTS49
let-60(n2021) OMMO127 / OMMO128 0.5 kb OMMO127
bar-1(ga80) OTS33 / OTS36 0.5 kb OTS33 / OTS36
lin-10(e1439) OSMA159 / OSMA160 1.3 kb OSMA161
lin-7(e1413) OSMA162 / OSMA163 1.1 kb OSMA164
unc-119(ed3) OSMA165 / OSMA166 1.6 kb OSMA167
lin-45(sy96) OSMA199 / OSMA200 0.8 kb OSMA199
unc-32(e189) OSMA211 / OSMA212 0.8 kb OSMA213
Pegl-9::gfp::egl-9 3’ UTR OSMA264 / OSN73 0.5 kb -
nhr-75(tm4533) OSMA300 / OSMA301 0.5 kb / 1.0 kb -
tyr-2(ok1363) OSMA287 / OSMA288 1.0 kb / 1.9 kb -
rde-1(ne219) OMW207 / OEL1 5.6 kb OMW247
cdk-5(ok626)
OSN108 / OSN109 / 
OSN110
2.1 kb / 2.1 kb + 1.8 
kb
-
lin-2(n397) OJE61 / OJE62 2.0 kb / 9 kb -
lin-3(e1417) OMMO135 / OMMO136 0.5 kb OJE129
dpy-19(e1259) OMW223 / OMW224 0.7 kb OMW223
mCherry OEH86 / OEH87 0.9 kb -
sos-1(s1031) OAH295 / OAH296 0.3 kb OAH295
sem-5(n2019) OAS605 / OAS606 0.4 kb OAS605
ttr-11(tm3381) OSN7 / OSN8 0.5 kb / 0.8 kb -
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Position of introgression Primer sequence FLP (N2 to CB)
ZH1-01
TTTTGCGCGTCAAATATGTTGT
TGCTTTAACCTATATTTTGAATGCG
+3
ZH1-03
GACCCGACTGCCGTTCTAT
CTGCGTCTCCCTATGTTCG
-6
ZH1-05
GAAATCGATTCTTCATTCAGTT
GCCCCTGAAACCCGTGGT
+21
ZH1-06
TCAAGAAAAACGGTCATTATGCA
CATTGTATCGCACATCGAACG
+8
ZH1-08
GGGGAAAGCAAGATAGACTC
CGCTTCCGAACAACCACCT
+7
ZH1-09
CATATCGAAAATCAATCCCGTA
AGGAAAAATAAGCTGACCGAAT
+4
ZH1-15
GGCATTTTTTTGGTTCAACATTT 
CGAAGACTTCCTAAAAGAGTGGCA
-4 
ZH1-18a
AATATTTGATTGGATCGTCGCA
TTAGAAGTAAATTTGCAGTACCA
-5 
ZH1-22
CTCGTTGTGAGACTCTATGGAA
TCCATATTTTTTGGCTTCTGAGA
+4
ZH1-23
ATCAAATTTCTCTTGCCTTAATGAT
TAGGTGATTCATTTTTGCGGGAA
+2
ZH1-27
CACAGAAGTTTCGAAGTTACAG
AAATTGAGGTGGTATTTTCTCAT
+1
ZH1-34
GAAAAACAATCGCTACATAAAC
GCCTACACAGAAGAATTATGG
+1 
ZH3-02
ACATCACATCATAAGTCAAGC
AAAGTGAGAAATCTTGTCCAC
+3
ZH3-04
ATCAGCAGAGAATAGTTTCACA
CGAAATGAAGTGGGTATTTGAT
+3
ZH3-5a
CACTGAGGAGACGAGCATTT
AATGAAGATCAGAAATGAGCAA
+2
ZH3-10a
GAATTACCGCCATTTGCGTA
GTGGTGAAACGTGTGAAGACT
-4
ZH3-11
TCAACGTAGATCAAGCCGAA
CAACGTAGGTCGCCTTACA
+2
ZH3-12
AAATTGCCTGAAAACACCGAA
CAAGTATTTGGTAAATTGCCAA
+6
ZH3-23
GCGGTCAGTGCCAGAGCAT
TATGCAATGCAATTAAAAAATGTC
+1
ZH3-35
GAAAACAAGTAATCAATGCTGC
AAGAAGTTTCATGATTAAGGAC
+1
139
DNA methods
5.1.15 Genotyping by FLP mapping
FLP (fragment length polymorphism) mapping was carried out according to (“A universal method 
for automated gene mapping”) to determine whether the CB4856 Hawaiian or N2 Bristol se-
quence was present at a specific genomic position. For a schematic overview of the introgression 
lines created please consult section 3.1. The PCR was carried out using NEB LongAmp Taq DNA 
Polymerase as described above (5.1.2) with the cycle program below. 
Cycles Temperature Time
1x 95 °C 2 min
10x 95 °C 20 sec
61 °C 30 sec
Decrease by 0.5 °C / cycle
72 °C 45 sec
28x 95 °C 20 sec
56 °C 30 sec
72 °C 45 sec
1x 72 °C 5 min
12 °C ∞
For each introgression eight genomic positions were analysed as listed below. 
CB4856 introgression Loci
ewIR5 (Chr I) ZH1-18a, ZH1-03, ZH1-27, ZH1-34, ZH1-01, ZH1-22, ZH1-23, ZH1-15
ewIR9 (Chr I) ZH1-03, ZH1-27, ZH1-34, ZH1-01, ZH1-23, ZH1-15, ZH1-08, ZH1-06
ewIR10 (Chr I) ZH1-01, ZH1-22, ZH1-23, ZH1-15, ZH1-05, ZH1-08, ZH1-09, ZH1-06
ewIR10 (Chr III) ZH3-04, ZH3-02, ZH3-05a, ZH3-35, ZH3-10a, ZH3-23, ZH3-11, ZH3-12
ewIR17 (Chr I) ZH1-03, ZH1-27, ZH1-34, ZH1-01, ZH1-23, ZH1-15, ZH1-08, ZH1-06
5.1.16 Generation of an extra-chromosomal translational LET-23::mCherry 
reporter strain
A translational LET-23::mCherry reporter was created from a pre-existing LET-23::GFP reporter 
construct. mCherry was amplified from pCFJ90 with overhangs to allow insertion into pJE05 via 
Gibson assembly®. pJE05 was amplified accordingly and the fragments were assembled. The re-
sulting plasmid pSMa11 containing the partial let-23 sequence fused to mCherry in the Gateway 
vector pDONRP2r-P3 was used in a Gateway LR reaction with the 5’ and 3’ parts of let-23 (pJE06 
and pJE07) and the destination vector pCFJ150 to obtain the final reporter construct pSMa12. 
The construct was bombarded on the strain DP38 and transgenic lines were isolated. 
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5.1.17 Generation of hif-1(zh111) mutant worms
The Co-CRISPR method was applied according to (Arribere et al. 2014). The sgRNA sequence 
GATAGAAAAGTGAGTCCTAA was inserted into plasmid #46169 (PU6::unc-119_sgRNA) via si-
te-directed mutagenesis to obtain pSMa03. 25 ng/µl dpy-10 sgRNA (pJA58) was co-injected into 
N2 Bristol animals with 25 ng/µl of pSMa03, 500 nM of dpy-10(cn64) repair template AF-ZF-827, 
500 nM of OSMA89 and 50 ng/µl of pDD162. Candidate worms were selected from plates har-
bouring a large number of Rol progeny and analysed by PCR for deletions and further sequen-
cing. The zh111 deletion spans 2464 bp and removes exons three to five between the regions 
ATTTCAAAAAATTTTTGACA (upstream) and CTAAGTTAAAAAAACAACAG (downstream).
5.1.18 CRISPR/Cas9 to obtain pfd-3 deletion mutants
CRISPR/Cas9 was employed as described in (Friedland et al. 2013). The sgRNA sequen-
ces GCGGACAGTCTATCAGCACG (sgRNA1), GTCATATTCGACCATTACGT (sgRNA2), 
GAAAAAACGCAAAAAATTCG (sgRNA3) or GCCGCTCTCGCTGTCAATAA (sgRNA4) were in-
serted into plasmid #46169 (PU6::unc-119_sgRNA) via site-directed mutagenesis. The pfd-3 ge-
nomic sequence was amplified with OKJ1 and OKJ2, sub-cloned and BglII restriction sites were 
inserted using OKJ7/8 and OKJ9/10 to flank the CDS. The CDS was removed via an enzymatic 
restriction digest and the resulting plasmid was used as repair template. N2 Bristol animals were 
injected with 2x 25 ng/µl sgRNA plasmid (sgRNA1 and 2 or sgRNA3 and 4 respectively), 50 ng/µl 
Peft-3::Cas9-SV40 NLS::tbb-2 3’UTR, 50 ng/µl repair template and 5 ng/µl pCFJ104. The proge-
ny was screened for deletions by PCR using OTS121 and OTS122. To balance lethal deletions, 
the strain KR2151 was used.
5.1.19 Generation of an extra-chromosomal Pnhr-57::nhr-57(CDS)::gfp::nhr-57 
3‘ UTR reporter strain
A 1206 bp fragment upstream of the nhr-57 transcriptional start site was amplified together with 
the coding genomic region (without the stop codon) using the primers OSMA302 and OSMA303. 
The gfp sequence was amplified from pPD95.75 using the primers OMMO76 and OSMA304. 
459 bp of the nhr-57 3’ UTR were amplified using the primers OSMA305 and OSMA306. A 
vector backbone containing a CB-unc-119(+) rescue as well as the AmpR gene was amplified 
using the primers OMW405 and OMW443. The four fragments were combined into a 10.170 kb 
plasmid (pSMa32) using Gibson Assembly®. N2 animals were injected (due to a mutation in the 
CB-unc-119(+) gene) with 5 ng/µl pSMa32, 2.5 ng/µl pCFJ104 and 100 ng/µl pBS. Transformants 
were isolated based on the presence of the co-injection marker.
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5.1.20 Generation of an extra-chromosomal Pbar-1::nhr-57(CDS)::gfp::nhr-57 3‘ UTR 
reporter strain
A 3237 bp fragment upstream of the bar-1 transcriptional start site was amplified using the pri-
mers OSMA327 and OSMA328. The nhr-57(CDS)::gfp::nhr-57 3’ UTR sequence within a vector 
backbone containing a CB-unc-119(+) rescue as well as the AmpR gene was amplified from 
pSMa05 using the primers OMW405 and OSMA326. The two fragments will be combined into a 
12.201 kb plasmid (pSMa33) using Gibson Assembly®. N2 animals will be injected (due to a mu-
tation in the CB-unc-119(+) gene) with 5 ng/µl pSMa33, 2.5 ng/µl pCFJ104 and 100 ng/µl pBS. 
Transformants will be isolated based on the presence of the co-injection marker.
5.2 Protein methods
5.2.1 SDS-PAGE
SDS-PAGE with subsequent Western blotting was performed using pre-cast Novex® Tris-Glycine 
Mini Gels (Invitrogen) with the XCell SureLock™ Mini-Cell Electrophoresis System including the 
XCell SureLock® Mini-Cell and the XCell II™ Blot Module. SDS gels were run at 100 V in freshly 
prepared 1X running buffer. MOPS buffer was used for the separation of medium- to large-sized 
proteins and MES buffer for small- to medium-sized proteins. Per genotype, 45 L4 larvae were 
picked into 15 µl 1x SDS loading buffer and proteins were denatured at 95 °C for 5 min. Samples 
were either frozen at -20 °C or centrifuged for 2 min at 14’000 rpm. 15 µl sample were loaded 
together with 5 µl Precision Plus Protein™ Dual Color Standards (Biorad).  
2X SDS loading buffer 100 mM Tris-HCL pH = 6.8, 4% SDS, 0.2% bromophenol blue, 
20% glycerol, 200 mM DTT / ß-mercaptoethanol
20X MOPS running buffer 104.6 g MOPS, 60.6 g Tris, 50 ml SDS (20%), 20 ml EDTA (0.5M), 
ddH20 to 0.5l
20X MES running buffer 195.2 g MES, 121.2 g Tris, 20 g SDS, 6 g EDTA, ddH2O to 1l
5.2.2 Western blot
SDS-PAGE gels were blotted onto PVDF membranes (Merck Millipore) of 5.5 x 8.5 cm using the 
XCell II™ Blot Module. While the gel was running, the blotting buffer and solution was prepared 
and cooled to 4 °C. The membrane was activated in 100% MeOH for 5 min and stored in blotting 
buffer at 4 °C until used. Blotting was carried out at 30 V for 1h at 4 °C. The membrane was remo-
ved from the gel sandwich and blocked in 4% milk/TBS-T for 2-4h at room temperature to prevent 
unspecific binding of antibodies. The membrane was probed with the 1° antibody diluted in 4% 
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milk/TBS-T while shaking at 4 °C overnight. The antibody was removed and the membrane was 
washed 3x 15 min with TBS-T at RT before the HRP coupled 2° antibody was added for 60 min 
at RT. The membrane was washed again with TBS-T 3x 15 min. The HRP reaction was activated 
using the Amersham™ ECL™ Western blotting detection kit (GE Healthcare) and the membrane 
was illuminated to visualise the protein bands and protein ladder. 
If a second protein of similar size was analysed, the horseradish peroxidase was inactivated by 
applying 15% H2O2 in TBS-T for 30 min. The membrane was washed extensively with TBS-T and 
probed with the second 1° antibody.
Transfer buffer 600 ml H2O, 150 ml 100% MeOH, 2.4 g Tris, 10.8 g glycine. Stir 
with magnetic stirrer to dissolve. 
5.2.3 Antibodies
Antibody Company Cat. No. Dilution
Monoclonal mouse anti-GFP Roche 11814460001 1:2000
Polyclonal rabbit anti-MAP Kinase (ERK-1, 
ERK-2)
Sigma-Aldrich M5670 1:5000
Monoclonal mouse anti-MAP Kinase, activated 
(dephosphorylated ERK-1&2)
Sigma-Aldrich M8159 1:1000
Polyclonal rabbit anti-alpha tubulin Abcam ab18251 1:2000
Monoclonal mouse anti-alpha tubulin Sigma-Aldrich T6074 1:2000
Polyclonal HRP goat anti-rabbit
Jackson Immuno 
Research
111-035-144 1:3000
Polyclonal HRP goat anti-mouse
Jackson Immuno 
Research
115-035-003 1:3000
5.2.4 Biarsenical labelling
Biarsenical labelling of tetracysteine tagged proteins was performed by adapting published pro-
tocols for staining with MitoTracker™, since the molecular weight of the molecules is comparable 
(MitoTracker™: 531.5 g/mol, TC-FlAsH™ (ThermoFisher Scientific): 664.5 g/mol, TC-ReAsH™ 
(ThermoFisher Scientific): 545.4 g/mol). At least one small NGM plate crowded with worms was 
washed into a 1.5 ml Eppendorf tube. After centrifugation at 1000 rpm for 1 min, the liquid was 
removed to 500 µl and 2.5 µl of the dye (2 mM) was added to obtain a working concentration 
of 10 µM. The tube was wrapped in aluminium foil. The sample was incubated for at least 8h at 
RT while shaking. The liquid was removed after briefly centrifuging and the sample was washed 
twice with BAL wash buffer (ThermoFisher Scientific) that had been diluted according to the 
manufacturer’s protocol. The worms were resuspended in H2O and transferred back to small 
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NGM plates seeded with OP50 E. coli. After 1h of recovery in the dark, the worms were imaged 
using standard fluorescence microscopy.
5.3 Animal Methods
5.3.1 Strains and general handling of C. elegans
C. elegans strains derived from either N2 Bristol (Brenner 1974) or CB4856 Hawaii (Wicks et al. 
2001) were maintained at 15 °C, 20 °C or 25 °C on NGM (Nematode Growth Medium) plates ac-
cording to standard methods (Brenner 1974). Unless otherwise noted, the mutations used have 
been described previously and are listed below.
5.3.1.1 Mutations
Linkage 
group
Allele Reference
Present in
strain
LG I:
lin-10(e1439)
F44F1.1(ok1765)
F44F1.3(ok1878)
H28O16.1(ok2203)
dpy-5(e907)
hT2 [bli-4(e937) let-?(q782) qIs48]
gon-2(ok465)
ceh-6(ok3388)
hIn1 [unc-54(h1040)]
(Whitfield et al. 1999)
(Consortium 2012)
(Consortium 2012)
(Consortium 2012)
(Thacker et al. 2006)
(McKim et al. 1993)
(Church and Lambie 2003)
(Consortium 2012)
(Zetka and Rose 1992)
CB1439
RB1497
VC1418
VC2824
BC13915, 
BC15199
several
VC1463
VC2666
KR2151
LG II:
let-23(sy1)
lin-7(e1413)
rrf-3(pk1426)
ttTi5605
(Aroian and Sternberg 1991)
(Simske et al. 1996)
(Sijen et al. 2001)
(Frøkjær-Jensen et al. 2008)
AH13
CB1413
NL2099
EG6699
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LG III:
unc-32(e189) lin-12(n137n720)
dpy-19(e1259) lin-12(n137)
pha-1(e2123)
cdka-1/p35(gm335)
unc-119(ed3)
tyr-2(ok1363)
cdk-5(ok626)
hT2 [bli-4(e937) let-?(q782) qIs48]
(Greenwald et al. 1983)
(Greenwald and Seydoux 
1990)
(Mani and Fay 2009)
(Juo et al. 2007)
(Maduro and Pilgrim 1995)
(Consortium 2012)
(Consortium 2012)
(McKim et al. 1993)
MT2343
MT2343
GS6387
AH4538
several
RB1272
RB814
several
LG IV:
let-60(n1046)
let-60(zh121)
let-60(zh122)
let-60(ga89)
let-60(n2021)
lin-1(n304)
lin-3(e1417)
lin-45(sy96)
(Beitel et al. 1990)
Maxeiner et al., unpublished 
data
Maxeiner et al., unpublished 
data
(Eisenmann and Kim 1997)
(Beitel et al. 1990)
(Beitel et al. 1995)
(Hwang 2004)
(Sternberg et al. 1993)
MT2124
AH3345
AH3340
SD551
MT4866
MT8022
CB1417
PS427
LG V:
sos-1(s1031)
egl-9(sa307)
egl-9(n586)
egl-9(ia60)
hif-1(ia04)
hif-1(zh111)
nhr-57(tm4533)
ttr-11(tm3381)
(Chang et al. 2000)
(Darby et al. 1999)
(Darby et al. 1999)
(Shao et al. 2009)
(Jiang et al. 2001)
Maxeiner et al., unpublished 
data
National BioResource Project
(Consortium 2012)
BC1925
JT307
MT1216
ZG448
CB6088
AH4533
FX04533
FX03381
LG X:
vhl-1(ok161)
rde-1(ne219)
sem-5(n2019)
bar-1(ga80)
lin-2(n397)
(Epstein et al. 2001)
(Qadota et al. 2007)
(Clark et al. 1992)
(Natarajan et al. 2004)
(Horvitz and Ferguson 1985)
CB6116
several
MT4755
EW15
MT397
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5.3.1.2 Transgenes
Linkage 
group
Transgene Reference
Present in
strain
LG I: ayIs4[Pegl-17p::NLSgfp; dpy-20(+)] (Burdine et al. 1998) NH2466
LG II: saIS14[lin-48p::gfp] (Johnson et al. 2001) AH472
LG III: zhIs4[lip-1::GFP, unc-119(+)] (Berset et al. 2001) AH142
LG IV:
zhIs038[let-23::gfp, unc-119(+)]
ayIs7[hlh-8::gfp fusion + dpy-20(+)]
swIs79[ajm-1::GFP, seamcell::GFP, unc-119(+)]
(Haag et al. 2014)
(Harfe et al. 1998)
(Mohler et al. 1998)
AH1779
PD4666
SU140
LG un-
known:
iaIs38[egl-9p::egl-9::tag + unc-119(+)]
sIs13915[rCes H28O16.1::GFP + pCeh361]
opIs206[Phif-1::hif- 1::gfp::hif-1(3’UTR)]
gaIs47[lin-31::mpk-1(gf); lin-31::D-mek(gf)]
(Shao et al. 2009)
(MCKAY et al. 2003)
(Sendoel et al. 2010)
(Lackner et al. 1994)
ZG494
BC15199
WS4274
SD573
extra-chromosomal:
iaEx101[egl-9p::egl-9(H487A)::tag + unc-119(+)] (Shao et al. 2009) ZG686
zhEx550[let-23::mCherry, unc-119(+)]
Maxeiner et al., unpub-
lished data
AH4568, 
AH4569, 
AH4570
zhEx418[lin-31::rde-1; myo-2::mCherry] (Haag et al. 2014) AH2927
sEx13915 [rCes H28O16.1::GFP + pCeh361] (MCKAY et al. 2003) BC13915
Ex?[elt-2p::rde-1; pRF4[rol-6(su1006)]] (Pilipiuk et al. 2009) OLB11
arEx1528[lin-31p::YFP::lin-45(+)]
(de la Cova and Gre-
enwald 2012)
GS6387
vhEx37[pttx-3::gfp + plin-31::gfp::lin-10]
Gauthier et al., unpub-
lished data
QR600
zhEx555[tetracysteine::lin-3 + Pmyo-2::mCherry]
Maxeiner et al., unpub-
lished data
AH4640
zhEx579[Pmyo-2::mCherry::tetracysteine]
Maxeiner et al., unpub-
lished data
AH4825
zhEx605[Pnhr-57::gfp::nhr-57 3’ UTR + Pmyo-
2::mCherry]
Maxeiner et al., unpub-
lished data
AH5707
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5.3.1.3 N2/CB4856 introgression lines
CB4856 introgressions as published in (Doroszuk et al. 2009) were used to obtain miRILs with 
either the let-60(n1046) or bar-1(ga80) allele. Specifically, we made use of the strains ewIR5, 
ewIR9, ewIR10 and ewIR17 (LG I). The raw mapping data of the obtained strains are listed and 
described in 3.1.
5.3.2 Crosses
To obtain homozygous mutant males plates with 20 L4 hermaphrodites were tightly sealed with 
parafilm and incubated at 30 °C for 5h to favour non-disjunction during meiosis and increase the 
incident of male sex to occur (adapted from Hodgkin 1993). After a few days, single males were 
enriched by crossing them to hermaphrodites of the same genotype. 15 hermaphrodites and five 
males were kept on an NGM plate with a small drop of E. coli OP50 for two days. Hermaphrodites 
were singled out and screened for male F1 progeny. Animals of the F1 generation were either 
used for further crossing or singled out for subsequent genotyping of the F2 generation.
5.3.3 Worm liquid cultures
To obtain large quantities of worms, e.g. for ballistic transformation, three to six small well-crow-
ded NGM plates were washed down into 100 ml of liquid medium as follows:
Amount Component
100 ml S-Basal
300 µl 1M MgSO4
300 µl 1M CaCl2
1 ml KCitrate pH = 6
1 ml 100X trace metals
1 ml 100X Pen/ Strep
100 µl 1000X Nystatin
100 µl Cholesterol (5 mg/ml)
4 ml Na22 worm food (see below)
Worm liquid cultures were incubated at 20 °C on a shaker at 150 rpm for approximately one week 
or until a sufficient number of worms was obtained. The superbroth media to prepare worm food 
consists of:
147
Animal Methods
Amount Component
24 g Bacto tryptone
48 g Yeast extract
16 ml 50% Glycerol
2 l ddH2O
The mixture was autoclaved and 100 ml KPO4 was added. The media were inoculated with Na22 
E. coli and grown overnight at 37 °C. The next day, the culture was centrifuged for 15 min at 
4000 rpm and the supernatant was discarded. The pelleted bacteria were dissolved in appro-
ximately 60 ml 2xTY and aliquoted into 15 ml falcon tubes that were stored at -20 °C.
5.3.4 Freezing of C. elegans
Freshly starved L1 larvae were washed down from three NGM plates with M9 and mixed with 
an equal amount of freezing solution (30% glycerine in S-basal, autoclaved). The worms were 
slowly cooled down to -80 °C using boxes filled with isopropanol. A few days later, a test vial was 
thawed to check for successful freezing. 
5.3.5 Cleaning of C. elegans
To clean contaminated C. elegans strains, ten gravid hermaphrodites were picked into a drop of 
1:1 (v/v) 10-15% sodium hypochlorite and 2M NaOH on a clean NGM plate. The following day, 
clean L1 larvae were picked onto fresh plates. 
To obtain more worms or to synchronise strains, animals were washed into 15 ml falcon tubes 
and centrifuged for 1 min at 1000 rpm. The supernatant was removed leaving 1 ml. 70 µl sodium 
hypochlorite (10-15%) and 200 µl 2M NaOH were added and the tube was gently rocked for 
8-10 min, until adult worms were dissolved. The cleaned eggs were washed three times by filling 
the tube with M9 buffer or ddH2O, centrifuging at 2000 rpm for 1 min and removing most of the 
supernatant. After the final washing step, 6 ml M9 buffer were added and the eggs were allowed 
to hatch overnight while rocking slightly.
5.3.6 RNAi
Gene knockdown via RNAi feeding was performed according to Kamath et al. (2003). HT115 
(DE3) E. coli RNAi clones were grown on agar plates containing ampicillin and tetracycline. The 
RNAi feeding plates containing 3 mM IPTG to induce expression of the dsRNA were prepared 
2-3 days prior to seeding of the bacterial clones (for recipe see table below). The bacterial clones 
were grown in 2xTY containing ampicillin overnight and 350 µl per IPTG NGM plate were applied. 
1-2 days later, approximately 10 synchronised L1 larvae were pipetted onto the RNAi feeding 
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plates and the F2 progeny was analysed (unless stated otherwise).
Protocol for 40 – 50 NGM RNAi feeding plates
Amount Component
1.5 g NaCl
1.25 g Peptone (Tryptone Peptone)
9.5 g Bacto Agar
0.5 l ddH2O
autoclave, when T = 55 °C add while stirring:
0.5 ml Cholesterol (5 mg/ml)
12.5 ml KPO4 buffer 1M, pH = 6
0.5 ml 1M MgSO4
0.5 ml 1M CaCl2
1.5 ml 1M IPTG
0.5 ml Ampicillin
The mixture was stirred using a magnetic stirrer for a few minutes and 10 ml medium per plate 
were poured into 6 cm petri dishes. 
5.3.7 Drug treatment on NGM plates
The experiments to treat C. elegans with drugs were adapted from (Wang et al. 2007; Locke et 
al. 2008; Romney et al. 2011; Ackerman and Gems 2012; Padmanabha et al. 2015). The drugs 
were dissolved to a stock concentration of 100 mM and distributed evenly to 6 cm NGM plates 
containing 10 ml medium. 
Amount for 100 mM stock Component
46.8 mg DIP (Sigma)
3000 µl EtOH
store at -20 °C, use within one month
47.4 mg CoCl2  6 H2O (Sigma)
1978 µl H2O
filter-sterilise, store at 2-8 °C
The working concentrations were 10 µM (500 µl of 0.2 mM dilution) and 1 µM (500 µl of 
0.02 mM dilution). The plates were left to dry for some hours during which time the worm food 
was heat-inactivated. We heat-inactivated previously concentrated Na22 E. coli prior to feeding, 
since i) bacterial growth is affected by the drugs and ii) we we wanted to prevent the emergence 
of bacterial drug metabolites. 
One bacterial clone was incubated in 250 ml 2xTY overnight at 37 °C. The following day, the 
bacterial culture was centrifuged for 15 min at 4000 rpm and resuspended in a total of 25 ml (10x 
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concentrated). Aliquots of 750 µl (sufficient for two NGM plates) were stored frozen at -20 °C and 
heat-inactivated for 1h in a 70 °C water bath prior to use. A small aliquot was streaked out onto an 
agar plate to check the efficiency of heat-killing. 350 µl heat-inactivated Na22 E. coli were pipet-
ted onto each NGM plate with or without drug and left to dry for one or two days, after which 10 
synchronised L1 larvae were added. The vulval induction index was scored in the F2 generation.
5.4 Instruments
DNA experiments
PCR machine BioRad Tetrad® 2 Thermal Cycler
Nanodrop NanoDrop® ND-1000 Spectrophotometer
Protein experiments
Western blot XCell SureLock™ Mini-Cell 
XCell II™ Blot Module
Microscopes
Fluorescent and Nomarski Leica DMRA, equipped with a cooled CCD camera 
(Hamamatsu ORCA-ER)
Dissecting scope Leica MS5
Fluorescence dissecting scope Leica MZDLIII
Injection scope Leica DM-IRB
Further instruments
Centrifuges Eppendorf Centrifuge 5804
Eppendorf Centrifuge 5417 R
Homogenizer Fastprep®-24, MP Biomedicals
5.5 Media and buffers
S-Basal 5.85 g NaCl, 50 ml KPO4, 1 l H2O
2xTY (pH = 7)
16 g Bacto Tryptone, 10 g Yeast extract, 5 g NaCl, ddH2O to 1 l, auto-
clave
KCitrate (1M, pH = 6)
21.01 g Citric acid monohydrate, adjust to pH = 6 with solid KOH (approx. 
17 g) fill to 100 ml with ddH2O, autoclave
KH2PO4 (1M, pH = 6)
136.1 g KH2PO4, adjust to pH = 6 with solid KOH (approx. 15 g), fill to 1 l 
with ddH2O, autoclave
KPO4 buffer (1M, pH = 6) 87.8 ml 2M KH2PO4, 12.3 ml 2M K2HPO4, 100 ml ddH2O
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Worm lysis buffer (10X)
500 mM KCl, 100 mM Tris (pH = 8.2), 25 mM MgCl2, 4.5% NP-40, 4.5% 
Tween 20, 0.1% Gelatine
M9
3 g KH2PO4, 6 g Na2HPO4, 5 g NaCl, ddH2O to 1l, autoclave and cool to 
55 °C, then add 1 ml MgSO4
STET 8% Sucrose, 5% Triton-X 100, 50 mM EDTA, 50 mM Tris (pH = 8)
50x TAE
242 g Tris base, 57.1 ml Glacial acetic acid, 100 ml 0.5M EDTA (pH = 8), 
ddH2O to 1 l
TE 2 ml Tris (1M, pH = 7.5), 0.4 ml EDTA (0.5M), 197.6 ml ddH2O
Trace metals
0.346 g FeSO4  7 H2O, 0.930 g Na2EDTA, 0.098 g MnCl2  4 H2O, 
0.144 g ZnSO4  7 H2O, 0.012 g CuSO4  5 H2O, ddH2O to 500 ml, auto-
clave, keep in dark at 4 °C
TBS-T 50 ml 1M Tris, 150 ml 5M NaCl, 2.5 ml Tween 20, 5 l ddH2O
5.6 Software used for data analysis
Leica operating software Openlab 5.0.1, VisiView®
Image processing ImageJ 1.48f
Adobe Illustrator CS6, Version 16.0.4
DNA analysis CLC Main Workbench 7
GeneMapper (AppliedBiosystems)
Statistical software R 3.3.3
Spyder 3.0.0 (The Scientific PYthon Development EnviRonment) 
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5.7 Python, R and ImageJ macro scripts
The following Python, R and ImageJ scripts can be found on the accompanying CD-ROM and 
are described briefly in the following table.
Name Purpose
bootstrapping_VI.R
Input data is bootstrapped 1000 times and mean and p values as well as 
the 95% confidence intervals are given.
evaluation_sgRNA.py
A DNA sequence is given as input and sgRNA sequences and their 
evaluation scores analysed according to Doench et al., 2014 are saved 
in an Excel sheet.
fishers_exact_test.py
Performs the Fisher’s exact test of independence to test whether propor-
tions of two variables are different from each other. 
bootdif.R
The difference of the mean of two samples is bootstrapped 1000 times. 
The output is the mean difference, the sample means and the 95% con-
fidence intervals. 
background_correction.ijm
The programme uses a folder containing sample and background imag-
es as an input. Using the “Calculator Plus” option in ImageJ, the sample 
images are background subtracted and saved in a new folder.
sorting_stages.ijm
The programme uses a folder with sample images of various cell stages 
and sorts the images into cell stage specific folders according to the 
user’s decision. 
zproject_1cs_allVPCs.ijm
zproject_2cs_allVPCs.ijm
zproject_4cs_allVPCs.ijm
Image stacks to quantify are opened and background subtracted. A z 
project is performed (“sum slices”) and the intensity values are mea-
sured within a selection given by the user. Programmes adapted for 1-, 
2- and 4-cell stages. 
stk_to_tiff.ijm
Macro opens images with file extension “.stk” and saves as “.tiff” files. 
This can be applied prior to other ImageJ applications that fail to work 
with “.stk”. 
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7.1 Supplementary data
Table 7.1. List of polymorphic genes within the QTL1A region in the bar-1(ga80) mutant background. 
Brackets indicate that several isoforms are affected by the SNP.
Gene
Sequence 
name
Amino acid change
rpn-10 B0205.3 [Asn75Thr, Asn75Thr]
- B0205.9 Val273Leu
- B0379.2 Ser85Cys
mut-16 B0379.3 [Ser449Phe, Ser445Phe, Ser445Phe]
- B0379.7 [Ala347Glu, Ala347Glu]
- B0511.12 Ala347Glu, Ser795Gly, Gly1307Glu, Ser186Gly
- B0511.14 His549Tyr
npp-14 C03D6.4 Glu4Asp, Ser773Ile, Thr930Ser, Ser1144Pro, Ser1157Pro, Leu266Phe
asfl-1 C03D6.5 His218Leu, Met230Val
lab-1 C03D6.6 Gly159Asp
- C04F12.1 Asn423Lys
fce-1 C04F12.10 [Ile124Val, Ile124Val]
- C04F12.6 Val170Ala
- C04F12.8 Asn70Ser
rnh-1.3 C04F12.9 Asn77Tyr
dao-5 C25A1.10 [Asp620Tyr, Asp345Tyr]
tag-272 C34B2.1 Ala56Thr
- C35E7.5 [Thr867Ala, Thr867Ala]
rig-5 C36F7.4 [Leu66His, Leu66His, Leu66His]
- F16C3.3 Asn203Ile
- F26E4.2 Glu113Ala
- F26E4.4 [Asp147Asn, Asp147Asn, Asp147Asn]
ncx-4 F35C12.2 Gly251Arg
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- F35C12.3
[Ser152Phe, Ser152Phe, Ser328Phe, Ser328Phe, Ser328Phe, Ser-
302Phe]
oct-1 F52F12.1 [Glu320Lys, Glu320Lys, Glu337Lys]
col-64 F52F12.2 Tyr50Phe
mom-4 F52F12.3 [Arg423Pro, Arg423Pro]
gpx-8 F55A3.5 Arg23Cys
- F59C6.14 [Gln139Arg, Gln102Arg]
- K07A1.1 Phe167Ser
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Table 7.2. Polymorphisms in selected genes. If several isoforms are affected by the SNP, they are 
indicated in brackets. Note that a SNP occurrence frequency of 80% was set as a threshold. 
Gene Sequence name Polymorphism
Q
T
L1
b 
re
gi
on
 
an
d 
as
so
ci
at
ed
pfd-31) T06G6.9 Ala5Val 
- F44F1.12) deletion
- F44F1.31)
Gly131Ser, His217Leu, Pro408Gln, Ala418Thr, Asp-
468Gly
amx-21) B0019.1
Leu617Pro, Asn535Ser, Thr532Ser, Arg521Gly, As-
n461Ser, Val410Ile
hy
po
xi
a 
re
sp
on
se
 
pa
th
w
ay
egl-91) F22E12.4 [Pro16Ser, Pro16Ser, Pro16Ser, Pro16Ser, Pro16Ser]
vhl-13) F38A6.3 none
hif-11) F38A6.3
[Lys258Arg, Lys258Arg, Lys258Arg, Lys258Arg, Ly-
s42Arg], splice site donor
aha-11) C25A1.11 none
E
G
FR
/R
A
S
/M
A
P
K
 p
at
hw
ay
lin-31) F36H1.4 none
let-231) ZK1067.1 none
sem-51) C14F5.5 none
sos-11) T28F12.3 none
lin-71) Y54G11A.10 none
lin-101) C09H6.2 none
lin-21) F17E5.1 [Glu536Asp, Glu195Asp]
let-601) ZK792.6 none
gap-13) T24C12.2 none
lin-451) T24C12.2 none
mek-21) Y54E10BL.6 none
mpk-13) F43C1.2 none
lin-311) K10G6.1 none
lin-11) C37F5.1 Ille63Thr
lin-151) unknown (WS261)
[Asp844Gly, Asp844Gly], 
Asn656Lys
N
O
TC
H
 
pa
th
w
ay
lin-121) R107.8 none
lip-13) C05B10.1 none
lag-21) Y73C8B.4 Ala227Val
lag-11) K08B4.1 [Asp342Asn, Asp340Asn]
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fu
rt
he
r 
ge
ne
s
- H28O16.11) none
nhr-571) T05B4.2 none
cdk-51) T27E9.3 none
cdka-1/
p353)
T27E9.3 none
ddx-351) Y67D2.6 Ille218Met
bar-13) C54D1.6 none
lin-391) C07H6.7 [Pro13Ser, Pro13Ser]
1) Sequence contains synonymous SNPs.
2) non-coding sequence (pseudogene).
3) Sequence does not contain any synonymous SNPs. 
7.2 Abbreviations
5-HIAA  5-Hydroxyindoleacetic acid
°C   Degree Celsius
1°   Primary
2°   Secondary
3°   Tertiary
AC   Anchor cell
Amp / Tet  Ampicillin / Tetracycline
AmpR   Ampicillin resistance gene
ANK  Ankyrin
bHLH  Basic helix-loop-helix
bp   Base pair
CaCl2  Calcium chloride
Cas  CRISPR-associated system
CB4856 C. elegans Hawaii strain
cDNA  Complementary DNA
CDS  Coding sequence
C. elegans  Caenorhabditis elegans
CGC   Caenorhabditis Genetics Center
Co2+  Cobalt ion
CoCl2  Cobalt chloride
CRISPR Clustered regularly interspaced short palindromic repeats
CSL   CBF1, Suppressor of Hairless, Lag-1, transcription factor
DIC   Differential interference contrast
DIP  2,2’-Dipyridyl
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Abbreviations
DLL  Delta-like ligand
DMOG  Dimethyloxalylglycine
DNA   Deoxyribonucleic acid
dNTP   Deoxyribonucleotide
dpy  Dumpy phenotype
DSB  Double strand break
5-HIAA  5-Hydroxyindoleacetic acid
°C   Degree Celsius
1°   Primary
2°   Secondary
3°   Tertiary
AC   Anchor cell
Amp / Tet  Ampicillin / Tetracycline
AmpR   Ampicillin resistance gene
ANK  Ankyrin
bHLH  Basic helix-loop-helix
bp   Base pair
CaCl2  Calcium chloride
Cas  CRISPR-associated system
CB4856 C. elegans Hawaii strain
cDNA  Complementary DNA
CDS  Coding sequence
C. elegans  Caenorhabditis elegans
CGC   Caenorhabditis Genetics Center
Co2+  Cobalt ion
CoCl2  Cobalt chloride
CRISPR Clustered regularly interspaced short palindromic repeats
CSL   CBF1, Suppressor of Hairless, Lag-1, transcription factor
DIC   Differential interference contrast
DIP  2,2’-Dipyridyl
DLL  Delta-like ligand
DMOG  Dimethyloxalylglycine
DNA   Deoxyribonucleic acid
dNTP   Deoxyribonucleotide
dpy  Dumpy phenotype
DSB  Double strand break
dsRNA  Double stranded DNA
DTC   Distal tip cell
E. coli   Escherichia coli
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EGF   Epidermal growth factor
EGFR   Epidermal growth factor receptor
egl   Egg-laying defective phenotype
EIF  Eukaryotic initiation factor
EPO  Erythropoietin
ER  Endoplasmatic reticulum
ERK  Extracellular-signal regulated kinase
EtBr   Ethidium bromide (DNA stain)
EtOH   Ethanol
eQTL  Expression quantitative trait locus
Fe2+  Ferrous
Fe3+  Ferric
F1  First filial generation
F2  Second filial generation
FAP  Familial adenomatous polyposis
FGF   Fibroblast growth factor
FGFR  Fibroblast growth factor receptor
FlAsH-EDT2 Fluorescin arsenical hairpin binder-ethanedithiol
FLP  Fragment length polymorphism
g   Gram
GAP  GTPase activating protein
GEF  Guanine nucleotide exchange factor
gf   Gain-of-function
GFP   Green fluorescent protein
GWAS  Genome-wide association study
h   Hour
H2O2  Hydrogen peroxide
HIF  Hypoxia inducible factor
HRE  Hypoxia response element
HRP  Horseradish peroxidase
InDel  Insertion/deletion
IPTG   Isopropyl ß-D-1-thiogalactopyranoside
Kan  Kanamycin
kb   Kilobases
kD  Kilo dalton
l  Liter
L1 - L4  Larval stage 1 to 4
LB   Lysogeny broth
let   LEThal
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Abbreviations
lf   Loss-of-function
lin   Abnormal cell LINeage
LIP   Lateral-singal-induced phosphatase
LNG  LIN-12, NOTCH, GLP-1
LNR  LIN-12/NOTCH Repeat
LOD  Likelihood of disequilibrium
LongAmp  Long amplification polymerase
M   Molar
MAPK   Mitogen activated protein kinase
Mb   Mega bases
mCherry  Red monomeric (m) fluorescent protein
mg   Milligram
min   Minute
miIL  Mutation included introgression line
miRIL  Mutation included recombinant inbred line
ml   Milliliter
μl   Microliter
µm  Micrometer
mm   Millimeter
mM   Millimolar
μg/ml   Microgram per milliliter
MosSCI  Mos1-mediated Single Copy Insertion
mRNA   Messenger RNA
ms   Millisecond
Muv   Multivulva phenotype
MW   Molecular weight
N2   N2 Bristol, wild-type C. elegans strain
NGM   Nematode Growth Medium
NLS   Nuclear localisation signal
nm   Nanometer
NICD   Notch intracellular domain
nt   Nucleotide
O2  Oxygen
ODDD  Oxygen dependent degradation domain
oligo   Olignucleotide
ORF   Open reading frame
ORFeome  Complete set of open reading frames in a genome
P0  Parental generation
PAGE  Polyacrylamide gel electrophoresis
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PAS  Per, ARNT, Sim
PCR   Polymerase chain reaction
Pen / Strep  Penicillin / Streptomycin
PEST  Sequence rich in Pro (P), Glu (E), Ser (S) and Thr (T)
PHD  Prolyl hydroxylase domain
PI3K  Phosphoinositide 3-kinase
PLC  Phospholipase C
Pn.a cells  Neuroblast cell lineage
Pn.p cells  Ventral ectodermal blast cells
Pvl   Protruding vulva phenotype
QTL  Quantitative trait locus
RAM  RBPJ-associated
RAS  Rat sarcoma
RCC  Renal cell carcinoma
ReAsH -EDT2 Resofurin arsenical hairpin binder-ethanedithiol
rf  Reduction of function
RIL  Recombinant inbred line
RNA  Ribonucleic acid
RNAi   RNA interference
Rol  Roller phenotype
ROS  Reactive oxygen species
rpm   Rounds per minute
RSK  Ribosomal protein S6 kinase
RT  Room temperature
RTK   Receptor tyrosine kinase
s   Second
SDS  Sodium dodecyl sulfate
sgRNA  Single guide RNA
SLiCE  Seamless Ligation Cloning Extract
SNP  Single nucleotide polymorphisms
STET   Saline / Tris / EDTA / Triton
synMuv Synthetic Multivulva
TAD  Transactivation domain
TAE   Tris / glacial acetic acid / EDTA
TC  Tetra-cysteine
TE   Tris-EDTA
TM  Transmembrane
TY   Trypton yeast extract
unc   Uncoordinated movement phenotype
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Abbreviations
UPR  Unfolded protein response
UTR  Untranslated region
UV   Ultraviolet
VEGF  Vascular endothelial growth factor
VEGFR Vascular endothelial growth factor receptor
VHL  Von Hippel-Lindau
VI  Vulval induction index
VPC   Vulval precursor cell
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7. Appendix
194
7.3 Curriculum vitae
SABRINA MAXEINER 
 
Margrit-Rainer-Strasse 11A 
8050 Zurich 
sabrina.maxeiner@gmail.com 
Mobile +41 76 595 36 33 
Date of birth: 28.02.1990 
Swiss / German 
 
 
Strengths in the preparation and implementation of project ideas. 
Solid communication skills adapted to the level of the counterpart. 
Reliable, highly organised and independent.   
 
PROFESSIONAL EXPERIENCE  
01/2013 - present University of Zurich, Institute of Molecular Life Sciences 
Doctoral Researcher 
• training and mentoring of a master student and several 
semester students 
• coordination of a small team of experts to plan and craft 
customized experimental gas chambers 
• presentation of project outcomes at international 
conferences 
 
06/2016 – present Life Science Learning Center (LSLC), Zurich 
Teacher 
• Running of practical biology courses for high school 
students and teachers 
• Introducing high school students to research at university 
 
04/2012 – 12/2012 SUBWAY® Zurich 
Sandwich Artist® and Assistant to the Store Manager 
• Regular inspections of equipment and fixtures 
• Solicitation of customer feedback and ensuring customer 
satisfaction 
• Spontaneous deputizing during rush hours in nearby 
subsidiary  
 
06/2012 – 08/2012 University of Zurich, Institute of Molecular Life Sciences 
Scientific assistant 
• Internship in developmental biology, completion with 
highest grade 
 
195
Curriculum vitae
07/2011 – 09/2011 University of Zurich, Institute of Molecular Life Sciences 
Scientific assistant 
• Internship in cellular and molecular biology, completion 
with highest grade 
• Autonomous work in strict compliance with the guidelines 
as defined by the Good Laboratory Practice 
EDUCATION 
 
01/2013 – present University of Zurich, Institute of Molecular Life Sciences 
• Master & Doctoral study within the Fast Track program for 
outstanding students  
 
09/2009 – 08/2012  University of Zurich 
• Bachelor studies in natural sciences in biology, grade: 5.7  
 
03/2009 – 06/2009 English Language College Langports, Brisbane, Australia 
• Certificate of Advanced English (CAE), C1 
• Certificate in Proficiency of English (CPE), C2  
AWARDS 
 
2009   Schweizer Jugend forscht  
• High school thesis judged among the 50 best in the Canton 
of Zurich 
2009   SRF Einstein 
• Audience award, 3rd position for presentation of high school 
thesis 
LANGUAGES 
 
German (native language) 
English (C1)  
French (B2) 
COMPUTER SKILLS 
MS Office Suite  
Statistical software: R, Python, MATLAB  
Image processing software: Adobe Illustrator, Fiji 
 
References available upon request.  
7. Appendix
196
7.4 Acknowledgements
This thesis would not have been possible without a number of people and I would like to leave a 
few words to express my cordial thanks to all these who have accompanied me through the past 
years and supported me in achieving my goals. 
Firstly, my thanks go to Prof. Dr. Alex Hajnal who guided me through the turmoil of a doctoral 
thesis and helped me follow a satisfying path. I am grateful for the valuable time he sacrificed to 
discuss scientific issues, his open ear and understanding in non-work related trouble, his never-
ending optimism and his knack for motivating people over and over again. He is not only our boss 
and slightly absent-minded professor, but also the “lab dad” who takes care of his students and 
the working atmosphere. 
Further, my thanks go to all present and former members of our lab who contributed to a lively 
atmosphere. Erika Fröhli, the good spirit and organised “lab mum” apparently knew a solution to 
any problem be it work-related or private, and the world seemed lighter after talking to her. She 
turned tears and anger into relief and laughter. The lab lost a great person when she left for her 
well-earned retirement. Irene Hofmann, although working in the adjacent building and therefore 
physically a little more distant, is the woman who truly keeps things running. She eliminated and 
reminded of administrative issues before they could arise and in that saved me a large amount of 
labour and trouble. Special thanks go to Dr. Michael Walser who fortunately decided to re-join our 
lab as a Postdoc after a temporary position at the hospital and with whom I had the luck to share 
an office. His enthusiasm, motivation and humour brought me back to a work-mode smoothly 
and softly every Monday morning that tends to arrive incredibly quickly. Thank you for your trust, 
the discussions that were sometimes deep, sometimes silly and relaxing and sometimes heavy. 
I would argue that his expertise in Adobe as well as lab techniques has saved many nerves and 
experiments – not only mine but of the entire lab. More special thanks are dedicated to Michael 
Daube, who fortunately joined our lab as a technician after his time in the Hengartner lab. He is 
the slightly odd bird and there is always an anecdote in stock. Whenever there was something 
missing, he immediately took care of it, he invested intense time and effort to provide us with 
protocols, lists, material, in short with whatever is necessary. I speak for the institute when I say 
you enrich any good week and save any bad week with the regular TGIFs, not only because 
you organise them but because how you organise them – with so much care and attention that 
everyone feels at ease. 
Moreover, my thanks address Dr. Juan Miguel Escobar, he was always up for a discussion – with 
or without cafecito. I am grateful to Jonas Hartmann for his direct way and valuable discussions 
about science, private life and how future might look like, to Sabrina Steiert for the close friend-
ship we could establish during our time together in the lab, to Dr. Qiutan Yang for her contagious 
light-heartedness, to Dr. Daniel Roiz for sharing his extensive scientific knowledge and for spea-
king his mind, to Dr. Matthias Morf for scientific support, Charlotte Lambert, Philipp Leu, Dr. Itay 
197
Acknowledgements
Nakdimon and Dr. Stephanie Nusser-Stein for their contribution to such a nice atmosphere. I 
thank Adrian Henggeler, the “coffee-bell” in the morning, for his friendliness, easiness and hu-
mour that so often compensated for failed experiments or a bad mood and I thank Andrea Haag 
for her cheeriness and fun company with a glass of wine or two. Another thank you goes to Lou-
isa Mereu who conveyed the ease with which she managed work and family to the lab and eve-
ryone working therein, to Silvan Spiri for an awesome teamwork in teaching high school classes, 
scientific and private discussions and the musical instrument equipment via the family business 
and to Aleksandra Fergin for her impressive mix of funny, serious, honest and dedicated attitude. 
I am grateful to our Ticino-Italy fraction presented by Tea Kohlbrenner and Svenia Dilaria Heinze 
– with you ladies, no problem seems to exist and I would not miss the times we spent at the TGIF 
in having a good time and forget bad days. Still further thanks go to Dr. Evelyn Lattmann for her 
persistent good mood and helpfulness, to Dr. Tinri Aegerter-Wilmsen for interesting non-science 
related discussions about everything and anything, to Christoph alias Stefan alias Christian alias 
Whatevercomestomind Umbricht for his wittiness and sarcasm, to Ting Deng, to Steve Grein, to 
Elisa Pircher and to Kirsti Arumae. I would like to mention here and thank Giuseppe Ianiri and 
Hatip Zenuni for their provision of worm and bacteria plates as well as media. Without their sup-
port, the lab would not be running as smoothly as it was and is. 
There are several students who have closely worked with me and supported my work. I had the 
honour to guide Seraina Boetschi through her Master thesis and although experiments did not 
work out as intended, she pursued her goals and managed to find her way out of disappoint-
ments. She is not only a great colleague to work with, but became a dear friend and I am happy 
that she does not work far away and comes over for visiting us frequently. Katharina Jovic spent 
several months with us to work on the RNAi screen to find modifiers of WNT and RAS/MAPK 
signalling and did so with great success. I value the discussions and fun moments I shared with 
her. Judith Grolleman is a person who always bounces back and has indulged us with her exube-
rant attitude and baking qualities. It was an indescribable experience to witness and attend her 
personal and scientific development, through which she became a dear friend. Finally, I want to 
thank Kateřina Apolínová, the summer entertainer of our lab. She spent nine weeks with us and 
worked with me on the RNAi screen while developing her scientific confidence and bringing life 
into the lab. 
I would like to express my gratefulness to Reto Maier and Daniel Schnarwiler. They have helped 
in designing the hypoxic chambers, provided all the material necessary and most importantly, 
manufactured them and supported me with in troubleshooting. Without you, the project would 
have taken another direction and I am relieved it did not. Along the line, I want to thank Dr. Tanja 
Restin who carried out the initial hypoxia experiments with me by providing her own material. She 
did not only kick-start the story on hypoxia, but also took me for a coffee and shared scientific 
knowledge with me. 
I was accompanied and support by the members of the thesis committee meeting and I have to 
say I chose them well. I highly appreciated the yearly meetings to discuss the progress of my 
7. Appendix
198
work but also to spend intense and interesting hours to define further steps. A cordial thank you 
to Prof. Dr. Konrad Basler for his always realistic input and sincere support, to Prof. Dr. Beatrice-
Beck Schimmer for her reassuring smile and warmth and to Prof. Dr. Jan Kammenga who came 
from the Netherlands to share his ideas and constructive comments. 
Although the Hengartner lab was gradually closed, I had the pleasure to work with several peo-
ple still. Thanks go to Luca Ducoli for his cheeriness combined with scientific seriousness, to 
Dr. Sergio Pinto for sharing his extensive scientific knowledge, to Dr. Deni Subasic for the fun 
moments we had as lab bench mates, to Polina Kamkina for the fun times in the lab and during 
social events and to all former lab members. 
Prof. Dr. Daniel Kiper, Dr. Alex Butschi, Helen Stauffer and Claudia Bischoff gave me the oppor-
tunity to enrich my doctoral thesis with the regular supervision and tuition of high school classes 
and offered me the freedom to shape the lessons or create courses. I am grateful not only for 
this experience but also for the numerous times when I was able to receive the most valuable 
present: Gratefulness and interest of students and their teachers. 
Last but certainly not least, there are my family and friends. They have guided me, caught me 
in tough times, cheered me up, brought me back to reality – they have lived the years with me. 
My dear partner and friend Tobias Schmid probably had to endure most of my moodiness but is 
still there with me. Thank you Tobi for being there whatever the situation, for giving me advice, 
reassurement and togetherness. I want to thank my brother Sascha and my dad Harald for their 
realistic view of the world and their ability to calm me in emotional crises, my mom Cornelia and 
Sascha’s partner Lina for their warmth and emotional support. On the Schmid family side, I want 
to thank Vreni and Guido, Fabian and Ines as well as the little naughty boys Mats and Levi for 
fun times with games, cats, beer and wine. I want to thank all of you for being a family to me and 
enriching life. 
It has been and is a pleasure to work with all of you and have you by my side respectively. Alt-
hough there were periods where times seemed to stand still, the past five years have flown by 
and became filled with invaluable memories that I will gladly keep with myself. I want to close by 
stressing that although in the end, I had to undertake the doctoral adventure by my own, I would 
not have succeeded in passing the “finish line” of that curvy marathon without all of you. 
Danke, Thank you, Merci, Grazie, Kiitos.
                      Zurich, February 2018
199
